<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.europeanpharmaceuticalreview.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.3.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.6" -->
<!-- generated-on="February 2, 2012 10:39 am" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/</loc>
		<lastmod>2011-04-19T09:04:27+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10994/events/industry-events/development-and-validation-of-bioanalytical-assays-for-biologics-quantification-pk-and-immunogenicity-assays/</loc>
		<lastmod>2012-02-02T10:39:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazenecas-new-restructuring-initiatives-to-drive-productivity-and-support-innovation/</loc>
		<lastmod>2012-02-02T10:00:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/</loc>
		<lastmod>2012-02-01T15:44:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/</loc>
		<lastmod>2012-02-01T12:02:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/</loc>
		<lastmod>2012-02-01T09:46:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/</loc>
		<lastmod>2012-01-31T11:15:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/</loc>
		<lastmod>2012-01-31T11:03:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/</loc>
		<lastmod>2012-01-31T11:00:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10941/news/industry-news/dndi-and-abbott-expand-partnership-to-boost-innovation-for-neglected-tropical-diseases/</loc>
		<lastmod>2012-01-31T10:57:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/</loc>
		<lastmod>2012-01-31T10:33:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/</loc>
		<lastmod>2012-01-31T10:14:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10946/news/industry-news/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases-by-2020/</loc>
		<lastmod>2012-01-31T10:09:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10937/news/industry-news/ascend-study-to-evaluate-the-effectiveness-of-tysabri-natalizumab-as-a-treatment-for-spms/</loc>
		<lastmod>2012-01-30T12:03:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10934/news/industry-news/roche-commences-tender-offer-for-illumina-inc-for-44-50-per-share-in-cash/</loc>
		<lastmod>2012-01-30T11:56:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10931/news/industry-news/pfizer-announces-fda-acceptance-of-new-drug-application-for-bosutinib/</loc>
		<lastmod>2012-01-30T11:52:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10928/news/industry-news/u-s-food-and-drug-administration-approves-pfizers-inlyta-axitinib/</loc>
		<lastmod>2012-01-30T11:41:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10921/news/industry-news/boehringer-ingelheim-launches-lean-to-clinic-program-for-fast-drug-product-supply/</loc>
		<lastmod>2012-01-30T11:30:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10919/news/industry-news/roche-responds-to-adoption-of-shareholder-rights-plan-by-illumina-board-of-directors/</loc>
		<lastmod>2012-01-30T11:21:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10916/news/industry-news/gsk-announces-changes-to-the-board/</loc>
		<lastmod>2012-01-30T10:04:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10914/news/industry-news/amgen-to-acquire-micromet/</loc>
		<lastmod>2012-01-30T09:56:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10911/news/industry-news/new-fda-approved-labeling-for-vytorin-ezetimibesimvastatin/</loc>
		<lastmod>2012-01-26T12:05:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10908/news/industry-news/boehringer-ingelheim-moves-into-phase-iii-for-its-head-and-neck-cancer-trial-programme-for-afatinib/</loc>
		<lastmod>2012-01-26T11:57:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10902/news/featured-news/syrris-custom-reactors-built-for-you/</loc>
		<lastmod>2012-01-26T11:37:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10898/news/industry-news/elanco-animal-health-announces-lillys-agreement-to-acquire-chemgen-corp/</loc>
		<lastmod>2012-01-25T11:06:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10896/news/industry-news/roche-offers-to-acquire-all-outstanding-shares-of-illumina-inc-to-further-strengthen-its-leading-role-in-diagnostics/</loc>
		<lastmod>2012-01-25T11:01:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10894/news/industry-news/novo-nordisk-establishes-type-1-diabetes-rd-center-in-seattle/</loc>
		<lastmod>2012-01-25T10:54:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10891/news/industry-news/bristol-myers-squibb-names-gerald-l-storch-to-board-of-directors/</loc>
		<lastmod>2012-01-25T10:49:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10881/news/industry-news/genzyme-announces-fda-approval-of-framingham-manufacturing-plant/</loc>
		<lastmod>2012-01-24T11:36:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10475/events/industry-events/lyophilization-technology-practical-application-of-the-scientific-principles/</loc>
		<lastmod>2012-01-23T16:20:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10868/news/industry-news/novartis-drug-signifor-recommended-by-chmp-for-eu-approval-to-treat-patients-with-cushings-disease/</loc>
		<lastmod>2012-01-23T11:52:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10866/news/industry-news/fda-updates-tysabrir-natalizumab-label-to-include-anti-jcv-antibody-status-as-a-pml-risk-factor/</loc>
		<lastmod>2012-01-23T11:40:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10860/news/industry-news/chmp-recommends-eu-approval-to-update-novartis-drug-glivec-label-to-include-three-year-treatment-for-gist-patients-after-surgery/</loc>
		<lastmod>2012-01-23T11:34:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10857/news/industry-news/roche-supports-cancer-care-development-program-in-ethiopia/</loc>
		<lastmod>2012-01-23T11:28:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10853/news/industry-news/merck-resolves-vioxx-litigation-in-canada/</loc>
		<lastmod>2012-01-20T09:52:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10850/news/industry-news/bristol-myers-squibb-announces-charitable-donation-of-6-9-million-to-support-cancer-patients/</loc>
		<lastmod>2012-01-20T09:49:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10711/news/featured-news/bw-tek-celebrates-15-years-of-providing-innovative-solutions-for-photonics/</loc>
		<lastmod>2012-01-20T09:16:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10837/news/featured-news/foss-releases-new-features-for-vision/</loc>
		<lastmod>2012-01-20T09:13:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10458/events/industry-events/pharma-outsourcing-procurement-summit-2012/</loc>
		<lastmod>2012-01-19T16:28:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10831/news/featured-news/bw-tek-to-introduce-spectral-data-acquisition-software-at-spies-bios-photonics-west-exhibits/</loc>
		<lastmod>2012-01-19T15:58:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/email-newsletter-archive/</loc>
		<lastmod>2012-01-19T15:41:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10823/news/industry-news/u-s-food-and-drug-administration-approves-new-formulations-of-viread-for-use-by-children-living-with-hiv/</loc>
		<lastmod>2012-01-19T11:40:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10814/news/industry-news/brazil-introduces-inactivated-polio-vaccine-in-national-immunization-program-with-sanofi-pasteur-vaccine/</loc>
		<lastmod>2012-01-19T11:12:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10807/news/industry-news/roy-d-baynes-md-phd-to-join-gilead-sciences-as-senior-vice-president-oncology-therapeutics/</loc>
		<lastmod>2012-01-19T10:54:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10802/news/industry-news/sandoz-initiates-two-more-phase-iii-biosimilar-trials-reinforcing-long-term-global-leadership-commitment/</loc>
		<lastmod>2012-01-19T10:40:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10798/news/industry-news/first-hepatitis-c-treatment-data-demonstrating-proof-of-principle-with-direct-acting-antiviral-only-therapy-published/</loc>
		<lastmod>2012-01-19T10:34:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10794/news/industry-news/astrazeneca-and-bristol-myers-squibb-receive-complete-response-letter-from-us-food-and-drug-administration-for-dapagliflozin/</loc>
		<lastmod>2012-01-19T10:27:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10791/news/industry-news/abbotts-starlims-lims-technology-to-be-installed-in-fda-testing-laboratories/</loc>
		<lastmod>2012-01-19T10:22:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/contact-us/</loc>
		<lastmod>2012-01-18T14:54:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10786/news/industry-news/daiichi-sankyo-receives-approval-in-japan-to-market-ranmark/</loc>
		<lastmod>2012-01-18T09:38:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10780/news/industry-news/novartis-receives-approval-for-lucentis-and-launches-galvus-in-china-two-innovative-therapies-that-support-public-health-goals/</loc>
		<lastmod>2012-01-18T09:31:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10775/news/industry-news/genzyme-announces-european-approval-of-framingham-manufacturing-plant/</loc>
		<lastmod>2012-01-18T09:22:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10772/news/industry-news/medivation-and-pfizer-announce-results-from-phase-3-concert-trial-of-dimebon-in-alzheimers-disease/</loc>
		<lastmod>2012-01-18T09:15:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10768/news/industry-news/gilead-sciences-completes-acquisition-of-pharmasset-inc/</loc>
		<lastmod>2012-01-18T09:09:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10763/news/industry-news/pan-european-stroke-prevention-in-atrial-fibrillation-registry-prefer-in-af-enrols-first-patient/</loc>
		<lastmod>2012-01-17T15:13:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10756/reports/product-insight-country-and-industry-analysis/</loc>
		<lastmod>2012-01-17T14:37:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10759/reports/ultimate-go-to-guides-for-reliable-insights-on-the-consumer-industry/</loc>
		<lastmod>2012-01-17T14:36:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10752/reports/product-insight-company-profiles/</loc>
		<lastmod>2012-01-17T14:24:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10748/reports/united-kingdom-pharmaceuticals-industry-guide-2011/</loc>
		<lastmod>2012-01-17T14:17:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/next-issue/</loc>
		<lastmod>2012-01-17T14:15:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10274/reports/biotechnology-global-industry-guide/</loc>
		<lastmod>2012-01-17T12:31:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3701/reports/the-future-of-molecular-diagnostics-innovative-technologies-driving-market-opportunities-in-personalized-medicine/</loc>
		<lastmod>2012-01-17T12:29:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3722/reports/drug-discovery-collaborations-between-academia-and-the-pharmaceutical-industry/</loc>
		<lastmod>2012-01-17T12:29:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3729/reports/innovations-and-opportunities-in-therapeutic-vaccines/</loc>
		<lastmod>2012-01-17T12:29:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4232/reports/commercial-insight-cancer-targeted-therapies-and-immunotherapies/</loc>
		<lastmod>2012-01-17T12:29:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4505/reports/the-top-10-biotechnology-companies-positioning-performance-and-swot-analyses/</loc>
		<lastmod>2012-01-17T12:28:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7127/reports/advances-in-the-design-and-regulation-of-adaptive-clinical-trials/</loc>
		<lastmod>2012-01-17T12:28:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7131/reports/pipeline-insight-cancer-overview-malignant-melanoma-neuroendocrine-tumors-and-thyroid-cancer-new-drug-approvals-likely-after-decades-of-little-progress/</loc>
		<lastmod>2012-01-17T12:27:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7137/reports/case-study-personalized-cancer-therapy-the-era-of-biomarker-identification-and-companion-diagnostic-co-development/</loc>
		<lastmod>2012-01-17T12:27:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7133/reports/the-drug-discovery-outsourcing-market/</loc>
		<lastmod>2012-01-17T12:27:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7140/reports/future-directions-in-regenerative-medicine/</loc>
		<lastmod>2012-01-17T12:26:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10730/reports/pharmaceutical-key-trends-2011-socio-demographic-and-economic-overview/</loc>
		<lastmod>2012-01-17T12:24:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10725/news/industry-news/bristol-myers-squibb-begins-tender-offer-to-acquire-inhibitex-inc/</loc>
		<lastmod>2012-01-16T09:27:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10720/news/industry-news/lundbeck-awarded-prize-for-world-class-production/</loc>
		<lastmod>2012-01-16T09:20:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10717/news/industry-news/novartis-to-restructure-us-business-to-strengthen-competitive-position-in-light-of-loss-of-diovan-patent/</loc>
		<lastmod>2012-01-13T09:58:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10713/news/featured-news/bw-tek-to-introduce-micro-lensed-fiber-optic-raman-probe-at-spies-bios-photonics-west-exhibits/</loc>
		<lastmod>2012-01-13T09:39:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10707/news/industry-news/gilead-sciences-completes-tender-offer-for-all-outstanding-shares-of-pharmasset-inc/</loc>
		<lastmod>2012-01-12T11:48:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10705/news/industry-news/gsk-responds-to-the-recent-court-ruling-on-the-compas-study-in-mendoza-argentina/</loc>
		<lastmod>2012-01-12T11:38:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10701/news/featured-news/flavor-and-fragrance-production-with-the-syrris-atlas-calorimeter/</loc>
		<lastmod>2012-01-11T15:13:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10695/news/featured-news/tecans-infinite-m1000-and-a-plate-of-live-fish/</loc>
		<lastmod>2012-01-11T12:30:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10690/events/industry-events/2-laupheimer-zelltage/</loc>
		<lastmod>2012-01-11T11:24:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10685/news/industry-news/sanofi-and-venture-capital-firms-third-rock-ventures-and-greylock-partners-jointly-launch-warp-drive-bio/</loc>
		<lastmod>2012-01-11T10:36:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10682/news/industry-news/astrazeneca-and-ims-health-announce-real-world-evidence-collaboration-in-europe/</loc>
		<lastmod>2012-01-11T10:27:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10012/events/industry-events/interphex-2012/</loc>
		<lastmod>2012-01-10T09:28:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10675/news/industry-news/sfj-pharma-ltd-ii-announces-agreement-with-pfizer-to-develop-axitinib/</loc>
		<lastmod>2012-01-09T11:52:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10670/uncategorized/fda-approves-mercks-isentress-raltegravir/</loc>
		<lastmod>2012-01-09T10:30:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10665/news/industry-news/astrazeneca-reaffirms-december-2011-financial-guidance-for-2011-and-mid-term-planning-assumptions-for-the-2010-to-2014-period/</loc>
		<lastmod>2012-01-09T10:22:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10658/news/industry-news/novartis-consumer-health-inc-voluntarily-recalls-certain-over-the-counter-products-in-the-us/</loc>
		<lastmod>2012-01-09T10:13:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/advertising/</loc>
		<lastmod>2012-01-09T10:06:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10651/news/industry-news/gsk-and-theravance-announce-initial-outcomes-from-pivotal-phase-iii-studies-for-once-daily-relovairtm-in-copd-and-asthma/</loc>
		<lastmod>2012-01-09T10:05:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10648/news/industry-news/gilead-sciences-announces-early-termination-of-hart-scott-rodino-waiting-period/</loc>
		<lastmod>2012-01-09T09:48:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10646/news/industry-news/bristol-myers-squibb-to-acquire-inhibitex/</loc>
		<lastmod>2012-01-09T09:42:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10640/news/industry-news/new-director-sales-and-business-development-for-gea-pharma-systems-in-latin-america/</loc>
		<lastmod>2012-01-06T11:00:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10635/news/industry-news/merck-millipore-collaborates-with-peking-university-to-advance-training-of-pharmaceutical-development-manufacturing-and-regulatory-professionals-in-china/</loc>
		<lastmod>2012-01-05T14:38:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10631/news/industry-news/biogen-idec-and-isis-pharmaceuticals-announce-global-collaboration/</loc>
		<lastmod>2012-01-05T11:21:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10567/news/industry-news/teva-announces-management-succession/</loc>
		<lastmod>2012-01-04T13:34:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10621/events/industry-events/isscr-2012/</loc>
		<lastmod>2012-01-04T11:20:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10606/news/industry-news/janssen-research-development-submits-application-to-u-s-fda-for-xarelto-rivaroxaban-to-reduce-secondary-cardiovascular-events-in-patients-with-acs/</loc>
		<lastmod>2012-01-04T10:02:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10602/news/industry-news/icon-announces-dr-anthony-murphy-to-retire-from-board-of-directors/</loc>
		<lastmod>2012-01-04T09:56:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10596/news/industry-news/fda-to-review-potential-new-use-of-xgeva-denosumab-at-odac-meeting/</loc>
		<lastmod>2012-01-04T09:53:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10593/news/industry-news/pfizer-receives-fda-approval-to-extend-use-of-prevnar-13/</loc>
		<lastmod>2012-01-04T09:29:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10586/news/industry-news/aveo-and-astellas-announce-tivozanib-successfully-demonstrated-progression-free-survival-superiority-over-sorafenib-in-patients-with-advanced-renal-cell-cancer-in-phase-3-tivo-1-trial/</loc>
		<lastmod>2012-01-04T09:21:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10581/news/industry-news/advanced-magnetic-resonance-imaging-technology-suggests-axonal-repair-in-multiple-sclerosis-patients-treated-with-copaxone/</loc>
		<lastmod>2012-01-04T08:58:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/subscription-confirmation/</loc>
		<lastmod>2012-01-03T16:09:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/whitepapers/</loc>
		<lastmod>2012-01-03T11:17:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10282/news/featured-news/tecan-launches-infinite%c2%ae-m1000-pro-with-alphascreen%c2%ae-and-alphalisa%c2%ae-technology/</loc>
		<lastmod>2012-01-03T09:55:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10541/news/industry-news/astrazeneca-updates-on-olaparib-and-tc-5214-development-programmes/</loc>
		<lastmod>2012-01-03T09:47:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10570/news/industry-news/onfi-clobazam-tablets-now-available-in-the-us-at-retail-pharmacies/</loc>
		<lastmod>2012-01-03T09:32:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10555/news/industry-news/bayers-xarelto-approved-in-the-eu-for-the-prevention-of-stroke-in-patients-with-af/</loc>
		<lastmod>2011-12-23T12:09:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10551/news/industry-news/amgen-and-watson-announce-collaboration-to-develop-and-commercialise-oncology-biosimilars/</loc>
		<lastmod>2011-12-20T10:39:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10546/news/industry-news/alkermes-initiates-phase-3-clinical-study-of-alks-9070-for-treatment-of-schizophrenia/</loc>
		<lastmod>2011-12-20T10:28:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10538/news/industry-news/roches-personalised-medicine-zelboraf-receives-positive-opinion-from-european-authority/</loc>
		<lastmod>2011-12-19T12:02:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10536/news/industry-news/pfizer-reports-positive-results-from-phase-3-trial-of-lyrica-pregabaline/</loc>
		<lastmod>2011-12-19T11:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10533/news/industry-news/gsk-extends-pneumococcal-vaccine-agreement-with-gavi-alliance/</loc>
		<lastmod>2011-12-19T11:54:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10530/news/industry-news/sharer-to-step-down-as-chairman-and-chief-executive-officer-of-amgen/</loc>
		<lastmod>2011-12-19T11:44:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10526/news/industry-news/merck-announces-initiation-of-clinical-development-collaboration-with-roche/</loc>
		<lastmod>2011-12-16T10:39:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10523/news/industry-news/changes-to-the-roche-corporate-executive-committee-2/</loc>
		<lastmod>2011-12-16T10:35:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10521/news/industry-news/novartis-drug-gilenya-showed-positive-clinical-outcomes-for-relapsing-remitting-ms-patients-in-third-large-phase-iii-clinical-trial/</loc>
		<lastmod>2011-12-16T10:30:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10518/news/industry-news/glaxosmithkline-and-human-genome-sciences-initiate-phase-iii-trial-of-belimumab-benlysta-administered-subcutaneously-in-subjects-with-systemic-lupus-erythematosus/</loc>
		<lastmod>2011-12-16T10:27:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10516/news/industry-news/boehringer-ingelheim-significantly-expands-its-supply-center-for-china/</loc>
		<lastmod>2011-12-16T10:22:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10514/news/industry-news/g-ba-issues-positive-final-medical-benefit-assessment-for-brilique-in-germany/</loc>
		<lastmod>2011-12-16T10:18:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10508/news/industry-news/simcere-and-bristol-myers-squibb-enter-innovative-partnership-to-develop-cardiovascular-compound/</loc>
		<lastmod>2011-12-15T12:30:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10505/news/industry-news/new-intrauterine-system-for-long-term-contraception-submitted-for-marketing-authorization-both-in-the-eu-and-the-u-s/</loc>
		<lastmod>2011-12-15T12:24:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10499/news/industry-news/amgen-presents-final-results-from-the-largest-phase-3-open-label-study-assessing-the-safety-and-efficacy-of-nplate-romiplostim/</loc>
		<lastmod>2011-12-15T12:10:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://content.yudu.com/Library/A1uds9/RAMANSupplement/resources/index.htm?referrerUrl=http%3A%2F%2Ffree.yudu.com%2Fitem%2Fdetails%2F423900%2FRAMAN-Supplement</loc>
		<lastmod>2011-12-15T09:49:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://content.yudu.com/Library/A1udzp/RAPIDMETHODSSuppleme/resources/index.htm?referrerUrl=http%3A%2F%2Ffree.yudu.com%2Fitem%2Fdetails%2F424186%2FRAPID-METHODS-Supplement</loc>
		<lastmod>2011-12-15T09:49:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/pat-2011</loc>
		<lastmod>2011-12-15T09:47:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10487/news/featured-news/syrris-chemical-reactors-good-under-pressure/</loc>
		<lastmod>2011-12-14T17:22:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10093/events/industry-events/g-protein-coupled-receptors-in-drug-discovery/</loc>
		<lastmod>2011-12-14T11:47:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10482/events/industry-events/process-validation-for-drugs-and-biologics-2/</loc>
		<lastmod>2011-12-14T11:46:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10478/events/industry-events/cgmp-quality-principles-for-pharmaceuticals-biopharmaceuticals-biologics-and-medical-devices/</loc>
		<lastmod>2011-12-14T11:44:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10467/events/industry-events/the-drug-development-process-from-discovery-to-commercialization-2/</loc>
		<lastmod>2011-12-14T11:38:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9834/events/industry-events/adme-and-predictive-toxicology/</loc>
		<lastmod>2011-12-14T11:36:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10450/european-pharmaceutical-review-magazine/latest-issue/detection-of-microorganisms-using-micro-electro-mechanical-systems-mems/</loc>
		<lastmod>2011-12-13T14:25:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10444/european-pharmaceutical-review-magazine/latest-issue/drug-discovery-leaders-roundtable/</loc>
		<lastmod>2011-12-13T14:18:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10441/european-pharmaceutical-review-magazine/latest-issue/discovery-and-validation-of-biomarkers-for-multiple-sclerosis/</loc>
		<lastmod>2011-12-13T13:54:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10435/european-pharmaceutical-review-magazine/latest-issue/status-and-challenges-in-structure-based-drug-discovery-for-g-protein-coupled-receptors/</loc>
		<lastmod>2011-12-13T12:07:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10429/european-pharmaceutical-review-magazine/latest-issue/reverse-phase-protein-microarrays-for-targeted-analysis-of-cellular-proteomes/</loc>
		<lastmod>2011-12-13T11:54:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10426/european-pharmaceutical-review-magazine/latest-issue/implementing-electronic-lboratory-notebooks-to-improve-the-efficiency-of-pre-clinical-drug-discovery/</loc>
		<lastmod>2011-12-13T11:40:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10416/european-pharmaceutical-review-magazine/latest-issue/microrna-manipulation-as-a-host-targeted-antiviral-therapeutic-strategy/</loc>
		<lastmod>2011-12-13T11:30:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10351/news/industry-news/katherine-baicker-elected-to-lilly-board-of-directors/</loc>
		<lastmod>2011-12-13T11:29:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10373/news/industry-news/pfizer-elects-ceo-ian-read-as-chairman-of-the-board/</loc>
		<lastmod>2011-12-13T11:19:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10414/european-pharmaceutical-review-magazine/latest-issue/expression-profiling-of-circulating-mirnas-as-a-novel-non-invasive-diagnostic-tool/</loc>
		<lastmod>2011-12-13T11:15:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10409/european-pharmaceutical-review-magazine/latest-issue/dna-sequencing-technologies-and-emerging-applications-in-drug-discovery/</loc>
		<lastmod>2011-12-13T11:03:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10406/european-pharmaceutical-review-magazine/latest-issue/spray-drying-pharmaceuticals/</loc>
		<lastmod>2011-12-13T10:45:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10402/european-pharmaceutical-review-magazine/latest-issue/under-the-microscope-philip-irving-foss-nirsystems-inc/</loc>
		<lastmod>2011-12-13T10:27:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10386/news/featured-news/bw-tek-announces-polymeriqtm-for-quantification-of-polymers-in-partnership-with-gnosys-global-ltd/</loc>
		<lastmod>2011-12-13T10:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9466/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/under-the-microscope-steve-turner/</loc>
		<lastmod>2011-12-13T10:21:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9468/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/the-forgotten-fragments/</loc>
		<lastmod>2011-12-13T10:21:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9478/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/maldi-mass-spectrometry-imaging-applied-to-drug-discovery-and-development/</loc>
		<lastmod>2011-12-13T10:21:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9493/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/drug-screens-on-human-stem-cells-from-understanding-cell-biology-to-predicting-drug-toxicity/</loc>
		<lastmod>2011-12-13T10:20:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9498/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/lead-discovery-for-targeting-g-protein-coupled-receptors/</loc>
		<lastmod>2011-12-13T10:20:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9501/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/hox-transcription-factors-as-biomarkers-in-cancer/</loc>
		<lastmod>2011-12-13T10:19:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9505/european-pharmaceutical-review-magazine/past-issues/issue-5-2011/unconventional-rna-interference-recent-approaches-to-robust-rnai/</loc>
		<lastmod>2011-12-13T10:19:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10383/news/industry-news/merck-announces-results-of-zolinza%c2%ae-vorinostat-phase-iii-and-iib-trials-for-investigational-use-for-multiple-myeloma-at-american-society-of-hematology-annual-meeting/</loc>
		<lastmod>2011-12-13T10:04:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10379/news/industry-news/two-novartis-phase-iii-studies-show-twice-as-many-ph-cml-patients-achieve-deeper-levels-of-response-with-tasigna%c2%ae-compared-to-glivec%c2%ae/</loc>
		<lastmod>2011-12-13T09:53:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10375/news/industry-news/new-phase-iii-data-shows-novartis-jak-inhibitor-inc424-significantly-reduced-disease-burden-in-patients-with-myelofibrosis/</loc>
		<lastmod>2011-12-13T09:47:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10362/news/industry-news/takeda%e2%80%99s-edarbi%c2%ae-azilsartan-medoxomil-receives-european-marketing-authorisation-for-the-treatment-of-essential-hypertension/</loc>
		<lastmod>2011-12-12T16:20:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10358/news/industry-news/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators/</loc>
		<lastmod>2011-12-12T15:16:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10353/news/industry-news/lilly-oncology-reveals-findings-from-study-of-jak2-inhibitor-for-blood-cancers-at-ash-meeting/</loc>
		<lastmod>2011-12-12T14:16:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10347/news/industry-news/icon-acquires-beijingwits-medical-consulting-ltd/</loc>
		<lastmod>2011-12-12T13:56:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10342/news/industry-news/university-college-dublin-and-elan-announce-initiative-to-create-leadership-in-biotechnology/</loc>
		<lastmod>2011-12-12T13:52:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10338/news/industry-news/janssen-biotech-inc-announces-collaborative-development-and-worldwide-license-agreement-for-investigational-anti-cancer-drug-pci-32765/</loc>
		<lastmod>2011-12-12T13:43:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10335/news/industry-news/abbott-initiates-clinical-trial-to-evaluate-the-absorb%e2%84%a2-bioresorbable-vascular-scaffold-compared-to-a-metallic-drug-eluting-stent/</loc>
		<lastmod>2011-12-09T10:30:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10333/news/industry-news/roche-announces-positive-results-of-pivotal-phase-iii-study-with-pertuzumab-in-her2-positive-metastatic-breast-cancer/</loc>
		<lastmod>2011-12-09T10:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10328/news/industry-news/boehringer-ingelheim-completes-patient-entry-for-phase-iii-trial-programme-in-hepatitis-c/</loc>
		<lastmod>2011-12-09T10:18:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10323/news/industry-news/new-data-confirms-novartis-drug-afinitor%c2%ae-significantly-extends-time-women-with-advanced-breast-cancer-live-without-tumor-growth/</loc>
		<lastmod>2011-12-09T10:12:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10318/news/industry-news/gsk-presents-phase-lll-data-for-lapatinib-at-san-antonio-breast-cancer-symposium/</loc>
		<lastmod>2011-12-09T09:46:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10315/news/industry-news/astrazeneca-to-acquire-generics-company-to-broaden-patient-access-to-medicines-in-china/</loc>
		<lastmod>2011-12-09T09:42:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10313/news/industry-news/astrazeneca-to-streamline-us-sales-organisation/</loc>
		<lastmod>2011-12-08T16:52:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10296/news/featured-news/syrris-releases-new-batch-chemistry-reactors-catalogue/</loc>
		<lastmod>2011-12-07T15:11:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10292/news/industry-news/amgen-and-fda-agree-to-modify-nplate%c2%ae-romiplostim-risk-evaluation-and-mitigation-strategy/</loc>
		<lastmod>2011-12-07T10:01:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10287/news/industry-news/government-boost-to-world-leading-uk-life-science-industry/</loc>
		<lastmod>2011-12-06T14:59:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10278/news/industry-news/merck-millipore-launches-chromatalk%e2%84%a2-the-first-of-its-kind-interactive-online-chromatography-community/</loc>
		<lastmod>2011-12-06T12:26:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10264/news/industry-news/pooled-analysis-fewer-major-adverse-cardiovascular-events-in-type-2-diabetes-patients-treated-with-msds-januvia-%c2%ae-sitagliptin-compared-to-a-sulphonylurea/</loc>
		<lastmod>2011-12-06T11:44:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10251/news/industry-news/data-show-that-the-combination-insulin-degludecinsulin-aspart-significantly-reduced-hypoglycaemia-in-type-1-and-type-2-diabetes-patients/</loc>
		<lastmod>2011-12-06T11:24:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10244/news/industry-news/sanofi-reports-positive-results-for-once-daily-lyxumia%c2%ae-lixisenatide-in-combination-with-lantus%c2%ae-insulin-glargine-in-type-2-diabetes/</loc>
		<lastmod>2011-12-06T11:00:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10256/news/industry-news/samsung-and-biogen-idec-announce-joint-venture-to-develop-manufacture-and-market-biosimilars/</loc>
		<lastmod>2011-12-06T10:59:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10254/news/industry-news/study-in-type-2-diabetes-shows-low-rates-of-hypoglycaemia-and-significant-improvements-in-blood-glucose-control-with-insulin-analogue-treatment/</loc>
		<lastmod>2011-12-06T10:55:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10249/news/industry-news/merck-establishes-new-msd-rd-asia-headquarters/</loc>
		<lastmod>2011-12-06T10:45:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10246/news/industry-news/gsk-statement-in-response-to-the-prime-minister%e2%80%99s-speech-on-life-sciences/</loc>
		<lastmod>2011-12-06T10:42:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10240/news/industry-news/novartis-drug-galvus%c2%ae-approved-in-eu-for-type-2-diabetes-patients-with-moderate-or-severe-renal-impairment-with-limited-treatment-options/</loc>
		<lastmod>2011-12-06T10:28:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10222/news/industry-news/novartis-highlights-advances-for-patients-with-breast-cancer-and-hematological-diseases-with-over-160-sabcs-and-ash-abstracts/</loc>
		<lastmod>2011-12-05T17:24:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10229/news/industry-news/bristol-myers-squibb-enters-clinical-collaboration-agreement-with-tibotec-pharmaceuticals/</loc>
		<lastmod>2011-12-05T11:04:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10225/news/industry-news/pfizer-completes-acquisition-of-excaliard/</loc>
		<lastmod>2011-12-05T10:59:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10217/news/industry-news/groundbreaking-scientific-collaboration-gives-uk-academia-access-to-compounds-to-advance-medical-research/</loc>
		<lastmod>2011-12-05T10:49:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10209/news/industry-news/boehringer-ingelheim-and-aveo-pharmaceuticals-announce-manufacturing-agreement-for-ficlatuzumab/</loc>
		<lastmod>2011-12-02T11:51:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10187/news/industry-news/teva-announces-agreement-with-ranbaxy-regarding-generic-lipitor%c2%ae/</loc>
		<lastmod>2011-12-02T11:43:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10201/news/featured-news/seeing-is-believing/</loc>
		<lastmod>2011-12-01T14:05:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10195/news/industry-news/abbott-receives-fda-clearance-for-new-test-to-detect-vitamin-d-levels/</loc>
		<lastmod>2011-12-01T11:24:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10193/news/industry-news/pfizer-completes-acquisition-of-ferrosan-consumer-health%e2%80%99s-business/</loc>
		<lastmod>2011-12-01T11:18:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10190/news/industry-news/roches-cobas-egfr-mutation-test-for-personalized-treatment-of-non-small-cell-lung-cancer-receives-ce-mark/</loc>
		<lastmod>2011-12-01T11:15:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10183/news/industry-news/sanofi-confirms-its-decades-long-commitment-to-the-fight-against-malaria/</loc>
		<lastmod>2011-11-30T11:39:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10181/news/industry-news/roche-to-present-important-new-data-for-her2-positive-breast-cancer-at-2011-sabcs/</loc>
		<lastmod>2011-11-30T11:33:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10178/news/industry-news/fda-accepts-eliquis%c2%ae-apixaban-new-drug-application-for-review/</loc>
		<lastmod>2011-11-30T11:27:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10169/news/industry-news/edurant%c2%ae-rilpivirine-approved-in-europe/</loc>
		<lastmod>2011-11-29T13:56:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10165/news/industry-news/gilead-receives-european-marketing-authorization-for-eviplera%c2%ae/</loc>
		<lastmod>2011-11-29T10:28:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10163/news/industry-news/komboglyze%e2%84%a2-receives-marketing-authorisation-in-the-european-union-for-adult-patients-with-type-2-diabetes/</loc>
		<lastmod>2011-11-29T08:52:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10156/news/industry-news/abbott-expands-agreement-with-gsk-to-include-development-of-a-companion-diagnostic-test-for-an-additional-investigational-cancer-immunotherapy-antigen/</loc>
		<lastmod>2011-11-28T17:03:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10159/news/industry-news/onglyza%c2%ae-saxagliptin-approved-for-use-in-europe-as-combination-therapy-with-insulin-in-adults-with-type-2-diabetes/</loc>
		<lastmod>2011-11-28T17:02:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10153/news/industry-news/astrazeneca-commits-an-additional-100-million-to-venture-capital-arm-medimmune-ventures/</loc>
		<lastmod>2011-11-28T16:52:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10149/news/industry-news/cambridge-elan-centre-for-research-innovation-and-drug-discovery-launched/</loc>
		<lastmod>2011-11-28T12:41:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10145/news/industry-news/novartis-gains-european-commission-approval-for-rasitrio%c2%ae/</loc>
		<lastmod>2011-11-28T12:32:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10140/news/industry-news/merck-resolves-previously-disclosed-seven-year-investigation-led-by-u-s-attorneys-office-for-the-district-of-massachusetts-related-to-vioxx%c2%ae/</loc>
		<lastmod>2011-11-25T13:58:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10138/news/industry-news/pfizer-to-acquire-excaliard-pharmaceuticals/</loc>
		<lastmod>2011-11-25T13:53:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10136/events/industry-events/genomics-research-europe/</loc>
		<lastmod>2011-11-24T17:26:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10132/events/industry-events/rnai-single-cell-biology-2012-summit/</loc>
		<lastmod>2011-11-24T17:11:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10130/events/industry-events/qpcr-symposium/</loc>
		<lastmod>2011-11-24T17:07:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10126/events/industry-events/biomarker-summit-2012/</loc>
		<lastmod>2011-11-24T16:57:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10119/events/industry-events/gddif-2012/</loc>
		<lastmod>2011-11-24T16:51:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10116/events/industry-events/drug-discovery-for-neurodegeneration/</loc>
		<lastmod>2011-11-24T16:40:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10113/events/industry-events/1st-international-genomics-research-asia/</loc>
		<lastmod>2011-11-24T16:38:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10111/events/industry-events/stem-cells-bioprocessing-europe/</loc>
		<lastmod>2011-11-24T16:35:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10108/events/industry-events/discovery-summit-2012/</loc>
		<lastmod>2011-11-24T16:29:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9820/events/industry-events/13th-drug-discovery-summit-2012/</loc>
		<lastmod>2011-11-24T16:18:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10102/events/industry-events/ela-2012/</loc>
		<lastmod>2011-11-24T16:17:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10099/events/industry-events/2nd-annual-oncology-biomarkers-congress-2012/</loc>
		<lastmod>2011-11-24T16:12:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10097/events/industry-events/next-generation-sequencing-asia-congress-2012/</loc>
		<lastmod>2011-11-24T16:10:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10091/events/industry-events/2nd-annual-drug-discovery-global-summit/</loc>
		<lastmod>2011-11-24T15:52:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10089/events/industry-events/pharma-rd-europe-summits/</loc>
		<lastmod>2011-11-24T15:49:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10087/events/industry-events/infarma2012/</loc>
		<lastmod>2011-11-24T15:39:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10082/events/industry-events/ilmac/</loc>
		<lastmod>2011-11-24T15:38:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10079/events/industry-events/biotechnica-2/</loc>
		<lastmod>2011-11-24T15:33:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10077/events/industry-events/p-mec-europe/</loc>
		<lastmod>2011-11-24T15:30:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10075/events/industry-events/drug-diagnostic-development/</loc>
		<lastmod>2011-11-24T15:28:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10065/events/industry-events/fce-pharma/</loc>
		<lastmod>2011-11-24T15:25:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10058/events/industry-events/austropharm/</loc>
		<lastmod>2011-11-24T15:17:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10052/news/featured-news/new-syrris-asia-catalogue-highlights-the-benefits-of-flow-chemistry/</loc>
		<lastmod>2011-11-23T13:39:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10043/news/industry-news/a-drug-for-type-1-diabetes-meets-primary-and-secondary-goals-of-phase-iii-clinical-trials/</loc>
		<lastmod>2011-11-23T10:18:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10039/news/featured-news/sunrise%e2%84%a2-in-mongolia/</loc>
		<lastmod>2011-11-23T09:27:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10026/news/industry-news/pfizer-and-mit-break-ground-on-new-research-units-in-kendall-square/</loc>
		<lastmod>2011-11-22T10:08:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10034/news/industry-news/abbott-introduces-the-first-fda-approved-supplemental-blood-test-for-chagas-disease/</loc>
		<lastmod>2011-11-22T09:55:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10029/news/industry-news/gilead-sciences-to-acquire-pharmasset-inc-for-11-billion/</loc>
		<lastmod>2011-11-22T09:46:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10019/news/industry-news/nda-for-aripiprazole-depot-formulation-for-maintenance-treatment-of-adult-patients-with-schizophrenia-accepted-by-the-fda/</loc>
		<lastmod>2011-11-22T09:35:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10008/events/industry-events/eupa-2012-scientific-congress/</loc>
		<lastmod>2011-11-21T17:11:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/10002/events/industry-events/logipharma-europe/</loc>
		<lastmod>2011-11-21T17:01:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9997/news/industry-news/fda-commissioner-announces-final-decision-on-avastin-for-metastatic-breast-cancer/</loc>
		<lastmod>2011-11-21T12:04:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9994/news/industry-news/pfizer-announces-ema-acceptance-of-regulatory-submission-for-tofacitinib-for-the-treatment-of-rheumatoid-arthritis/</loc>
		<lastmod>2011-11-21T11:58:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9989/news/industry-news/glaxosmithkline-welcomes-innovative-knowledge-sharing-collaboration-to-break-deadlock-in-antibiotic-discovery-and-development/</loc>
		<lastmod>2011-11-18T12:26:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9985/news/industry-news/gsk-welcomes-gavi-alliance-decision-to-introduce-vaccines-against-cervical-cancer-and-rubella-in-the-world%e2%80%99s-poorest-countries/</loc>
		<lastmod>2011-11-18T12:21:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9982/news/industry-news/novartis-and-collaborators-discover-new-dual-acting-class-of-antimalarial-compounds-with-potential-to-both-prevent-and-treat-malaria-infections/</loc>
		<lastmod>2011-11-18T12:15:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9978/news/industry-news/lilly-provides-additional-funding-to-infectious-disease-research-institute-to-identify-new-tuberculosis-therapies/</loc>
		<lastmod>2011-11-18T12:08:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9974/news/industry-news/caprelsa%e2%84%a2-vandetanib-receives-positive-chmp-opinion-in-the-european-union-for-treating-advanced-medullary-thyroid-cancer/</loc>
		<lastmod>2011-11-18T12:01:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9967/news/featured-news/4th-tecan-symposium-enjoys-chinese-success/</loc>
		<lastmod>2011-11-18T09:34:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9963/news/industry-news/new-analysis-of-data-presented-at-aha-regarding-effect-of-effient%c2%ae-prasugrel-on-cardiovascular-events-in-stemi-patients/</loc>
		<lastmod>2011-11-17T09:25:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9959/news/industry-news/vectibix%c2%ae-panitumumab-granted-approval-for-expanded-indications-in-the-european-union/</loc>
		<lastmod>2011-11-16T15:20:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9956/news/industry-news/abbott-statement-on-the-results-of-the-aim-high-study/</loc>
		<lastmod>2011-11-16T15:13:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9953/news/industry-news/gsk-receives-initial-data-from-the-first-completed-phase-lll-study-of-albiglutide-in-type-2-diabetes/</loc>
		<lastmod>2011-11-16T15:08:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9950/news/industry-news/gilead-sciences-finalizes-agreement-with-tibotec-pharmaceuticals/</loc>
		<lastmod>2011-11-16T15:04:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9947/news/industry-news/saturn-demonstrated-effect-of-intensive-statin-treatment-on-reducing-atherosclerosis/</loc>
		<lastmod>2011-11-16T15:00:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9943/news/featured-news/syrris-sponsor-1st-flow-chemistry-symposium-in-brazil/</loc>
		<lastmod>2011-11-16T14:45:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9931/events/industry-events/9th-annual-pat-and-quality-by-design/</loc>
		<lastmod>2011-11-15T15:25:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9839/events/industry-events/2nd-international-conference-of-the-flow-chemistry-society/</loc>
		<lastmod>2011-11-15T11:07:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9923/news/featured-news/avacta-analytical-partners-with-ucl-as-sponsor-of-their-epsrc-centre-for-innovative-manufacturing/</loc>
		<lastmod>2011-11-14T16:46:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9920/news/industry-news/data-from-tracer-study-of-vorapaxar-mercks-investigational-medicine-for-cardiovascular-disease-presented-at-aha/</loc>
		<lastmod>2011-11-14T15:58:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9916/news/industry-news/new-data-presented-on-phase-3-trial-of-eliquis%c2%ae-apixaban/</loc>
		<lastmod>2011-11-14T14:57:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9913/news/industry-news/dramatic-increase-in-diabetes-prevalence-calls-for-action/</loc>
		<lastmod>2011-11-14T14:52:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9908/news/industry-news/genzyme-announces-successful-phase-iii-results-for-alemtuzumab-lemtradatm-in-multiple-sclerosis/</loc>
		<lastmod>2011-11-14T14:46:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9904/news/industry-news/sanofi-and-regeneron-report-positive-preliminary-phase-2-program-results-for-anti-pcsk9-antibody-in-hypercholesterolemia/</loc>
		<lastmod>2011-11-11T14:00:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9901/news/industry-news/novartis-appoints-timothy-wright-m-d-as-global-head-development-novartis-pharmaceuticals/</loc>
		<lastmod>2011-11-11T12:25:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9898/news/industry-news/merck-highlights-pipeline-progress-and-showcases-novel-innovations-at-rd-and-business-briefing/</loc>
		<lastmod>2011-11-11T12:18:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9894/news/industry-news/lundbeck-and-otsuka-pharmaceutical-sign-historic-agreement-to-deliver-innovative-medicines-targeting-psychiatric-disorders-worldwide/</loc>
		<lastmod>2011-11-11T12:13:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9885/news/industry-news/lilly-ceo-lechleiter-outlines-opportunities-for-improved-health-and-economic-growth-in-asia-pacific-region/</loc>
		<lastmod>2011-11-11T12:05:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9881/news/industry-news/12-week-on-treatment-results-from-large-phase-iib-study-command-1-of-bristol-myers-squibbs-ns5a-inhibitor-daclatasvir-support-anti-hcv-activity-and-safety-profile-observed-in-earlier-studie/</loc>
		<lastmod>2011-11-11T11:57:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9879/news/industry-news/abbott-receives-ce-mark-for-new-hepatitis-test/</loc>
		<lastmod>2011-11-11T11:50:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9877/news/industry-news/fda-accepts-roche%e2%80%99s-new-drug-application-for-vismodegib-in-advanced-form-of-skin-cancer/</loc>
		<lastmod>2011-11-11T11:46:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9874/news/featured-news/syrris-process-chemistry-systems-support-scale-up-experiments-in-brazil/</loc>
		<lastmod>2011-11-10T13:42:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9864/events/industry-events/pittcon-2012/</loc>
		<lastmod>2011-11-08T12:11:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9857/events/industry-events/4th-international-conference-on-drug-discovery-and-therapy/</loc>
		<lastmod>2011-11-08T11:55:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9854/events/industry-events/7th-annual-biomarkers-congress/</loc>
		<lastmod>2011-11-08T11:51:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9852/events/industry-events/10th-annual-pharmaceutical-it-congress/</loc>
		<lastmod>2011-11-08T11:47:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8995/events/industry-events/ipheb-2012-2nd-st-petersburg-international-pharmacy-engineering-and-biotechnology-forum/</loc>
		<lastmod>2011-11-08T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9844/events/industry-events/8th-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology/</loc>
		<lastmod>2011-11-08T11:40:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9830/events/industry-events/drug-discovery-diagnostic-development-week-2012/</loc>
		<lastmod>2011-11-08T11:22:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9826/events/industry-events/miptec-2012/</loc>
		<lastmod>2011-11-08T11:19:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9823/events/industry-events/elrig-drug-discovery-2012/</loc>
		<lastmod>2011-11-08T11:16:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9811/events/industry-events/bia-research-development-conference/</loc>
		<lastmod>2011-11-08T10:54:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9804/news/industry-news/daiichi-sankyo-brasil-and-kyorin-pharmaceutical-reach-agreement-in-brazil-for-activities-related-to-the-development-and-marketing-of-imidafenacin/</loc>
		<lastmod>2011-11-08T10:29:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9801/news/industry-news/fda-approves-erbitux%c2%ae-cetuximab-for-first-line-recurrent-locoregional-or-metastatic-head-and-neck-cancer-in-combination-with-platinum-based-chemotherapy-with-5-fluorouracil/</loc>
		<lastmod>2011-11-08T10:24:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9793/news/industry-news/abbott-presents-humira%c2%ae-adalimumab-phase-3-study-results/</loc>
		<lastmod>2011-11-08T10:12:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9790/news/industry-news/gsk-presents-phase-iii-results-for-eltrombopag-in-hepatitis-c-virus-related-thrombocytopenia/</loc>
		<lastmod>2011-11-08T09:57:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9786/news/industry-news/pfizer-to-present-clinical-data-from-its-hematology-portfolio/</loc>
		<lastmod>2011-11-08T09:52:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9783/news/industry-news/astrazeneca-and-targacept-announce-first-top-line-phase-iii-results-for-tc-5214-as-an-adjunct-treatment-in-patients-with-major-depressive-disorder/</loc>
		<lastmod>2011-11-08T09:43:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://content.yudu.com/Library/A1tmpq/GenseqSupplement/</loc>
		<lastmod>2011-11-07T14:09:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://content.yudu.com/Library/A1tm8c/eLNSupplement/resources/index.htm?referrerUrl=http%3A%2F%2Fwww.yudu.com%2Fitem%2Fdetails%2F391273%2FeLN-Supplement</loc>
		<lastmod>2011-11-07T14:04:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9770/news/industry-news/prolia%c2%ae-denosumab-open-label-extension-trial-showed-continued-increase-in-bone-mineral-density-over-six-years-with-similar-safety-profile-observed-in-original-fracture-trial/</loc>
		<lastmod>2011-11-07T12:01:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9766/news/industry-news/abbott-announces-new-long-term-data-evaluating-use-of-humira%c2%ae-adalimumab-for-patients-with-long-standing-moderate-to-severe-rheumatoid-arthritis-and-for-patients-with-early-moderate-to-severe-r/</loc>
		<lastmod>2011-11-07T11:55:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9762/news/industry-news/interim-data-for-mercks-victrelis%e2%84%a2-boceprevir-in-prior-null-responder-patients-with-chronic-hepatitis-c-genotype-1-to-be-presented/</loc>
		<lastmod>2011-11-07T11:35:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9757/news/industry-news/treatment-with-enbrel%c2%ae-etanercept-shows-significant-and-sustained-clinical-benefits-in-rheumatoid-arthritis-ra-patients-with-moderately-active-disease/</loc>
		<lastmod>2011-11-07T11:28:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9753/news/industry-news/gilead-announces-positive-five-year-data-showing-effect-of-vireadr-on-liver-fibrosis-and-cirrhosis-caused-by-chronic-hepatitis-b/</loc>
		<lastmod>2011-11-07T11:18:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9749/news/industry-news/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-in-45-of-patients-with-serious-form-of-childhood-arthritis/</loc>
		<lastmod>2011-11-07T11:04:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9739/news/industry-news/glaxosmithkline-reaches-agreement-in-principle-to-resolve-multiple-investigations-with-us-government/</loc>
		<lastmod>2011-11-03T15:56:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9736/news/industry-news/lilly-ceo-says-appropriate-assessment-of-both-benefits-and-risks-critical-in-regulatory-process/</loc>
		<lastmod>2011-11-03T15:53:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9731/news/industry-news/aslan-pharmaceuticals-and-bristol-myers-squibb-enter-innovative-partnership/</loc>
		<lastmod>2011-11-03T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9729/news/industry-news/abbott-to-present-new-data-for-key-vascular-products-at-tct-2011/</loc>
		<lastmod>2011-11-03T15:42:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9725/news/featured-news/raman-seminar-at-the-natural-history-museum/</loc>
		<lastmod>2011-11-03T15:29:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9721/news/industry-news/daiichi-sankyo-establishes-new-vaccine-research-unit-in-japan/</loc>
		<lastmod>2011-11-02T11:52:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9716/news/industry-news/sanofi-tops-pfizer-as-number-one-for-global-pharma-sales/</loc>
		<lastmod>2011-11-02T11:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9712/news/industry-news/richard-daniell-appointed-as-managing-director-of-teva-uk-limited/</loc>
		<lastmod>2011-11-02T09:33:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9705/news/industry-news/abbott-receives-u-s-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent/</loc>
		<lastmod>2011-11-02T08:54:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9699/events/industry-events/achema-2012/</loc>
		<lastmod>2011-11-01T10:18:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/PAT-QbD</loc>
		<lastmod>2011-11-01T09:06:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/advertising/2012-digital-media-pack/</loc>
		<lastmod>2011-10-31T17:27:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9685/news/industry-news/university-opens-36-million-facility-for-pharmacy-and-biomedical-sciences/</loc>
		<lastmod>2011-10-31T10:34:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9679/news/industry-news/boehringer-ingelheim-implements-additional-guidance-supporting-appropriate-use-of-pradaxa%c2%ae-dabigatran-etexilate-in-europe/</loc>
		<lastmod>2011-10-31T09:52:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9677/news/industry-news/pfizer-completes-acquisition-of-icagen/</loc>
		<lastmod>2011-10-31T09:38:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9674/news/industry-news/lundbeck-strengthens-its-rd-organisation/</loc>
		<lastmod>2011-10-28T07:59:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9669/news/featured-news/a-new-approach-to-quality-control-and-cost-reduction-in-manufacturing/</loc>
		<lastmod>2011-10-27T16:12:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9664/news/industry-news/us-food-and-drug-administration-extends-action-date-for-dapagliflozin-by-three-months/</loc>
		<lastmod>2011-10-27T08:55:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9659/news/industry-news/biogen-idec-announces-positive-top-line-results-from-second-phase-3-trial-investigating-oral-bg-12-dimethyl-fumarate-in-multiple-sclerosis/</loc>
		<lastmod>2011-10-26T15:42:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9656/news/industry-news/bristol-myers-squibb-and-gilead-sciences-announce-licensing-agreement/</loc>
		<lastmod>2011-10-26T15:37:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9653/news/industry-news/fda-approves-onfi%e2%84%a2-clobazam-for-the-adjunctive-treatment-of-seizures-associated-with-lennox-gastaut-syndrome/</loc>
		<lastmod>2011-10-26T15:25:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9649/news/industry-news/gsk-joins-wipo-research-open-innovation-platform-as-part-of-its-commitment-to-tackling-diseases-of-the-developing-world/</loc>
		<lastmod>2011-10-26T15:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9640/news/featured-news/tecans-pressure-monitored-pipetting-supports-swiss-bioquants-dedication-to-excellence/</loc>
		<lastmod>2011-10-25T16:13:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8778/whitepapers/rna-seq-data-comparison-with-gene-expression-microarrays/</loc>
		<lastmod>2011-10-25T13:55:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9627/whitepapers/whitepaper-utilizing-colony-forming-cell-assays-in-toxicity-testing/</loc>
		<lastmod>2011-10-25T13:45:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9595/news/industry-news/sanofi-appoints-david-meeker-chief-executive-officer-of-genzyme/</loc>
		<lastmod>2011-10-25T09:50:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9611/news/industry-news/stelara%c2%ae-ustekinumab-is-effective-well-tolerated-and-improves-quality-of-life-in-patients-with-moderate-to-severe-plaque-psoriasis-inadequately-responsive-to-methotrexate12/</loc>
		<lastmod>2011-10-25T09:30:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9608/news/industry-news/biogen-idec-and-abbott-present-positive-data-for-daclizumab-hyp-from-select-phase-2b-trial-at-ectrimsactrims/</loc>
		<lastmod>2011-10-25T09:22:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9605/news/industry-news/merck-announces-presentation-of-phase-iii-investigational-studies-evaluating-dulera%c2%ae-mometasone-furoate-and-formoterol-fumarate-dihydrate-inhalation-aerosol-in-copd/</loc>
		<lastmod>2011-10-25T09:17:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9601/news/industry-news/gilead-and-globeimmune-announce-license-and-collaboration-agreement-to-develop-therapeutic-vaccine-products/</loc>
		<lastmod>2011-10-25T09:12:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9598/news/industry-news/abbotts-genetic-test-for-acute-myeloid-leukemia-prognosis-cleared-by-fda/</loc>
		<lastmod>2011-10-25T09:07:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/</loc>
		<lastmod>2011-10-24T10:50:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/</loc>
		<lastmod>2011-10-24T10:47:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/webinars/</loc>
		<lastmod>2011-10-24T10:47:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/reports/</loc>
		<lastmod>2011-10-24T10:46:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/</loc>
		<lastmod>2011-10-24T10:45:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/events/</loc>
		<lastmod>2011-10-24T10:45:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/contribute/</loc>
		<lastmod>2011-10-24T10:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/2011-microbiology-series/</loc>
		<lastmod>2011-10-24T10:43:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/special-editions-supplements/</loc>
		<lastmod>2011-10-24T10:42:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/micro-qc-webinar</loc>
		<lastmod>2011-10-24T10:02:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9551/news/industry-news/alemtuzumab-significantly-reduces-relapses-in-multiple-sclerosis-vs-interferon-beta-1a-in-a-phase-iii-study/</loc>
		<lastmod>2011-10-24T09:19:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9545/news/industry-news/novartis-phase-ii-data-show-ain457-provided-rapid-and-significant-relief-of-symptoms-in-up-to-81-of-patients-with-psoriasis/</loc>
		<lastmod>2011-10-24T08:57:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9541/news/industry-news/astrazeneca-to-present-new-healthcare-economics-data-demonstrating-cost-effectiveness-of-brilique-at-ispor-eu/</loc>
		<lastmod>2011-10-24T08:53:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9533/news/industry-news/janssen-data-focus-on-tolerability-and-treatment-simplification-in-hiv-compounds/</loc>
		<lastmod>2011-10-21T13:33:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9531/news/industry-news/oral-bg-12-dimethyl-fumarate-significantly-reduced-multiple-sclerosis-ms-relapses-and-disability-progression/</loc>
		<lastmod>2011-10-21T13:27:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9529/news/industry-news/icon-selected-by-the-biomarkers-consortium-of-the-fnih/</loc>
		<lastmod>2011-10-21T13:23:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9521/news/industry-news/amgen-appoints-anthony-tony-hooper-executive-vice-president-global-commercial-operations/</loc>
		<lastmod>2011-10-20T10:44:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9519/news/industry-news/bristol-myers-squibb-announces-changes-in-senior-management-team/</loc>
		<lastmod>2011-10-20T10:40:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9515/news/industry-news/byetta%c2%ae-approved-for-use-with-insulin-glargine-in-the-u-s/</loc>
		<lastmod>2011-10-20T10:37:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9510/news/industry-news/phase-ii-study-showed-ocrelizumab-maintained-significant-reduction-in-disease-activity-for-multiple-sclerosis-patients-for-almost-two-years/</loc>
		<lastmod>2011-10-20T10:31:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9481/news/industry-news/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rtss-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/</loc>
		<lastmod>2011-10-19T14:19:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9469/news/industry-news/abbott-to-separate-into-two-leading-companies/</loc>
		<lastmod>2011-10-19T14:11:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8861/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/under-the-microscope-steve-delity/</loc>
		<lastmod>2011-10-19T13:50:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8863/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/thermodynamics-and-kinetics-driving-quality-in-drug-discovery/</loc>
		<lastmod>2011-10-19T13:50:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8868/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/emergence-and-identification-of-new-designer-drug-products-from-the-internet/</loc>
		<lastmod>2011-10-19T13:49:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8873/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/implementation-of-high-throughput-quality-control-processes-within-compound-management/</loc>
		<lastmod>2011-10-19T13:49:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8876/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/inhibition-of-microbial-growth-in-solid-dosages-at-ich-stability-storage-conditions/</loc>
		<lastmod>2011-10-19T13:49:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8880/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/detection-of-microorganisms-using-optical-spectroscopic-based-rapid-method-technologies/</loc>
		<lastmod>2011-10-19T13:49:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8883/european-pharmaceutical-review-magazine/past-issues/issue-4-2011/stabilisation-of-nanoparticles-during-freeze-drying-the-difference-to-proteins/</loc>
		<lastmod>2011-10-19T13:49:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9451/news/industry-news/astrazeneca-and-forest-laboratories-to-initiate-phase-iii-clinical-trials-for-ceftazidimeavibactam/</loc>
		<lastmod>2011-10-18T10:11:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9445/news/industry-news/roche-reports-positive-study-of-herceptin-given-by-subcutaneous-injection/</loc>
		<lastmod>2011-10-18T09:49:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9443/news/industry-news/abbotts-absorb%e2%84%a2-bioresorbable-vascular-scaffold-honored-with-wall-street-journal-technology-innovation-award/</loc>
		<lastmod>2011-10-18T09:45:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9423/news/industry-news/euticals-and-intraco-chemicals-sign-an-agreement-for-euticals-to-acquire-40-of-pharmintraco/</loc>
		<lastmod>2011-10-18T09:39:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9433/news/industry-news/novartis-drug-gilenya%c2%ae-fingolimod-has-more-than-20000-patient-years-of-exposure-and-shows-up-to-71-reduction-in-annualized-relapse-rates-in-ms-patients-with-highly-active-disease/</loc>
		<lastmod>2011-10-17T11:13:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9431/news/industry-news/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/</loc>
		<lastmod>2011-10-17T11:06:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9427/news/industry-news/icon-appoints-colin-stanley-president-of-docs/</loc>
		<lastmod>2011-10-17T10:50:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9408/news/industry-news/mercks-isentress%c2%ae-raltegravir-in-combination-therapy-demonstrated-virological-and-immunological-efficacy-versus-the-efavirenz-regimen-at-192-weeks-of-treatment/</loc>
		<lastmod>2011-10-14T11:14:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9414/news/industry-news/cephalon-announces-enrollment-in-the-risk-evaluation-and-mitigation-strategy-program-for-fentora-and-actiq/</loc>
		<lastmod>2011-10-14T11:12:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9412/news/industry-news/amgen-appoints-robert-a-bradway-to-the-companys-board-of-directors/</loc>
		<lastmod>2011-10-14T11:05:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9405/news/industry-news/humana-and-pfizer-form-research-partnership-to-improve-health-care-delivery-for-seniors/</loc>
		<lastmod>2011-10-14T10:56:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9401/news/industry-news/lundbeck-establishes-research-centre-in-china/</loc>
		<lastmod>2011-10-14T10:44:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9395/news/featured-news/tecan-and-attana-extend-distribution-agreement/</loc>
		<lastmod>2011-10-12T09:29:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9382/news/featured-news/radiometer%e2%80%99s-aqt90-flex-aids-point-of-care-d-dimer-testing-at-frimley-park/</loc>
		<lastmod>2011-10-11T10:36:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9378/news/featured-news/the-omega-series-with-acu-%e2%80%93-complete-and-individual-control-of-o2-and-co2-in-your-microplate-reader/</loc>
		<lastmod>2011-10-11T10:23:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9369/news/industry-news/study-shows-that-roche%e2%80%99s-investigational-drug-for-alzheimer%e2%80%99s-disease-removes-amyloid-plaques-from-the-brain1/</loc>
		<lastmod>2011-10-11T10:01:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9364/news/industry-news/victoza%c2%ae-now-available-to-people-with-type-2-diabetes-in-china/</loc>
		<lastmod>2011-10-10T08:59:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9361/news/industry-news/fda-approves-mercks-juvisync%e2%84%a2-sitagliptin-and-simvastatin-tablets/</loc>
		<lastmod>2011-10-10T08:56:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9359/news/industry-news/lundbeck-appoints-three-vice-presidents-in-supply-operations-engineering/</loc>
		<lastmod>2011-10-10T08:49:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9355/news/industry-news/astrazeneca-increases-investment-in-china-with-new-200-million-manufacturing-facility/</loc>
		<lastmod>2011-10-10T08:21:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9349/news/featured-news/biomerieux-increases-pharmaceutical-culture-media-production-capacity-and-launches-revolutionary-locksure%ef%83%a2-plate-technology/</loc>
		<lastmod>2011-10-07T10:11:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9346/news/industry-news/cialis%c2%ae-for-once-daily-use-now-fda-approved/</loc>
		<lastmod>2011-10-07T09:41:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9343/news/industry-news/teva-uk-limited-launches-olanzapine-range/</loc>
		<lastmod>2011-10-07T09:35:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9340/news/industry-news/astrazeneca-enters-into-a-settlement-agreement-with-accord-healthcare-inc-and-intas-pharmaceuticals-ltd-regarding-us-seroquel-xr%c2%ae-patent-litigation/</loc>
		<lastmod>2011-10-07T09:26:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9337/news/industry-news/gilead-and-boehringer-ingelheim-sign-license-agreement-for-novel-hiv-non-catalytic-integrase-inhibitors/</loc>
		<lastmod>2011-10-07T09:20:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9330/news/industry-news/merck-announces-retirement-of-chairman-and-former-ceo-richard-t-clark/</loc>
		<lastmod>2011-10-07T09:09:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9325/news/featured-news/tecan-takes-annual-scientific-symposium-to-shanghai/</loc>
		<lastmod>2011-10-06T14:31:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9319/news/industry-news/fda-accepts-new-drug-application-filing-for-ridaforolimus-investigational-mtor-inhibitor/</loc>
		<lastmod>2011-10-05T12:21:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9315/news/industry-news/brilique-receives-a-positive-preliminary-medical-benefit-assessment-for-the-majority-of-acs-patients-in-germany-as-part-of-new-amnog-review-process/</loc>
		<lastmod>2011-10-05T12:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9311/news/industry-news/abbott-enrolls-first-u-s-patient-in-global-excel-trial/</loc>
		<lastmod>2011-10-05T12:09:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9307/news/featured-news/bw-tek-introduces-next-generation-handheld-raman-instrument-for-material-verification-in-cgmp-compliant-facilities/</loc>
		<lastmod>2011-10-05T07:55:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/advertising/2012-print-media-pack-request/</loc>
		<lastmod>2011-10-04T15:33:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9152/events/industry-events/slas-2012/</loc>
		<lastmod>2011-10-03T10:43:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9285/news/industry-news/pfizer-launches-new-benefix%c2%ae-room-temperature-storage-packs-for-haemophilia-b-in-europe/</loc>
		<lastmod>2011-10-03T09:57:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9281/news/industry-news/takeda-receives-positive-chmp-opinion-in-europe-for-edarbitm-azilsartan-medoxomil/</loc>
		<lastmod>2011-09-29T13:53:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9277/news/featured-news/tecan%e2%80%99s-new-mca-384-disposable-tips-offer-enhanced-pipetting-flexibility/</loc>
		<lastmod>2011-09-27T15:38:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9267/news/featured-news/wyatt-technologys-fff-mals-provides-efficient-liposome-characterization-2/</loc>
		<lastmod>2011-09-27T11:06:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9250/news/industry-news/boehringer-ingelheim-expands-its-business-with-biosimilars/</loc>
		<lastmod>2011-09-27T10:27:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9261/news/industry-news/alimta-helped-keep-most-common-form-of-lung-cancer-at-bay-in-elderly-patients/</loc>
		<lastmod>2011-09-27T09:32:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9257/news/industry-news/alimta-receives-positive-opinion-from-chmp/</loc>
		<lastmod>2011-09-27T09:28:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9253/news/industry-news/bibf-1120-in-patients-with-metastatic-colorectal-cancer-as-effective-as-bevacizumab-with-less-serious-adverse-events/</loc>
		<lastmod>2011-09-27T09:20:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9244/news/industry-news/new-novartis-data-show-potential-of-respiratory-portfolio-to-help-copd-patients-maintain-active-and-productive-lives/</loc>
		<lastmod>2011-09-27T09:04:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9242/news/industry-news/novartis-receives-approval-in-japan-for-two-innovative-therapies-gilenya%c2%ae-in-ms-and-ilaris%c2%ae-in-caps/</loc>
		<lastmod>2011-09-27T08:58:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9233/news/featured-news/your-successful-start-in-microencapsulation/</loc>
		<lastmod>2011-09-26T15:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9230/news/industry-news/european-chmp-adopts-positive-opinion-for-eviplerar/</loc>
		<lastmod>2011-09-26T10:33:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9228/news/industry-news/positive-opinion-on-the-usage-of-levemir%c2%ae-insulin-detemir-as-add-on-therapy-to-victoza%c2%ae-liraglutide-in-people-with-type-2-diabetes/</loc>
		<lastmod>2011-09-26T10:28:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9226/news/industry-news/positive-opinion-on-the-use-of-levemir%c2%ae-insulin-detemir-in-children-with-type-1-diabetes-aged-two-to-five-years/</loc>
		<lastmod>2011-09-26T10:25:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9222/news/industry-news/roche%e2%80%99s-investigational-medicine-t-dm1-shows-improvement-in-progression-free-survival-compared-to-standard-of-care-in-her2-positive-metastatic-breast-cancer/</loc>
		<lastmod>2011-09-26T10:13:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9214/news/industry-news/novartis-drug-afinitor%c2%ae-helps-women-with-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing/</loc>
		<lastmod>2011-09-26T10:02:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9211/news/industry-news/novartis-drug-afinitor%c2%ae-effective-in-patients-with-non-cancerous-kidney-tumors-associated-with-tsc-in-phase-iii-trial/</loc>
		<lastmod>2011-09-26T09:54:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9207/news/industry-news/novartis-gains-positive-chmp-opinion-for-rasitrio%c2%ae-first-rasilez-based-triple-combination-pill-in-europe-to-treat-high-blood-pressure/</loc>
		<lastmod>2011-09-26T09:46:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9203/news/industry-news/astrazeneca-announces-first-approval-of-faslodex%e2%84%a2-fulvestrant-in-japan/</loc>
		<lastmod>2011-09-26T08:26:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9198/news/industry-news/komboglyze%e2%84%a2-saxagliptin-and-metformin-hcl-immediate-release-receives-positive-chmp-opinion-in-the-european-union-for-the-treatment-of-type-2-diabetes/</loc>
		<lastmod>2011-09-23T12:44:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9192/news/industry-news/new-study-shows-investigational-bibf-1120-demonstrated-positive-trend-in-reducing-lung-function-loss-in-idiopathic-pulmonary-fibrosis/</loc>
		<lastmod>2011-09-22T11:03:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9189/news/industry-news/lilly-steps-up-efforts-to-improve-diversity-in-clinical-trials/</loc>
		<lastmod>2011-09-22T10:57:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9185/news/industry-news/viramune%c2%ae-nevirapine-prolonged-release-once-daily-formulation-for-the-treatment-of-hiv-1-infection-receives-approval-in-the-eu/</loc>
		<lastmod>2011-09-22T10:45:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9182/news/industry-news/bristol-myers-squibb-and-ono-enter-into-strategic-agreement/</loc>
		<lastmod>2011-09-22T10:40:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9177/news/industry-news/sanofi-pasteur-acquires-exclusive-worldwide-license-for-acne-vaccine-and-treatment/</loc>
		<lastmod>2011-09-22T10:36:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9172/news/industry-news/sygnature-chemical-services-becomes-sygnature-discovery-to-better-reflect-its-integrated-drug-discovery-service-offering/</loc>
		<lastmod>2011-09-21T14:49:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9164/news/industry-news/roche-highlights-data-that-demonstrate-a-range-of-new-approaches-to-target-breast-skin-and-lung-cancers-at-2011-european-multidisciplinary-cancer-congress/</loc>
		<lastmod>2011-09-19T14:53:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9158/news/industry-news/mercks-isentress%c2%ae-raltegravir-in-combination-therapy-demonstrated-efficacy-and-tolerability-in-an-observational-trial/</loc>
		<lastmod>2011-09-19T14:35:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9145/news/industry-news/pfizer-extends-subsequent-offering-period-of-tender-offer-to-acquire-icagen-inc/</loc>
		<lastmod>2011-09-16T11:07:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9141/news/industry-news/novartis-increases-growth-potential-through-integration-of-alcon/</loc>
		<lastmod>2011-09-16T10:57:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9137/news/industry-news/gsk-and-mclaren-group-announce-innovative-strategic-partnership/</loc>
		<lastmod>2011-09-16T10:47:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9134/news/industry-news/gsk-commits-1-million-in-cervical-cancer-vaccine/</loc>
		<lastmod>2011-09-16T10:33:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9126/news/featured-news/tecan%e2%80%99s-cavro%c2%ae-omni-robot-opens-up-new-applications-for-modern-circular-dichroism/</loc>
		<lastmod>2011-09-15T12:48:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9116/news/industry-news/new-data-show-people-with-type-2-diabetes-experience-greater-improvements-in-glycaemic-control-when-using-victoza%c2%ae-early-in-diabetes-treatment/</loc>
		<lastmod>2011-09-13T08:41:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9113/news/industry-news/lyxumia%c2%ae-lixisenatide-one-step-regimen-as-effective-as-two-step-regimen-in-improving-glycemic-control-in-type-2-diabetes/</loc>
		<lastmod>2011-09-13T08:30:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9110/news/industry-news/glaxosmithkline-and-amicus-therapeutics-commence-second-phase-iii-study-of-amigal%e2%84%a2-for-fabry-disease/</loc>
		<lastmod>2011-09-13T07:49:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9106/news/industry-news/analyses-find-type-2-diabetes-patients-treated-with-bydureon%e2%84%a2-experienced-reduction-in-cardiovascular-risk-factors/</loc>
		<lastmod>2011-09-12T12:06:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9103/news/industry-news/abbott-initiates-international-absorb-btk-clinical-trial-for-treatment-of-below-the-knee-critical-limb-ischemia/</loc>
		<lastmod>2011-09-12T11:25:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9100/news/industry-news/bristol-myers-squibb-completes-acquisition-of-amira-pharmaceuticals/</loc>
		<lastmod>2011-09-12T11:18:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9095/news/industry-news/lapatinib-clinical-trial-update/</loc>
		<lastmod>2011-09-12T11:07:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9092/news/featured-news/idbs-celebrates-queens-award-for-international-trade/</loc>
		<lastmod>2011-09-09T13:26:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9086/news/featured-news/bw-tek-announces-enhanced-high-resolution-raman-spectrometer-and-new-state-of-the-art-chemometric-software/</loc>
		<lastmod>2011-09-09T11:23:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9065/news/industry-news/perkinelmer-to-acquire-caliper-life-sciences-for-approximately-600-million/</loc>
		<lastmod>2011-09-08T13:44:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9060/news/industry-news/roche-named-dow-jones-sustainability-index-leader-in-healthcare-for-third-consecutive-year/</loc>
		<lastmod>2011-09-08T10:50:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9056/news/industry-news/novartis-receives-eu-approval-for-votubia%c2%ae/</loc>
		<lastmod>2011-09-08T10:42:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9052/news/industry-news/jens-eckstein-named-president-of-sr-one/</loc>
		<lastmod>2011-09-08T10:15:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/9048/news/featured-news/thermo-fisher-scientific-opens-new-biomarker-translational-center/</loc>
		<lastmod>2011-09-08T08:56:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8990/news/featured-news/tecan-brings-hp-direct-digital-titration-to-drug-discovery-biologists/</loc>
		<lastmod>2011-09-07T14:09:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8988/news/industry-news/biogen-idec-fully-acquires-biogen-dompe-joint-ventures/</loc>
		<lastmod>2011-09-07T09:37:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8981/news/industry-news/boehringer-ingelheim-wins-frost-sullivan-award-for-biopharmaceutical-contract-manufacturing/</loc>
		<lastmod>2011-09-07T09:31:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8978/news/industry-news/pfizer-announces-successful-completion-of-initial-cash-tender-offer-for-outstanding-shares-of-icagen-inc/</loc>
		<lastmod>2011-09-07T09:17:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8974/news/industry-news/novartis-drug-afinitor%c2%ae-gains-eu-approval-to-treat-patients-with-advanced-pancreatic-neuroendocrine-tumors/</loc>
		<lastmod>2011-09-07T09:10:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8969/news/industry-news/gsk-awarded-contract-by-barda-to-support-research-on-potential-novel-antibiotic/</loc>
		<lastmod>2011-09-07T09:03:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8944/news/industry-news/bayer-confident-in-results-of-rocket-af-study/</loc>
		<lastmod>2011-09-06T15:44:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8942/news/industry-news/gilead-to-make-changes-in-hepatitis-c-drug-trial-design/</loc>
		<lastmod>2011-09-06T10:23:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8938/news/featured-news/thermo-fisher-scientific-scientist-dr-alexander-makarov-receives-inaugural-hupo-science-and-technology-award/</loc>
		<lastmod>2011-09-06T10:13:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8936/news/industry-news/evotec-and-roche-to-develop-compound-that-could-slow-the-progression-of-alzheimers-disease/</loc>
		<lastmod>2011-09-06T07:44:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8933/news/industry-news/astellas-pharma-signs-a-license-agreement-with-evec-for-a-fully-human-antibody/</loc>
		<lastmod>2011-09-05T11:10:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8930/news/industry-news/pfizer-extends-tender-offer-to-acquire-icagen-inc/</loc>
		<lastmod>2011-09-05T11:00:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8923/news/featured-news/wyatt-technology%e2%80%99s-calypso-gc-mals-system-provides-fast-and-accurate-measurements-of-biomolecular-interactions/</loc>
		<lastmod>2011-09-02T14:43:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8919/news/industry-news/astrazeneca-announces-top-line-results-from-saturn-study/</loc>
		<lastmod>2011-09-02T11:23:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8916/news/industry-news/pfizer-signs-agreement-with-mit-for-future-cambridge-research-center/</loc>
		<lastmod>2011-09-02T11:08:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8914/news/industry-news/health-canada-approval-remicade%c2%ae-for-treatment-of-pediatric-ulcerative-colitis/</loc>
		<lastmod>2011-09-02T11:05:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8912/news/industry-news/bayer-healthcare-to-acquire-pathway-medical-technologies/</loc>
		<lastmod>2011-09-02T10:53:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8909/news/industry-news/sale-of-astra-tech-to-dentsply-international-complete/</loc>
		<lastmod>2011-09-01T15:51:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8907/news/industry-news/new-data-from-bristol-myers-squibb-on-nulojix%c2%ae-belatacept/</loc>
		<lastmod>2011-09-01T14:56:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8903/news/industry-news/icon-selected-as-a-preferred-provider-for-early-phase-clinical-development-by-bristol-myers-squibb/</loc>
		<lastmod>2011-08-31T15:25:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7609/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/under-the-microscope-fredrik-sundberg-ge-healthcare/</loc>
		<lastmod>2011-08-31T08:49:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7611/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/reducing-attrition-in-drug-discovery-the-role-of-biomarkers/</loc>
		<lastmod>2011-08-31T08:49:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7620/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/implementation-of-flow-cytometric-biomarker-assays-in-clinical-development/</loc>
		<lastmod>2011-08-31T08:49:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7622/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/isothermal-titration-calorimetry-and-thermal-shift-assay-in-drug-design/</loc>
		<lastmod>2011-08-31T08:48:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7635/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/high-content-screening-for-in-vitro-toxicity-testing/</loc>
		<lastmod>2011-08-31T08:48:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7659/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/application-of-deep-uv-resonance-raman-spectroscopy-to-bioprocessing/</loc>
		<lastmod>2011-08-31T08:48:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7673/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/micrornas-and-their-potential-involvement-in-hiv-infection/</loc>
		<lastmod>2011-08-31T08:47:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7678/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/evolution-and-revolution-in-time-of-flight-mass-spectrometry-and-its-impact-on-research-within-the-pharmaceutical-industry/</loc>
		<lastmod>2011-08-31T08:47:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7684/european-pharmaceutical-review-magazine/past-issues/issue-3-2011/detection-of-microorganisms-using-cellular-component-based-rapid-method-technologies/</loc>
		<lastmod>2011-08-31T08:47:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8818/news/industry-news/boehringer-ingelheim-broadens-its-breast-cancer-trial-programme-for-afatinib/</loc>
		<lastmod>2011-08-30T12:36:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8845/news/industry-news/novo-nordisk-to-build-new-corporate-centre/</loc>
		<lastmod>2011-08-30T10:29:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8843/news/industry-news/linagliptin-receives-approval-in-europe-for-treatment-of-type-2-diabetes/</loc>
		<lastmod>2011-08-30T10:26:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8839/news/industry-news/abbott-receives-fda-approval-for-alk-gene-test/</loc>
		<lastmod>2011-08-30T10:19:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8835/news/industry-news/eliquis%c2%ae-apixaban-superior-to-warfarin-for-the-reduction-of-stroke-or-systemic-embolism/</loc>
		<lastmod>2011-08-30T10:15:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8830/news/industry-news/pradaxa%c2%ae-dabigatran-etexilate-150mg-bid-shows-significant-reduction-in-the-risk-of-stroke/</loc>
		<lastmod>2011-08-30T10:10:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8825/news/industry-news/tak-385-enters-into-phase-2-clinical-trials-in-japan/</loc>
		<lastmod>2011-08-30T09:59:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8823/news/industry-news/nucynta%c2%ae-er-tapentadol-extended-release-tablets-receives-fda-approval/</loc>
		<lastmod>2011-08-30T09:58:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8812/news/industry-news/trajenta%c2%ae-linagliptin-receives-approval-for-the-treatment-of-type-2-diabetes-in-europe/</loc>
		<lastmod>2011-08-26T09:56:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8807/news/featured-news/ert-appoints-linda-deal-head-of-health-outcomes-research/</loc>
		<lastmod>2011-08-25T15:22:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8803/news/industry-news/amgen-announces-pdufa-date-for-xgeva%c2%ae-supplemental-biologics-license-application/</loc>
		<lastmod>2011-08-23T16:14:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8800/news/industry-news/fda-clears-abbott%e2%80%99s-genetic-fish-panel-for-leukemia-patient-prognosis/</loc>
		<lastmod>2011-08-23T16:07:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8794/news/industry-news/bristol-myers-squibb-and-pfizer-announce-data-presentations-for-apixaban/</loc>
		<lastmod>2011-08-23T16:02:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8638/news/industry-news/automation-in-pharmaceutical-industry/</loc>
		<lastmod>2011-08-23T14:31:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/186/news/featured-news/cisbio-bioassays-introduces-tag-lite%c2%ae-multi-mode-cell-lines/</loc>
		<lastmod>2011-08-23T13:13:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8772/news/featured-news/wyatt-technologys-fff-mals-provides-efficient-liposome-characterization/</loc>
		<lastmod>2011-08-22T09:17:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8766/news/industry-news/merck-and-ariad-announce-ema-accepts-marketing-authorization-application-for-ridaforolimus-investigational-mtor-inhibitor/</loc>
		<lastmod>2011-08-22T08:15:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8764/news/industry-news/gsk-takes-minority-stake-in-new-spin-out-autifony-therapeutics/</loc>
		<lastmod>2011-08-22T08:03:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8752/news/industry-news/fda-approves-zelboraf-vemurafenib/</loc>
		<lastmod>2011-08-18T08:57:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8749/news/industry-news/fda-approval-of-zelboraftm-vemurafenib-establishes-oncology-foothold-in-us-for-daiichi-sankyo/</loc>
		<lastmod>2011-08-18T08:43:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8746/news/industry-news/pfizer-announces-european-medicines-agency-acceptance-of-regulatory-submissions-for-two-investigational-cancer-therapies/</loc>
		<lastmod>2011-08-18T08:34:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8739/news/industry-news/abbott-receives-fda-approval-for-two-three-month-strengths-of-lupron-depot-ped%c2%ae-leuprolide-acetate-for-depot-suspension/</loc>
		<lastmod>2011-08-17T13:11:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8734/news/featured-news/tecan%e2%80%99s-mca-384-adapter-plate-concept-provides-ultimate-flexibility-for-the-university-of-konstanz/</loc>
		<lastmod>2011-08-17T10:13:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8587/news/industry-news/drug-%e2%80%9chunter%e2%80%9d-honoured/</loc>
		<lastmod>2011-08-16T10:26:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8710/news/industry-news/bristol-myers-squibb-announces-the-winners-of-the-2011-reyataz%c2%ae-atazanavir-sulfate-%e2%80%9cfight-hiv-your-way%e2%80%9d-contest/</loc>
		<lastmod>2011-08-16T09:36:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8721/news/industry-news/gileads-investigational-antiretroviral-quad-regimen-meets-48-week-primary-objective-in-pivotal-phase-3-clinical-study-102/</loc>
		<lastmod>2011-08-16T09:06:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8704/news/industry-news/pfizer-wins-viagra-patent-trial/</loc>
		<lastmod>2011-08-16T08:38:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8698/news/industry-news/gsk-and-impax-announce-positive-topline-results-of-ascend-pd-phase-iii-study-of-ipx066-in-advanced-parkinson%e2%80%99s-disease/</loc>
		<lastmod>2011-08-16T08:28:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5759/news/featured-news/flexicon-ff30-new-and-improved-tabletop-filling-and-capping-machine/</loc>
		<lastmod>2011-08-15T16:05:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/386/news/featured-news/eminent-us-medical-institute-uses-dyversity-image-analysis-system-to-detect-proteins-associated-with-longer-human-life-span/</loc>
		<lastmod>2011-08-15T15:44:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/383/news/featured-news/top-ten-pharma-company-uses-automated-tlc-plate-reader-to-ensure-the-contents-of-drugs-and-raw-materials-are-safe/</loc>
		<lastmod>2011-08-15T15:43:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/379/news/featured-news/gbox-chemiluminescence-imager-is-used-at-prestigious-research-institute-to-rapidly-determine-the-pre-clinical-potential-of-anti-cancer-compounds/</loc>
		<lastmod>2011-08-15T15:43:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/375/news/featured-news/university-of-lausanne-uses-dyversity-for-analysing-triple-labelled-dige-gels/</loc>
		<lastmod>2011-08-15T15:43:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/371/news/featured-news/major-us-university-uses-genegnome-for-six-years-in-important-academic-study-to-elucidate-mechanisms-of-cell-division/</loc>
		<lastmod>2011-08-15T15:43:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/365/news/featured-news/gbox-ef-imaging-system-used-at-major-plant-breeding-centre/</loc>
		<lastmod>2011-08-15T15:43:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3813/news/featured-news/new-geni-system-extends-syngene%e2%80%99s-gel-documentation-range/</loc>
		<lastmod>2011-08-15T15:42:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/356/news/featured-news/automated-zone-measuring-system-used-at-major-vaccine-company-to-reduce-the-timelines-for-release-of-flu-vaccines/</loc>
		<lastmod>2011-08-15T15:35:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/353/news/featured-news/launch-of-new-automated-colony-counter-and-zone-sizing-system-with-unique-hd-imaging/</loc>
		<lastmod>2011-08-15T15:35:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/350/news/featured-news/make-analysing-the-potency-of-flu-vaccines-ten-times-faster-with-protocol%e2%80%99s-new-srd-zone-measurement-features/</loc>
		<lastmod>2011-08-15T15:35:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/347/news/featured-news/new-opka-assay-application-features-for-protocol-ensure-speedy-analysis-of-pneumococcal-vaccines/</loc>
		<lastmod>2011-08-15T15:35:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/345/news/featured-news/major-european-pharmaceutical-company-installs-tenth-protocol-system-to-increase-productivity-of-vaccine-testing/</loc>
		<lastmod>2011-08-15T15:35:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/342/news/featured-news/danish-biotech-reduces-vaccine-testing-time-from-two-days-to-one-hour-using-a-protocol-system-to-assess-vaccine-potency/</loc>
		<lastmod>2011-08-15T15:34:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/338/news/featured-news/new-brochure-for-colony-counter-and-zone-measurement-systems/</loc>
		<lastmod>2011-08-15T15:34:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/335/news/featured-news/new-protocol-2-system-speeds-up-quality-testing-of-swine-flu-vaccines/</loc>
		<lastmod>2011-08-15T15:34:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/331/news/featured-news/new-automated-zone-analysis-system/</loc>
		<lastmod>2011-08-15T15:34:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/325/news/featured-news/protocol-2-is-upgraded-to-offer-faster-route-for-determining-effectiveness-of-vaccines-and-anti-microbials/</loc>
		<lastmod>2011-08-15T15:33:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/319/news/featured-news/new-protocol-2-uv-imaging-accessory/</loc>
		<lastmod>2011-08-15T15:33:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3415/news/featured-news/hecus-x-ray-systems-with-s3-microcalix-on-winning-course/</loc>
		<lastmod>2011-08-15T14:59:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/479/news/featured-news/huber-launch-the-new-unistat%c2%ae-905w/</loc>
		<lastmod>2011-08-15T14:58:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3621/news/featured-news/budget-priced-laboratory-temperature-control-machines/</loc>
		<lastmod>2011-08-15T14:58:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5721/news/featured-news/huber-offer-atex-rated-solutions-for-the-unistat%c2%ae-range-of-high-precision-temperature-control-systems/</loc>
		<lastmod>2011-08-15T14:58:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7016/news/featured-news/small-smaller-ministat/</loc>
		<lastmod>2011-08-15T14:58:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/265/news/featured-news/the-latest-advancement-in-process-analytical-technology-%e2%80%93-the-anatel-pat700-on-line-toc-analyser/</loc>
		<lastmod>2011-08-15T14:20:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/269/news/featured-news/the-new-met-one-3400-series-portable-airborne-counter/</loc>
		<lastmod>2011-08-15T14:20:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/257/news/featured-news/accurate-drift-free-cost-saving-ozone-sensor/</loc>
		<lastmod>2011-08-15T14:20:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/239/news/featured-news/freeman-technology-highlights-relevance-of-the-ft4-for-dpi-characterisation-at-rdd-2010/</loc>
		<lastmod>2011-08-15T14:11:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6801/news/featured-news/market-leaders-expo-technologies-umetrics-provide-better-pat-tool-connectivity/</loc>
		<lastmod>2011-08-15T14:06:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5137/news/industry-news/discoverx-acquires-the-kinomescan-kinase-screening-services-division-from-ambit-biosciences/</loc>
		<lastmod>2011-08-15T13:59:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3843/news/featured-news/government-applies-pressure-for-continuous-temperature-monitoring/</loc>
		<lastmod>2011-08-15T13:44:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6242/news/featured-news/maxis-4g-uhr-qtof-redefines-high-performance-mass-spectrometry/</loc>
		<lastmod>2011-08-15T11:23:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-registration/</loc>
		<lastmod>2011-08-12T15:07:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/add-your-company/</loc>
		<lastmod>2011-08-12T14:48:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-registration-confirmation/</loc>
		<lastmod>2011-08-12T14:47:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-invoice/</loc>
		<lastmod>2011-08-12T14:46:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-sagepay/</loc>
		<lastmod>2011-08-12T14:46:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-payment-method/</loc>
		<lastmod>2011-08-12T14:46:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-directory-registration-2/</loc>
		<lastmod>2011-08-12T14:37:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-details-editor/</loc>
		<lastmod>2011-08-12T14:35:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-listing-editor/</loc>
		<lastmod>2011-08-12T14:34:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-listing-management/</loc>
		<lastmod>2011-08-12T14:33:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-login/</loc>
		<lastmod>2011-08-12T14:32:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/directory/company-details/</loc>
		<lastmod>2011-08-12T14:31:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8595/news/industry-news/u-s-fda-approves-gilead-sciences%e2%80%99-complera%e2%84%a2/</loc>
		<lastmod>2011-08-12T10:01:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8584/news/industry-news/abbott-receives-u-s-fda-approval-for-rx-herculink-elite%c2%ae-renal-stent-system/</loc>
		<lastmod>2011-08-11T09:42:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8577/news/industry-news/gsk-and-enigma-diagnostics-announce-collaboration-on-assay-development-and-commercialisation-of-enigma%e2%80%99s-ml-platform/</loc>
		<lastmod>2011-08-11T09:37:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8573/news/featured-news/greenphire-contracts-with-the-university-of-kansas-to-automate-clinical-payment-and-communication-processes/</loc>
		<lastmod>2011-08-10T14:45:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8564/news/industry-news/regulatory-update-gsk-and-xenoport-submit-supplemental-new-drug-application-to-fda/</loc>
		<lastmod>2011-08-10T10:58:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8561/news/industry-news/boehringer-ingelheim-licenses-probiogens-novel-glymaxx%c2%ae-technology/</loc>
		<lastmod>2011-08-10T10:08:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8558/news/industry-news/positive-first-half-year-2011-for-boehringer-ingelheim-%e2%80%93-new-growth-from-innovative-medicines-pradaxa-approved-in-europe/</loc>
		<lastmod>2011-08-10T10:05:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8554/news/industry-news/lilly-announces-review-of-data-on-long-term-raloxifene-treatment-for-postmenopausal-osteoporosis/</loc>
		<lastmod>2011-08-09T15:51:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8551/news/industry-news/biogen-idec-and-abbott-announce-positive-top-line-results/</loc>
		<lastmod>2011-08-09T15:42:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8545/news/featured-news/precos-partners-with-reliable-cancer-therapies-to-provide-rigorous-scientific-evidence-for-complementary-cancer-medicines/</loc>
		<lastmod>2011-08-09T15:01:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8538/news/industry-news/gilead-sciences-to-purchase-biologics-process-research-and-clinical-manufacturing-facility-from-genentech/</loc>
		<lastmod>2011-08-09T08:52:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8535/news/industry-news/pfizer-expands-california-centers-for-therapeutic-innovation/</loc>
		<lastmod>2011-08-09T08:42:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/digital-news-2/</loc>
		<lastmod>2011-08-08T16:27:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/notes-for-authors/</loc>
		<lastmod>2011-08-08T16:26:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/magazines/past-issues/</loc>
		<lastmod>2011-08-08T16:18:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/category/latest-issue/</loc>
		<lastmod>2011-08-08T16:09:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7124/news/industry-news/achieving-quality-process-excellence-in-the-pharma-industry/</loc>
		<lastmod>2011-08-08T16:09:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/email-newsletter/</loc>
		<lastmod>2011-08-08T15:20:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8491/news/featured-news/thermo-fisher-scientific-implements-and-extends-lims-solution-for-eastman-chemical-company/</loc>
		<lastmod>2011-08-05T11:32:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8480/news/featured-news/ceo-of-molecular-profiles-recognized-as-one-of-100-most-inspiring-people-in-the-life-sciences-industry/</loc>
		<lastmod>2011-08-05T09:40:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8477/news/industry-news/amylin-and-takeda-discontinue-development-of-pramlintidemetreleptin-combination-treatment/</loc>
		<lastmod>2011-08-05T08:31:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8472/news/industry-news/new-cancer-imaging-technique-uses-vitamin-c-to-detect-more-aggressive-tumours/</loc>
		<lastmod>2011-08-04T13:53:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8466/news/industry-news/breakthrough-therapy-pradaxa%c2%ae-dabigatran-etexilate-first-drug-in-50-years-to-gain-approval-for-stroke-prevention-in-atrial-fibrillation-in-europe/</loc>
		<lastmod>2011-08-04T13:22:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8461/news/featured-news/nsf-international-launches-nsf-reference-standards%e2%84%a2-program/</loc>
		<lastmod>2011-08-04T13:09:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8456/news/featured-news/thermo-fisher-scientific-launches-build-your-own-ft-ir-microsite/</loc>
		<lastmod>2011-08-04T09:37:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8453/news/industry-news/roche%e2%80%99s-investigational-treatment-for-asthma-met-its-primary-endpoint-in-a-phase-ii-study/</loc>
		<lastmod>2011-08-04T08:52:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8449/news/industry-news/nccn-receives-2m-educational-grant-from-pfizer/</loc>
		<lastmod>2011-08-04T08:45:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8446/news/industry-news/merck-and-serum-institute-announce-collaboration-to-develop-and-expand-global-access-to-pcv/</loc>
		<lastmod>2011-08-04T08:32:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8441/news/featured-news/sigma%c2%ae-life-science-reaches-milestone-in-gene-editing/</loc>
		<lastmod>2011-08-03T13:04:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8438/news/industry-news/roche%e2%80%99s-roactemra-approved-in-europe-for-children-living-with-a-rare-and-severe-form-of-arthritis/</loc>
		<lastmod>2011-08-03T10:31:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8368/news/industry-news/dr-david-alexandre-gros-appointed-chief-strategy-officer-of-sanofi/</loc>
		<lastmod>2011-08-02T10:07:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8407/news/industry-news/eli-lilly-india-and-lupin-announce-strategic-collaboration-to-help-fight-the-battle-against-diabetes/</loc>
		<lastmod>2011-08-02T10:06:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8417/news/industry-news/positive-agreement-received-for-approval-of-axanum-low-dose-asaesomeprazole-in-europe/</loc>
		<lastmod>2011-08-02T09:47:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8424/news/featured-news/prism-ideas-ceo-acknowledged-among-the-top-100-most-inspiring-people-in-the-pharmaceutical-industry/</loc>
		<lastmod>2011-08-02T09:44:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8412/news/industry-news/merck-millipore-completed-acquisition-of-microbiology-business-of-biotest-ag/</loc>
		<lastmod>2011-08-02T09:30:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8420/news/industry-news/pfizer-completes-sale-of-capsugel-business-to-kkr/</loc>
		<lastmod>2011-08-02T08:22:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8404/news/industry-news/u-s-fda-approves-subcutaneous-formulation-of-orencia%c2%ae-abatacept/</loc>
		<lastmod>2011-08-01T13:02:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8401/news/industry-news/pfizer-provides-u-s-regulatory-update-on-prevnar-13%c2%ae/</loc>
		<lastmod>2011-08-01T11:25:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8117/whitepapers/whitepaper-the-importance-of-being-profiled-improving-drug-candidate-safety-and-efficacy-using-cross-target-profiling/</loc>
		<lastmod>2011-08-01T09:22:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8394/whitepapers/whitepaper-an-interview-with-dr-john-rossi/</loc>
		<lastmod>2011-08-01T09:17:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8383/news/industry-news/biogen-idec-strengthens-ms-activesourcer-for-people-with-multiple-sclerosis/</loc>
		<lastmod>2011-07-28T10:40:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8378/news/industry-news/investigational-ultra-long-acting-insulin-degludec-reduces-hypoglycaemia-and-improves-long-term-control-in-patients-with-type-1-and-type-2-diabetes/</loc>
		<lastmod>2011-07-28T10:35:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8374/news/industry-news/teva-uk-limited-launches-generic-letrozole-tablets/</loc>
		<lastmod>2011-07-28T10:29:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8371/news/industry-news/abbott%e2%80%99s-hiv-combo-test-detects-infections-earlier-provides-valuable-information-to-help-prevent-further-hiv-transmission/</loc>
		<lastmod>2011-07-28T10:22:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8361/news/industry-news/viramune%c2%ae-nevirapine-prolonged-release-once-daily-formulation-for-the-treatment-of-hiv-1-infection-receives-chmp-recommendation-for-approval/</loc>
		<lastmod>2011-07-27T11:09:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8358/news/industry-news/merck-to-acquire-rights-to-vernakalant-i-v-in-canada-mexico-and-the-united-states-from-astellas/</loc>
		<lastmod>2011-07-27T10:50:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8354/news/featured-news/thermo-fisher-scientific-launches-new-lims-for-clinical-laboratories-at-aacc-2011/</loc>
		<lastmod>2011-07-27T10:26:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8350/news/featured-news/thermo-fisher-scientific-introduces-workflows-at-aacc-2011/</loc>
		<lastmod>2011-07-26T13:02:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8346/news/featured-news/wyatt-technology-to-host-the-22nd-annual-international-light-scattering-colloquium/</loc>
		<lastmod>2011-07-25T13:54:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8342/news/industry-news/new-senior-executives-appointed-at-sanofi/</loc>
		<lastmod>2011-07-25T09:40:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8339/news/industry-news/roche-to-provide-hivaids-tests-for-early-infant-diagnosis-in-south-africa/</loc>
		<lastmod>2011-07-25T09:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8336/news/industry-news/novartis-drug-afinitor%c2%ae-recommended-by-chmp-for-eu-approval/</loc>
		<lastmod>2011-07-25T09:30:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8332/news/industry-news/leukocare-and-sanofi-pasteur-sign-cooperation-agreement-for-vaccine-stabilization/</loc>
		<lastmod>2011-07-25T08:19:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8328/news/featured-news/sigma%c2%ae-life-science-launches-genetically-modified-human-cell-lines-for-breast-cancer-research/</loc>
		<lastmod>2011-07-22T13:20:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8323/news/featured-news/novozymes-biopharma-secures-business-innovation-award/</loc>
		<lastmod>2011-07-22T09:58:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8320/news/industry-news/edurant%e2%84%a2-96-week-phase-3-safety-and-efficacy-data-presented/</loc>
		<lastmod>2011-07-22T09:45:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8316/news/industry-news/idera-reports-clinical-hold-on-proposed-phase-2-clinical-trial-of-imo-3100/</loc>
		<lastmod>2011-07-22T09:36:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8312/news/industry-news/fda-advisory-committee-recommends-approval-of-remicade%c2%ae/</loc>
		<lastmod>2011-07-22T09:10:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8309/news/industry-news/millennium-submits-supplemental-new-drug-application-with-fda/</loc>
		<lastmod>2011-07-22T09:00:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8302/news/industry-news/european-medicines-agency-recommends-revised-labeling-and-guidance-for-pioglitazone-containing-products/</loc>
		<lastmod>2011-07-22T08:53:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8297/news/industry-news/cephalon-receives-fda-approval-for-risk-evaluation-and-mitigation-strategy-for-fentora-and-actiq/</loc>
		<lastmod>2011-07-22T08:40:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8293/news/industry-news/bristol-myers-squibb-to-acquire-amira-pharmaceuticals/</loc>
		<lastmod>2011-07-22T08:26:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8290/news/industry-news/merck-and-simcere-sign-agreement-to-establish-pioneering-china-joint-venture/</loc>
		<lastmod>2011-07-22T08:19:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8287/news/industry-news/glaxosmithkline-european-regulatory-update-on-pandemrix%e2%84%a2/</loc>
		<lastmod>2011-07-22T08:13:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8281/company-directory/biotek-instruments-inc/</loc>
		<lastmod>2011-07-22T07:48:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8278/news/industry-news/brecon-appoints-new-director-of-operations/</loc>
		<lastmod>2011-07-21T10:21:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8274/news/industry-news/pfizer-to-acquire-icagen/</loc>
		<lastmod>2011-07-21T09:16:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8271/news/industry-news/fda-approves-new-medicine-brilinta-ticagrelor-for-use-in-the-us/</loc>
		<lastmod>2011-07-21T09:08:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8267/news/featured-news/thermo-fisher-scientific-wins-rd-100-award-with-uv-vis-spectrophotometer/</loc>
		<lastmod>2011-07-21T07:47:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8264/news/industry-news/merck-and-roche-expand-agreement-in-fight-against-chronic-hepatitis-c/</loc>
		<lastmod>2011-07-20T11:14:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8261/news/industry-news/fda-advisory-committee-makes-recommendation-on-investigational-compound-dapagliflozin/</loc>
		<lastmod>2011-07-20T11:09:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8257/news/featured-news/optibrium-launches-new-version-of-free-starvue-app/</loc>
		<lastmod>2011-07-19T14:27:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8253/news/featured-news/sigma%c2%ae-life-science-launches-compozr%c2%ae-targeted-integration-kit-%e2%80%93-mrosa26-for-the-mouse-genome/</loc>
		<lastmod>2011-07-19T13:03:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3865/company-directory/cellular-dynamics-international-inc/</loc>
		<lastmod>2011-07-19T11:21:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8221/news/industry-news/new-data-showed-minimal-potential-for-drug-interaction-between-cholesterol-drug-livalo%c2%ae-and-a-common-antiretroviral-therapy/</loc>
		<lastmod>2011-07-19T10:33:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8244/news/industry-news/florbetapir-imaging-to-autopsy-study-awarded-alzheimers-associations-2011-de-leon-prize-in-neuroimaging/</loc>
		<lastmod>2011-07-19T08:46:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8241/news/industry-news/lilly-presents-follow-up-data-on-semagacestat-to-assist-future-alzheimers-disease-research/</loc>
		<lastmod>2011-07-19T08:22:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8236/news/industry-news/roche-acquires-mtm-laboratories-ag-expanding-offering-in-cervical-cancer-testing/</loc>
		<lastmod>2011-07-19T08:13:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8232/news/industry-news/victrelis%e2%84%a2-boceprevir-first-in-class-oral-hepatitis-c-virus-protease-inhibitor-approved-in-the-european-union-for-treatment-of-chronic-hepatitis-c/</loc>
		<lastmod>2011-07-19T08:05:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-2-2009.pdf</loc>
		<lastmod>2011-07-18T14:35:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-3-2009.pdf</loc>
		<lastmod>2011-07-18T14:35:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-1-2009.pdf</loc>
		<lastmod>2011-07-18T14:35:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-1-2010.pdf</loc>
		<lastmod>2011-07-18T14:34:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-2-2010.pdf</loc>
		<lastmod>2011-07-18T14:34:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-3-2010.pdf</loc>
		<lastmod>2011-07-18T14:33:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-4-2009.pdf</loc>
		<lastmod>2011-07-18T14:29:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-5-2009.pdf</loc>
		<lastmod>2011-07-18T14:28:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPRD-6-2009.pdf</loc>
		<lastmod>2011-07-18T14:27:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8193/news/industry-news/mercks-isentress%c2%ae-raltegravir-in-combination-therapy-demonstrated-efficacy-in-a-phase-ii-study/</loc>
		<lastmod>2011-07-18T13:31:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8191/company-directory/dca-design-international/</loc>
		<lastmod>2011-07-18T13:31:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8184/news/industry-news/pertuzumab-combined-with-herceptin-and-chemotherapy-significantly-extended-the-time-people-with-her2-positive-metastatic-breast-cancer-lived-without-their-disease-getting-worse/</loc>
		<lastmod>2011-07-18T13:07:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8169/news/industry-news/janssen-pharmaceuticals-inc-announces-definitive-agreement-to-divest-ortho-dermatologics-division/</loc>
		<lastmod>2011-07-18T11:17:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8166/news/industry-news/icon-acquires-firecrest-clinical/</loc>
		<lastmod>2011-07-18T10:59:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8161/news/industry-news/amgen-resolves-g-csf-patent-litigation-with-teva/</loc>
		<lastmod>2011-07-18T10:52:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8158/news/industry-news/xgeva%c2%ae-denosumab-granted-marketing-authorization-in-the-european-union/</loc>
		<lastmod>2011-07-18T08:49:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8155/news/industry-news/abbott-confirms-long-term-commitment-to-hiv-care-with-the-planned-development-of-new-formulations/</loc>
		<lastmod>2011-07-18T08:42:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8152/news/industry-news/novartis-begins-shipment-of-fluvirin%c2%ae/</loc>
		<lastmod>2011-07-18T08:25:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8147/news/industry-news/cephalon-shareholders-approve-acquisition-by-teva/</loc>
		<lastmod>2011-07-15T10:18:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8144/news/industry-news/gilead-expands-access-program-for-medications-in-developing-world/</loc>
		<lastmod>2011-07-15T10:11:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8142/news/industry-news/novo-nordisk-gains-eu-approval-for-flextouch%c2%ae/</loc>
		<lastmod>2011-07-15T09:59:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8135/news/industry-news/yervoy%e2%84%a2-ipilimumab-approved-for-the-treatment-of-previously-treated-advanced-melanoma-in-the-eu/</loc>
		<lastmod>2011-07-15T09:54:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8131/news/industry-news/sanofi-and-regeneron-report-positive-phase-2b-trial-results-with-sarilumab-in-rheumatoid-arthritis/</loc>
		<lastmod>2011-07-15T09:34:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8127/news/industry-news/clavis-pharma-appoints-nicholas-adams-as-chief-business-officer/</loc>
		<lastmod>2011-07-11T11:10:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8112/news/industry-news/lilly-ceo-says-biopharmaceuticals-should-be-included-in-transatlantic-trade-and-economic-discussions/</loc>
		<lastmod>2011-07-11T09:25:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8107/news/industry-news/sanofi-reports-positive-top-line-results-from-first-phase-3-study-of-alemtuzumab-lemtrada%e2%84%a2-in-multiple-sclerosis/</loc>
		<lastmod>2011-07-11T09:17:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8102/news/industry-news/sanofi-divests-dermik-dermatology-unit-to-valeant-pharmaceuticals-international-inc/</loc>
		<lastmod>2011-07-11T09:02:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8099/news/industry-news/sanofi-provides-multaq%c2%ae-phase-iiib-pallas-trial-update/</loc>
		<lastmod>2011-07-08T09:07:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8096/news/industry-news/phase-iii-trial-of-novartis-drug-afinitor%c2%ae-met-primary-endpoint-of-reducing-sega-tumor-size-in-patients-with-tuberous-sclerosis/</loc>
		<lastmod>2011-07-08T08:52:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8089/news/featured-news/sage-n-research-signs-agreement-with-the-u-s-army-edgewood-chemical-biological-center/</loc>
		<lastmod>2011-07-08T08:21:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8074/news/industry-news/pharminox-completes-1-5m-funding-round-to-progress-development-of-novel-anti-cancer-drug-candidates/</loc>
		<lastmod>2011-07-07T15:46:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8079/news/featured-news/novozymes-biopharma-to-present-latest-advances-in-drug-delivery-technology-at-controlled-release-society-meeting/</loc>
		<lastmod>2011-07-07T09:09:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8070/news/industry-news/amgen-and-ucb-team-up-with-nasa/</loc>
		<lastmod>2011-07-06T10:57:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8067/news/industry-news/boehringer-ingelheim-and-ashoka%e2%80%99s-changemakers-launch-making-more-health-competition/</loc>
		<lastmod>2011-07-06T10:52:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8064/news/industry-news/positive-top-line-results-for-pfizer%e2%80%99s-lyrica-in-phase-3-study-of-patients-with-fibromyalgia-in-japan/</loc>
		<lastmod>2011-07-06T10:42:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8032/news/industry-news/novartis-drug-afinitor%c2%ae-met-primary-endpoint-of-phase-iii-study-in-women-with-advanced-breast-cancer/</loc>
		<lastmod>2011-07-05T14:00:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8049/news/featured-news/wyatt-technology%e2%80%99s-mobius-mobility-instrument-facilitates-protein-net-charge-computation-at-low-concentrations/</loc>
		<lastmod>2011-07-05T13:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8044/news/industry-news/pfizer-affirms-chantixchampix-as-important-treatment-option-for-smokers-wanting-to-quit/</loc>
		<lastmod>2011-07-05T10:10:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8038/news/industry-news/london-2012-partner-glaxosmithkline-shares-scientific-expertise-with-world-anti-doping-agency-to-help-fight-against-abuse-of-drugs-in-sport/</loc>
		<lastmod>2011-07-05T10:04:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8015/news/industry-news/lilly-quality-leader-walsh-appointed-to-companys-executive-committee/</loc>
		<lastmod>2011-07-04T09:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8011/news/industry-news/lundbeck-appoints-senior-vice-president-of-hr/</loc>
		<lastmod>2011-07-04T09:49:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8008/news/industry-news/biogen-idec-researchers-identify-novel-approach-for-promoting-remyelination/</loc>
		<lastmod>2011-07-04T09:42:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8003/news/industry-news/novartis-receives-fda-approval-for-arcaptatm-neohalertm/</loc>
		<lastmod>2011-07-04T09:34:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/8000/news/industry-news/novartis-receives-approval-in-japan-for-onbrez%c2%ae-inhalation-capsules/</loc>
		<lastmod>2011-07-04T09:15:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7996/news/industry-news/merck-statement-on-voluntary-submission-of-clinical-research-protocols-for-its-investigational-and-approved-products/</loc>
		<lastmod>2011-07-04T09:10:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7993/news/industry-news/merck-receives-approval-to-market-gardasil%c2%ae-zolinza%c2%ae-and-cubicin%c2%ae-in-japan/</loc>
		<lastmod>2011-07-04T08:57:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7991/news/industry-news/glaxosmithkline-receives-new-approval-for-rotarix-and-significant-new-indication-for-lamictal%c2%ae-lamotrigine-in-japan/</loc>
		<lastmod>2011-07-04T08:50:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7988/news/industry-news/astrazenecas-nexium-receives-first-regulatory-approval-in-japan-for-the-treatment-of-acid-related-diseases/</loc>
		<lastmod>2011-07-04T08:21:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7983/news/featured-news/thermo-fisher-scientific-recognized-as-winner-of-the-2011-microsoft-life-sciences-innovation-awards/</loc>
		<lastmod>2011-06-30T16:01:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7978/news/industry-news/novartis-phase-iii-study-shows-once-daily-nva237-is-superior-to-placebo-and-similar-to-tiotropium-in-improving-lung-function-in-copd/</loc>
		<lastmod>2011-06-30T13:41:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7975/news/industry-news/pfizer-announces-data-presentations-for-investigational-compounds-in-its-lung-cancer-portfolio/</loc>
		<lastmod>2011-06-29T13:50:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7970/news/industry-news/astrazeneca-and-ptc-therapeutics-announce-strategic-oncology-drug-discovery-collaboration/</loc>
		<lastmod>2011-06-29T12:54:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7963/news/featured-news/tecan-launches-tecan-award-2011/</loc>
		<lastmod>2011-06-29T12:46:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7957/news/industry-news/macmillan-responds-to-nices-decision-not-to-recommend-lung-cancer-drug/</loc>
		<lastmod>2011-06-29T11:15:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/247/company-directory/ge-analytical-instruments/</loc>
		<lastmod>2011-06-29T07:56:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7949/news/industry-news/gilead-sciences-announces-agreement-with-tibotec-pharmaceuticals/</loc>
		<lastmod>2011-06-28T13:58:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7946/news/industry-news/amgen-submits-application-to-expand-indication-for-xgeva%c2%ae-denosumab/</loc>
		<lastmod>2011-06-28T13:41:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7943/news/industry-news/pfizer-files-with-the-fda-for-review-of-axitinib-for-patients-with-advanced-rcc/</loc>
		<lastmod>2011-06-28T13:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7937/news/industry-news/gsk-welcomes-external-scientists-to-diseases-of-the-developing-world-research-campus/</loc>
		<lastmod>2011-06-28T13:22:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7940/news/industry-news/ups-and-merck-expand-their-distribution-and-logistics-agreement/</loc>
		<lastmod>2011-06-28T13:21:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7932/news/featured-news/thermo-fisher-scientific-announces-breakthrough-workflow-for-metabolomics-research/</loc>
		<lastmod>2011-06-28T09:22:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7927/news/industry-news/investigational-ultra-long-acting-insulin-degludec-reduces-hypoglycaemia-and-improves-long-term-control/</loc>
		<lastmod>2011-06-28T07:48:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7924/news/industry-news/sanofi-appoints-peter-guenter-senior-vice-president-europe/</loc>
		<lastmod>2011-06-27T13:09:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7918/news/industry-news/bristol-myers-squibb-and-astrazeneca-announce-investigational-compound-dapagliflozin-sustained-glycemic-control-and-weight-reduction-in-study-of-type2-diabetes-patients-inadequately-controlled-with-me/</loc>
		<lastmod>2011-06-27T10:04:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7914/news/industry-news/sanofi-patient-group-bursary-winners-announced/</loc>
		<lastmod>2011-06-27T09:39:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7909/news/featured-news/wyatt-technology-mals-fulfils-latest-european-pharmacopoeia-standard-for-hes-characterization/</loc>
		<lastmod>2011-06-24T14:33:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7903/news/industry-news/linagliptin-recommended-for-approval-in-the-treatment-of-type-2-diabetes-in-europe/</loc>
		<lastmod>2011-06-24T13:19:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7900/news/industry-news/bristol-myers-squibb-foundation-awards-1-5-million-in-grants-to-help-african-american-women-fight-type-2-diabetes/</loc>
		<lastmod>2011-06-24T12:48:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7897/news/industry-news/sanofi-pasteur%e2%80%99s-typhoid-vaccine-typhim-vi%c2%ae-granted-prequalification-by-the-world-health-organization/</loc>
		<lastmod>2011-06-24T12:41:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7893/news/industry-news/roche-sets-up-rd-institute-in-france-to-foster-collaborative-translational-research/</loc>
		<lastmod>2011-06-24T12:30:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7889/news/industry-news/roche-and-evotec-to-jointly-develop-biomarkers-in-oncology/</loc>
		<lastmod>2011-06-24T12:26:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7884/news/industry-news/fda-complete-response-letter-received-for-remoxy/</loc>
		<lastmod>2011-06-24T12:20:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7880/news/industry-news/gsk-statement-on-agreements-with-state-attorneys-general-on-former-cidra-manufacturing-facility/</loc>
		<lastmod>2011-06-24T12:11:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7874/company-directory/topra/</loc>
		<lastmod>2011-06-23T13:25:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/claim-your-complimentary-copy-of-european-pharmaceutical-review/</loc>
		<lastmod>2011-06-23T11:34:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7868/news/featured-news/novozymes-biopharma-to-present-on-creating-market-opportunities-through-drug-half-life-extension-at-2011-bio-business-forum/</loc>
		<lastmod>2011-06-23T07:49:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7865/news/industry-news/bydureon%e2%84%a2-receivies-marketing-authorisation-in-europe/</loc>
		<lastmod>2011-06-22T16:11:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7861/news/industry-news/novo-nordisk-invests-1-billion-danish-kroner-in-new-factory-in-denmark/</loc>
		<lastmod>2011-06-22T16:03:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7857/news/industry-news/aesica-appoints-new-european-manager/</loc>
		<lastmod>2011-06-22T14:44:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7842/news/industry-news/fda-panel-endorses-efficacy-but-not-safety-of-novartis-drug-acz885-for-gouty-arthritis-did-not-support-approval-in-proposed-indication/</loc>
		<lastmod>2011-06-22T08:53:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7851/news/industry-news/sanofi-establishes-a-global-agreement-with-medco-and-ubc/</loc>
		<lastmod>2011-06-22T08:31:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7847/news/industry-news/pfizer%e2%80%99s-lyrica-top-line-results-positive-in-global-phase-3-study-of-central-neuropathic-pain-following-spinal-cord-injury/</loc>
		<lastmod>2011-06-22T08:21:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7839/news/industry-news/astrazeneca-to-sell-astratech-to-dentsply-international/</loc>
		<lastmod>2011-06-22T08:01:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7835/news/featured-news/pfizer-selects-exco-intouch%e2%80%99s-novel-ediary-technologies-to-initiate-first-ever-patient-centered-clinical-trial/</loc>
		<lastmod>2011-06-21T13:24:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7831/news/featured-news/ert-appoints-robert-kleiman-md-to-chief-medical-officer/</loc>
		<lastmod>2011-06-21T10:50:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7581/news/industry-news/horizon-successfully-completes-pilot-human-gene-editing-program-with-leading-pharma/</loc>
		<lastmod>2011-06-21T09:12:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7702/news/industry-news/new-data-confirm-superior-blood-pressure-reductions-in-diabetic-patients-treated-with-twynsta%c2%ae-compared-to-amlodipine-alone/</loc>
		<lastmod>2011-06-21T08:56:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7820/news/industry-news/pfizer-and-acura-announce-fda-approval-of-oxectatm-oxycodone-hcl-usp-cii/</loc>
		<lastmod>2011-06-21T08:14:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6766/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/article-2-direct-detection-of-microorganisms-using-viability-based-technologies/</loc>
		<lastmod>2011-06-21T08:03:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6769/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/overview-of-rapid-microbiological-methods-evaluated-validated-and-implemented-for-microbiological-quality-control/</loc>
		<lastmod>2011-06-21T08:03:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6729/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/discorverx-interview/</loc>
		<lastmod>2011-06-21T08:03:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6732/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/molecular-drug-targets-in-autophagy/</loc>
		<lastmod>2011-06-21T08:02:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6742/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/uv-vis-scan-based-quality-control-of-assay-ready-plates-for-improved-data-integrity/</loc>
		<lastmod>2011-06-21T08:02:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6754/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/is-it-ever-right-to-sue-a-client/</loc>
		<lastmod>2011-06-21T08:02:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6756/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/the-increasing-role-of-toxicology-in-early-decision-making-processes/</loc>
		<lastmod>2011-06-21T08:01:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6758/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/using-translational-pharmacology-biomarkers-to-drive-earlier-decision-making/</loc>
		<lastmod>2011-06-21T08:01:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6760/european-pharmaceutical-review-magazine/past-issues/issue-2-2011/in-search-of-the-holy-grail-engineering-the-stem-cell-niche/</loc>
		<lastmod>2011-06-21T08:01:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7805/news/featured-news/thermo-fisher-scientific-introduces-expanded-chromatography-portfolio-at-hplc-2011/</loc>
		<lastmod>2011-06-20T15:00:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7732/news/industry-news/abbott-receives-fda-approval-for-a-new-six-month-formulation-of-lupron-depot%c2%ae/</loc>
		<lastmod>2011-06-20T13:33:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7586/news/featured-news/tecan-and-technical-communities-sign-new-government-services-partnership-agreement/</loc>
		<lastmod>2011-06-20T11:12:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7722/news/featured-news/hudson-robotics-announces-its-new-fully-automated-colony-isolation-workcell/</loc>
		<lastmod>2011-06-20T11:10:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7710/news/industry-news/pivotal-study-showed-vismodegib-helped-shrink-tumours-or-heal-lesions-in-people-with-rare-form-of-advanced-skin-cancer/</loc>
		<lastmod>2011-06-20T10:54:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7528/news/featured-news/thermo-fisher-scientific-launches-new-gc-msms-instrument-for-superior-selectivity-and-sensitivity-at-asms-2011/</loc>
		<lastmod>2011-06-20T09:46:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7715/news/industry-news/boehringer-ingelheim-extends-one-stop-shop-service-with-new-fill-and-finish-capabilities/</loc>
		<lastmod>2011-06-20T08:29:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7698/news/industry-news/reata-and-abbott-initiate-global-phase-3-study-of-bardoxolone-methyl-in-patients-with-chronic-kidney-disease-and-type-2-diabetes/</loc>
		<lastmod>2011-06-17T13:42:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7696/news/industry-news/fda-approves-nulojix%c2%ae-belatacept/</loc>
		<lastmod>2011-06-17T13:37:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7693/news/industry-news/sanofi-enters-into-research-collaboration-with-biopharmaceutical-company-audion-therapeutics/</loc>
		<lastmod>2011-06-17T13:26:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7687/news/industry-news/novartis-begins-construction-of-new-state-of-the-art-pharmaceutical-manufacturing-plant/</loc>
		<lastmod>2011-06-17T13:20:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7661/news/featured-news/greenphire-partners-with-mytrus-to-provide-web-based-solutions-that-revolutionize-patient-recruitment-and-retention-enhancing-study-efficiency/</loc>
		<lastmod>2011-06-16T15:14:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7650/news/industry-news/boehringer-ingelheim-and-zealand-pharma-enter-into-a-licence-and-collaboration-agreement-to-advance-novel-compounds-to-treat-type-2-diabetes-and-obesity/</loc>
		<lastmod>2011-06-16T14:57:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7639/news/industry-news/pfizer-injectables-adds-doxorubicin-hydrochloride-injection-usp-to-its-portfolio-of-off-patent-oncology-products/</loc>
		<lastmod>2011-06-16T14:27:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7634/news/industry-news/novartis-application-for-expanded-menveo%c2%ae-indication-from-2-months-of-age-accepted-for-review-by-fda/</loc>
		<lastmod>2011-06-16T14:17:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7612/news/industry-news/astrazeneca-extends-its-investment-in-russia-with-new-predictive-science-centre-in-st-petersburg/</loc>
		<lastmod>2011-06-16T13:36:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7606/news/industry-news/abbott-receives-fda-approval-for-creon%c2%ae-pancrelipase-infant-specific-dosage/</loc>
		<lastmod>2011-06-15T09:07:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7600/news/industry-news/gsk-to-purchase-shenzhen-neptunus-stake-in-previously-formed-joint-venture-for-influenza-vaccines-in-china/</loc>
		<lastmod>2011-06-15T08:56:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7593/news/industry-news/corning-hires-biotechnology-expert-as-leader-of-corning-life-sciences/</loc>
		<lastmod>2011-06-14T13:39:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7576/company-directory/bd-diagnostics/</loc>
		<lastmod>2011-06-14T08:07:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7573/news/industry-news/lundbeck-announces-that-stig-l%c3%b8kke-pedersen-executive-vice-president-commercial-operations-resigns/</loc>
		<lastmod>2011-06-13T15:28:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7569/news/industry-news/gilead-sciences-executive-vice-president-kevin-young-appointed-a-commander-of-the-most-excellent-order-of-the-british-empire/</loc>
		<lastmod>2011-06-13T15:24:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7562/news/industry-news/merck-and-hanwha-chemical-corporation-establish-global-strategic-collaboration-to-develop-and-commercialize-biosimilar-candidate/</loc>
		<lastmod>2011-06-13T15:17:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7559/news/industry-news/glaxosmithkline-and-valeant-announce-us-fda-approval-of-potiga%e2%84%a2-ezogabine/</loc>
		<lastmod>2011-06-13T15:09:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7551/news/industry-news/abbott-reports-interim-results-from-phase-iii-open-label-study-of-investigational-treatment-for-advanced-parkinsons-disease/</loc>
		<lastmod>2011-06-10T08:46:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7547/news/industry-news/merck-and-intercell-terminate-phase-iiiii-clinical-trial-of-v710/</loc>
		<lastmod>2011-06-10T08:39:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7542/news/industry-news/novartis-candidate-vaccine-bexsero%c2%ae-shows-significant-potential-in-providing-broad-coverage-against-meningococcal-serogroup-b-infections/</loc>
		<lastmod>2011-06-10T08:20:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7539/news/industry-news/pfizer-conducts-first-%e2%80%9cvirtual%e2%80%9d-clinical-trial-allowing-patients-to-participate-regardless-of-geography/</loc>
		<lastmod>2011-06-09T16:23:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/about-us/</loc>
		<lastmod>2011-06-09T09:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7515/news/featured-news/in-shifting-regulatory-climate-greenphire-unveils-latest-clinical-payment-solutions-at-dia-2011/</loc>
		<lastmod>2011-06-07T15:34:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7518/news/featured-news/novozymes-biopharma-to-unveil-new-research-into-the-production-of-proteins-with-extended-circulatory-half-life-at-next-generation-protein-therapeutics-summit/</loc>
		<lastmod>2011-06-07T13:07:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7427/news/industry-news/merck-commends-gavi-alliance-on-continued-efforts-to-improve-access/</loc>
		<lastmod>2011-06-07T10:53:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7483/news/industry-news/millions-of-children-in-the-world%e2%80%99s-poorest-countries-could-receive-vaccination-against-rotavirus-diarrhoeal-disease-under-new-offer-made-by-gsk-to-the-gavi-alliance/</loc>
		<lastmod>2011-06-07T09:59:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7497/news/industry-news/biogen-idec-receives-approval-in-the-european-union-for-avonexr-pentm/</loc>
		<lastmod>2011-06-07T08:38:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7493/news/industry-news/new-data-in-breast-and-ovarian-cancer-presented-at-asco-support-continued-development-of-iniparib/</loc>
		<lastmod>2011-06-07T08:27:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7489/news/industry-news/merck-and-ariad-announce-presentation-of-results-of-phase-iii-succeed-trial-at-asco/</loc>
		<lastmod>2011-06-07T08:17:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7480/news/industry-news/late-breaking-asco-data-demonstrate-circulating-tumor-cells-as-potential-biomarker-for-metastatic-prostate-cancer-clinical-trials/</loc>
		<lastmod>2011-06-07T08:03:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7474/news/featured-news/almsco-international-highlights-its-benchtof-dx-for-improved-sensitivity-at-asms-2011/</loc>
		<lastmod>2011-06-06T14:18:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7466/news/featured-news/thermo-fisher-scientific-introduces-new-capabilities-for-comprehensive-qualitative-and-quantitative-proteomics/</loc>
		<lastmod>2011-06-06T14:05:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7450/news/industry-news/zaltrap%e2%84%a2-aflibercept-significantly-improved-survival-in-previously-treated-metastatic-colorectal-cancer-patients/</loc>
		<lastmod>2011-06-06T13:45:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7459/news/industry-news/second-phase-3-study-of-yervoy%e2%84%a2-ipilimumab-in-metastatic-melanoma-meets-primary-endpoint-of-overall-survival/</loc>
		<lastmod>2011-06-06T09:07:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7446/news/industry-news/roche-announces-data-to-show-avastin-based-regimen-halved-the-risk-of-disease-getting-worse-in-women-with-recurrent-ovarian-cancer/</loc>
		<lastmod>2011-06-06T08:47:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7441/news/industry-news/roche-announces-vemurafenib-improved-survival-in-people-with-metastatic-melanoma-who-have-braf-v600-mutations/</loc>
		<lastmod>2011-06-06T08:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7438/news/industry-news/pfizer-and-hisun-sign-mou-to-increase-access-to-quality-and-low-cost-medicines-for-patients-in-china/</loc>
		<lastmod>2011-06-06T08:25:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7434/news/industry-news/novartis-gains-european-commission-approval-for-lucentis%c2%ae-to-treat-vision-loss-due-to-macular-edema-secondary-to-rvo/</loc>
		<lastmod>2011-06-06T08:16:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7420/news/industry-news/glaxosmithkline%e2%80%99s-pazopanib-improved-progression-free-survival-in-adults-with-certain-soft-tissue-sarcomas/</loc>
		<lastmod>2011-06-06T08:01:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7415/news/industry-news/new-study-released-today-showed-patients-with-deadly-form-of-lung-cancer-lived-longer-without-disease-worsening/</loc>
		<lastmod>2011-06-06T07:58:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7409/news/featured-news/thermo-fisher-scientific-debuts-fastest-more-sensitive-ion-trap-mass-spectrometer/</loc>
		<lastmod>2011-06-06T07:41:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7391/news/featured-news/thermo-fisher-scientific-debuts-high-performance-benchtop-quadrupole-orbitrap-mass-spectrometer-at-asms-2011/</loc>
		<lastmod>2011-06-03T08:39:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7403/news/featured-news/thermo-fisher-scientific-introduces-new-high-field-orbitrap-mass-spectrometer-at-asms-2011/</loc>
		<lastmod>2011-06-03T08:38:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7387/news/industry-news/health-canada-approves-brilinta-ticagrelor-tablets/</loc>
		<lastmod>2011-06-01T13:41:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7381/news/industry-news/astrazeneca-and-heptares-collaborate-to-investigate-important-gpcr-drug-targets/</loc>
		<lastmod>2011-05-31T08:28:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7367/news/industry-news/icon-selected-by-pfizer-as-a-global-strategic-partner-for-clinical-research-and-development/</loc>
		<lastmod>2011-05-27T08:54:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7371/news/industry-news/data-supports-efficacy-of-xiapex%c2%ae-collagenase-clostridium-histolyticum-as-a-treatment-option-for-dupuytren%e2%80%99s-contracture/</loc>
		<lastmod>2011-05-27T08:50:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7357/news/featured-news/asco-eortc-esmo-inca-and-oeci-endorse-the-3rd-win-symposium-6-8-july-2011/</loc>
		<lastmod>2011-05-26T13:27:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7360/news/featured-news/tecan-offers-complete-automation-for-cell-based-screening/</loc>
		<lastmod>2011-05-26T11:10:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/subscription-confirmation/thank-you/</loc>
		<lastmod>2011-05-26T08:23:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7349/news/featured-news/sage-n-research-sorcerer-platform-implemented-by-the-university-at-buffalo/</loc>
		<lastmod>2011-05-25T15:03:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7328/news/featured-news/thermo-fisher-scientific-helps-optimize-productivity-of-bioequivalence-studies-and-regulatory-compliance-for-cro-customer/</loc>
		<lastmod>2011-05-25T14:46:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7343/news/featured-news/stardrop%e2%80%99s-glowing-molecule-provides-visual-link-between-chemical-structure-and-predicted-toxicities/</loc>
		<lastmod>2011-05-25T13:30:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7323/news/featured-news/tecans-new-infinite%c2%ae-m1000-%e2%80%93-the-future-of-microplate-detection-has-just-arrived/</loc>
		<lastmod>2011-05-24T12:56:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7246/news/industry-news/nexavar-in-combination-with-chemotherapy-improves-progression-free-survival-in-patients-with-advanced-breast-cancer-in-phase-2-study/</loc>
		<lastmod>2011-05-24T09:11:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7300/news/industry-news/cephalon-granted-temporary-restraining-order-in-amrix%c2%ae-patent-litigation/</loc>
		<lastmod>2011-05-24T09:10:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7285/news/industry-news/eliquis%c2%ae-apixaban-approved-in-europe-for-preventing-venous-thromboembolism-after-elective-hip-or-knee-replacement/</loc>
		<lastmod>2011-05-24T09:06:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7306/news/industry-news/lab21-acquires-molecular-diagnostics-company-myconostica-ltd/</loc>
		<lastmod>2011-05-24T09:03:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7271/news/industry-news/aesica-to-increase-presence-in-asia/</loc>
		<lastmod>2011-05-24T09:02:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7309/news/industry-news/astrazeneca-signs-agreement-in-japan-with-daiichi-sankyo-to-co-promote-denosumab-for-cancer/</loc>
		<lastmod>2011-05-24T08:04:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7297/news/industry-news/european-medicines-agencys-committee-for-medicinal-products-for-human-use-issues-positive-opinion-on-marketing-authorisation-application-for-fampyra/</loc>
		<lastmod>2011-05-23T14:07:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7294/news/industry-news/amgen-receives-chmp-positive-opinion-for-xgevatm-denosumab-in-the-european-union/</loc>
		<lastmod>2011-05-23T14:01:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7288/news/industry-news/abbott-completes-submission-of-new-molecular-test-intended-for-non-small-cell-lung-cancer-therapy-selection/</loc>
		<lastmod>2011-05-23T13:55:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7280/news/industry-news/chmp-issues-positive-opinion-for-mercks-victrelis%e2%84%a2-boceprevir/</loc>
		<lastmod>2011-05-23T13:37:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7274/news/industry-news/glaxosmithkline-and-human-genome-sciences-receive-positive-opinion-in-europe-from-the-chmp-for-benlysta%c2%ae-belimumab/</loc>
		<lastmod>2011-05-23T13:29:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7219/news/industry-news/preventing-prostate-cancer-cells-from-bodybuilding-provides-new-treatment-hope/</loc>
		<lastmod>2011-05-23T08:09:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7241/news/industry-news/abbott-statement-on-the-fda-advisory-committee-recommendations-on-fenofibric-acid/</loc>
		<lastmod>2011-05-20T08:44:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7238/news/industry-news/abbott-receives-fda-approval-for-molecular-test-for-hepatitis-c/</loc>
		<lastmod>2011-05-20T08:23:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7228/news/industry-news/pfizer-presents-new-phase-3-data/</loc>
		<lastmod>2011-05-20T08:16:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7225/news/industry-news/merck-and-roche-establish-strategic-agreements-in-fight-against-chronic-hepatitis-c/</loc>
		<lastmod>2011-05-20T08:01:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7214/news/industry-news/research-and-development-into-personalised-medicine-to-receive-new-government-investment/</loc>
		<lastmod>2011-05-19T13:21:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7210/news/industry-news/phase-ii-study-results-evaluating-effect-of-olaparib-on-progression-free-survival-in-serous-ovarian-cancer-announced-today/</loc>
		<lastmod>2011-05-19T09:07:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7206/news/industry-news/thrombogenics-and-bioinvent-announce-the-start-of-new-study-of-novel-antibody-anti-cancer-agent-tb-403-anti-plgf-by-partner-roche/</loc>
		<lastmod>2011-05-18T08:19:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7197/news/featured-news/thermo-fisher-scientific-introduces-the-fiberlite-lex-rotor-series/</loc>
		<lastmod>2011-05-18T08:04:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7194/news/industry-news/merck-completes-acquisition-of-inspire-pharmaceuticals-inc/</loc>
		<lastmod>2011-05-17T16:30:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7189/news/featured-news/novozymes-biopharma-to-showcase-hyaluronic-acid-for-ophthalmology-applications-at-joint-congress-of-soe-and-aao-2011/</loc>
		<lastmod>2011-05-17T15:46:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7179/news/industry-news/sanofi-and-glenmark-pharmaceuticals-sign-license-agreement-on-novel-monoclonal-antibody-for-crohn%e2%80%99s-disease/</loc>
		<lastmod>2011-05-17T15:34:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7176/news/industry-news/amylin-pharmaceuticals-files-suit-against-eli-lilly/</loc>
		<lastmod>2011-05-17T13:15:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7159/news/industry-news/why-streamlining-pharma-supply-chain-is-essential/</loc>
		<lastmod>2011-05-17T13:05:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7157/news/industry-news/pfizer-details-new-costs-to-settle-some-litigation/</loc>
		<lastmod>2011-05-16T15:29:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7153/news/industry-news/psivida-announces-resubmission-of-new-drug-application-for-iluvien%c2%ae/</loc>
		<lastmod>2011-05-16T15:12:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7149/news/industry-news/fda-approves-mercks-victrelis%e2%84%a2-boceprevir-oral-hepatitis-c-virus-hcv-protease-inhibitor/</loc>
		<lastmod>2011-05-16T15:06:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7052/news/industry-news/sanofi-aventis-and-medicines-for-malaria-venture-join-forces-to-develop-innovative-malaria-drugs/</loc>
		<lastmod>2011-05-10T09:22:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7049/news/industry-news/the-european-commission-approves-pfizer%e2%80%99s-revatio%c2%ae-sildenafil/</loc>
		<lastmod>2011-05-10T09:17:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7100/news/industry-news/merck-announces-hope-against-hepatitis-c-initiative-to-support-public-awareness-education-and-research-in-the-fight-against-hepatitis-c-virus/</loc>
		<lastmod>2011-05-10T09:09:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7103/news/industry-news/pfizer%e2%80%99s-prevnar-13%c2%ae-meets-all-study-endpoints-in-two-pivotal-phase-3-trials-in-adults-aged-50-and-older-presented-today/</loc>
		<lastmod>2011-05-10T09:03:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7106/news/industry-news/fda-licenses-sanofi-pasteur%e2%80%99s-new-influenza-vaccine-delivered-by-intradermal-microinjection/</loc>
		<lastmod>2011-05-10T08:52:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7092/news/industry-news/health-economics-substudy-of-plato-shows-brilique-to-be-a-cost-effective-treatment-versus-generic-clopidogrel/</loc>
		<lastmod>2011-05-10T08:18:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7085/news/industry-news/twelfth-milestone-payment-as-part-of-its-discovery-alliance-with-boehringer-ingelheim-received/</loc>
		<lastmod>2011-05-09T14:28:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7079/news/industry-news/alkermes-to-merge-with-elan-drug-technologies-to-create-alkermes-plc/</loc>
		<lastmod>2011-05-09T14:26:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7064/news/industry-news/biogen-idec-and-swedish-orphan-biovitrum-receive-opinion-from-ema-on-pediatric-plan/</loc>
		<lastmod>2011-05-09T11:14:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7069/news/industry-news/cephalon-presents-positive-results-with-nuvigil-in-largest-shift-work-disorder-trial-ever-conducted/</loc>
		<lastmod>2011-05-09T11:09:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7062/news/industry-news/gilead-extends-its-funding-support-for-the-gilead-sciences-research-centre-at-the-institute-of-organic-chemistry-and-biochemistry-in-prague/</loc>
		<lastmod>2011-05-09T11:03:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7056/news/industry-news/abbott-receives-fda-approval-to-expand-use-of-the-rx-acculink%c2%ae-carotid-stent-system-to-patients-at-standard-surgical-risk/</loc>
		<lastmod>2011-05-09T10:31:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7044/news/industry-news/novartis-gains-fda-approval-for-afinitor%c2%ae-as-first-new-treatment-in-nearly-three-decades-for-patients-with-advanced-pancreatic-net/</loc>
		<lastmod>2011-05-09T10:07:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7030/news/featured-news/thermo-fisher-scientific-to-highlight-new-laboratory-solutions-during-uk-summer-symposium-2/</loc>
		<lastmod>2011-05-06T14:24:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7037/news/featured-news/sigma%c2%ae-life-science-and-kings-college-london-co-developing-mirna-target-identification-technology/</loc>
		<lastmod>2011-05-05T15:11:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7025/news/featured-news/novozymes-biopharma-collaborates-with-the-university-of-oslo-to-develop-enhanced-albumin-fusion-technology-that-tailors-the-half-life-of-proteins/</loc>
		<lastmod>2011-05-05T14:44:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/477/company-directory/peter-huber-kaltemaschinenbau-gmbh/</loc>
		<lastmod>2011-05-05T09:36:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7011/news/featured-news/ert-announces-appointment-of-new-president-and-ceo/</loc>
		<lastmod>2011-05-04T10:55:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/316/company-directory/synbiosis/</loc>
		<lastmod>2011-05-04T09:57:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/362/company-directory/syngene/</loc>
		<lastmod>2011-05-04T09:55:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/7000/news/featured-news/thermo-fisher-scientific-announces-upgrade-program-for-nanodrop-instruments-that-includes-donations-to-academic-institutions-in-developing-nations/</loc>
		<lastmod>2011-05-03T16:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6990/news/industry-news/teva-to-acquire-cephalon-in-6-8-billion-transaction/</loc>
		<lastmod>2011-05-03T14:15:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6982/news/industry-news/ge-healthcare-to-acquire-cellular-imaging-company-applied-precision-inc/</loc>
		<lastmod>2011-05-03T14:15:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6986/news/industry-news/fda-approves-linagliptin-tablets-for-the-treatment-of-type-2-diabetes/</loc>
		<lastmod>2011-05-03T14:14:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6978/news/industry-news/non-hodgkins-lymphoma-drug-market-set-to-double-to-8-4-billion-by-2019/</loc>
		<lastmod>2011-04-28T14:35:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6970/news/industry-news/astrazeneca-and-pozen-sue-dr-reddys-over-vimovo-patent/</loc>
		<lastmod>2011-04-28T14:29:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6974/news/featured-news/thermo-fisher-scientific-to-highlight-new-laboratory-solutions-during-uk-summer-symposium/</loc>
		<lastmod>2011-04-28T11:01:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6967/news/industry-news/johnson-johnson-to-buy-orthopedic-device-maker-synthes-for-21-3-billion/</loc>
		<lastmod>2011-04-28T10:41:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6965/news/industry-news/lilly-and-medtronic-announce-drug-device-collaboration-for-parkinsons-disease/</loc>
		<lastmod>2011-04-27T15:53:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6960/news/industry-news/fda-approves-gsks-lamictalxr-lamotrigine/</loc>
		<lastmod>2011-04-27T15:29:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6951/news/industry-news/daiichi-sankyo-receives-first-market-approval-in-japan-for-lixiana%c2%ae-edoxaban/</loc>
		<lastmod>2011-04-26T13:06:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6899/news/industry-news/gilead-and-microdose-therapeutx-announce-license-and-collaboration-agreement-to-develop-mdt-637-for-treatment-of-respiratory-syncytial-virus/</loc>
		<lastmod>2011-04-26T12:46:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6942/news/featured-news/discoverx-announces-a-series-of-scientific-outreach-programmes/</loc>
		<lastmod>2011-04-26T12:29:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/news/</loc>
		<lastmod>2011-04-26T11:26:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6939/news/industry-news/merck-and-sanofi-pasteur-initiate-phase-iii-study-in-the-us-of-pediatric-combination-vaccine/</loc>
		<lastmod>2011-04-26T11:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6935/news/industry-news/idera-pharmaceuticals-delays-initiation-of-phase-2-clinical-trial-of-imo-2125-in-treatment-naive-hcv-patients/</loc>
		<lastmod>2011-04-26T11:12:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6932/news/industry-news/researchers-identify-genes-causing-antimalarial-drug-resistance/</loc>
		<lastmod>2011-04-26T11:03:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6929/news/industry-news/pfizer-comments-on-oral-sync-tofacitinib-data/</loc>
		<lastmod>2011-04-26T10:56:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6917/news/industry-news/sanofi-pasteur-announces-fda-approval-of-menactra%c2%ae/</loc>
		<lastmod>2011-04-26T10:47:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6884/news/featured-news/molecular-profiles-innovative-drug-development-services-win-queens-award-for-enterprise-2011/</loc>
		<lastmod>2011-04-26T08:31:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6904/news/industry-news/fda-approves-rituxan-plus-a-steroid-for-use-in-severe-forms-of-vasculitis/</loc>
		<lastmod>2011-04-21T13:11:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6892/news/industry-news/amgen-and-ucb-announce-positive-phase-2-results-of-amg-785cdp7851-in-patients-with-postmenopausal-osteoporosis-pmo/</loc>
		<lastmod>2011-04-21T09:19:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6888/news/industry-news/pfizer-and-shanghai-pharmaceutical-sign-memorandum-of-understanding-for-potential-strategic-partnership/</loc>
		<lastmod>2011-04-21T09:18:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6858/news/industry-news/fda-approves-roche%e2%80%99s-hpv-test-for-identifying-women-at-highest-risk-for-cervical-cancer/</loc>
		<lastmod>2011-04-20T14:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6869/news/industry-news/abbott-chairman-and-ceo-miles-d-white-elected-to-the-american-academy-of-arts-sciences/</loc>
		<lastmod>2011-04-20T14:20:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6850/news/industry-news/pfizer-announces-top-line-results-of-third-phase-3-clinical-trial-of-tofacitinib-cp-690550-in-patients-with-active-rheumatoid-arthritis/</loc>
		<lastmod>2011-04-20T14:19:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6861/news/industry-news/merck-and-johnson-johnson-reach-agreement-on-distribution-rights-for-remicade%c2%ae-and-simponi%c2%ae/</loc>
		<lastmod>2011-04-20T14:13:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6865/news/industry-news/merck-commences-tender-offer-for-all-outstanding-shares-of-inspire-pharmaceuticals-inc/</loc>
		<lastmod>2011-04-20T14:11:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6854/news/industry-news/novartis-drug-afinitor%c2%ae-recommended-by-fda-oncology-advisory-committee-for-approval-to-treat-advanced-net-of-pancreatic-origin/</loc>
		<lastmod>2011-04-20T08:33:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/169/company-directory/biomerieux/</loc>
		<lastmod>2011-04-19T13:18:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5654/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/proteomics-and-target-identification-in-oncology/</loc>
		<lastmod>2011-04-19T08:46:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5648/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/advancing-high-content-analysis-towards-improving-clinical-efficacy/</loc>
		<lastmod>2011-04-19T08:46:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5643/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/pharmaceutical-materials-science-and-disorder-the-next-steps/</loc>
		<lastmod>2011-04-19T08:46:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5635/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/establishing-assays-and-small-molecule-screening-facilities-for-drug-discovery-programs/</loc>
		<lastmod>2011-04-19T08:46:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5632/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/translational-science-the-future-of-medicine/</loc>
		<lastmod>2011-04-19T08:45:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5627/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/pulmonary-inhalation-aerosols-for-targeted-antibiotics-drug-delivery/</loc>
		<lastmod>2011-04-19T08:45:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5622/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/article-1-rapid-microbiological-methods-2011/</loc>
		<lastmod>2011-04-19T08:45:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5619/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/current-realities-in-cancer-biology/</loc>
		<lastmod>2011-04-19T08:44:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5609/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/authentication-of-medicines-using-raman-spectroscopy/</loc>
		<lastmod>2011-04-19T08:44:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5600/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/evaluation-of-cellular-response-to-nicotinic-compounds-using-optical-label-free-technology/</loc>
		<lastmod>2011-04-19T08:44:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6795/news/featured-news/analytik-launch-pharma%e2%80%a2idtm-the-world%e2%80%99s-smallest-raman-analyser-for-non-destructive-pharmaceutical-identification/</loc>
		<lastmod>2011-04-18T15:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6792/news/industry-news/aesica-in-sunday-times-pwc-profit-track-100/</loc>
		<lastmod>2011-04-18T13:52:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6665/company-directory/expo-technologies-llc/</loc>
		<lastmod>2011-04-18T13:08:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6784/news/featured-news/ttp-labtech-partner-with-leading-crystallographer/</loc>
		<lastmod>2011-04-15T13:51:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6775/news/featured-news/ert-awarded-over-10-million-of-epro-business-from-major-pharma-increasing-its-position-as-a-leading-epro-provider/</loc>
		<lastmod>2011-04-15T11:08:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6711/news/featured-news/novozymes-biopharma-to-present-latest-advances-in-cell-culture-technology-at-esact/</loc>
		<lastmod>2011-04-12T12:58:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6705/news/featured-news/sigma%c2%ae-life-science-and-kraig-biocraft-laboratories-to-develop-silkworms-for-the-production-of-spider-silk/</loc>
		<lastmod>2011-04-12T12:50:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6671/news/featured-news/leica-microsystems-releases-fully-automated-her2-fish-test/</loc>
		<lastmod>2011-04-12T11:15:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6660/news/industry-news/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo/</loc>
		<lastmod>2011-04-12T11:14:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6682/news/industry-news/dr-reddy%e2%80%99s-expands-its-rd-centre-in-cambridge-uk/</loc>
		<lastmod>2011-04-12T11:13:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6539/news/industry-news/sanofi-aventis-completes-acquisition-of-genzyme-corporation/</loc>
		<lastmod>2011-04-12T09:57:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6644/news/industry-news/social-media-and-the-pharma-industry/</loc>
		<lastmod>2011-04-11T15:47:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6635/news/featured-news/lonza-and-roche-enter-into-mycotool%c2%ae-distribution-agreement-for-rapid-mycoplasma-testing-solutions/</loc>
		<lastmod>2011-04-11T14:54:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6601/news/industry-news/johnson-johnson-announces-settlement-with-u-s-department-of-justice-and-u-s-securities-and-exchange-commission/</loc>
		<lastmod>2011-04-11T14:02:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6606/news/industry-news/amgen-establishes-commercial-operations-in-brazil/</loc>
		<lastmod>2011-04-11T13:52:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6613/news/featured-news/itt-analytics-ebro-introduces-the-ebi-40-multi-channel-thermocouple-data-logger-for-high-accuracy-measurement/</loc>
		<lastmod>2011-04-11T13:16:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6551/news/industry-news/update-on-phase-iiiii-clinical-trial-of-investigational-staphylococcus-aureus-vaccine-v710/</loc>
		<lastmod>2011-04-11T09:58:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6548/news/industry-news/fda-approves-orphan-drug-vandetanib/</loc>
		<lastmod>2011-04-11T09:46:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6545/news/industry-news/roche-announces-positive-phase-ii-results-for-trastuzumab-emtansine-t-dm1-in-her2-positive-metastatic-breast-cancer/</loc>
		<lastmod>2011-04-11T09:43:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6533/news/industry-news/immatics-to-receive-support-from-pfizer-for-its-pivotal-phase-iii-study-imprint-with-ima901-a-therapeutic-vaccine-for-advanced-renal-cell-cancer-patients/</loc>
		<lastmod>2011-04-11T09:38:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6444/news/featured-news/thermo-fisher-scientific-demonstrates-its-ft-ir-instrumentation-gives-increased-confidence-in-quality-assurancequality-control-testing-in-new-application-note/</loc>
		<lastmod>2011-04-08T13:26:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6495/news/industry-news/novartis-shareholders-approve-merger-of-alcon-into-novartis/</loc>
		<lastmod>2011-04-08T09:28:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/193/company-directory/colder-products-company/</loc>
		<lastmod>2011-04-07T13:45:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6453/news/featured-news/wyatt-technology-unveils-new-brochure-for-its-newly-launched-mobius-mobility-instrument/</loc>
		<lastmod>2011-04-07T13:29:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/236/company-directory/freeman-technology/</loc>
		<lastmod>2011-04-06T10:21:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6411/news/featured-news/idt-primetime-pre-designed-assays-increase-qpcr-accuracy-and-efficiency/</loc>
		<lastmod>2011-04-05T13:57:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6405/news/featured-news/tecan-infinite%c2%ae-f200-pro-offers-flexibility-for-drug-discovery/</loc>
		<lastmod>2011-04-05T09:17:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6386/news/featured-news/greenphire-revolutionizes-subject-payment-in-clinical-trials-with-launch-of-clincard-automated-payment-system/</loc>
		<lastmod>2011-04-05T09:09:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6383/news/featured-news/thermo-fisher-scientific-announces-samplemanager-10-0-lims-at-pittcon-2011/</loc>
		<lastmod>2011-04-05T09:07:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6391/news/featured-news/thermo-fisher-scientific-adds-pilgrim-software-to-informatics-global-partner-alliance/</loc>
		<lastmod>2011-04-05T09:06:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6396/news/industry-news/molecular-testing-has-a-long-way-to-go-says-nccn-panel/</loc>
		<lastmod>2011-04-05T09:05:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6376/news/industry-news/novartis-first-in-class-antiviral-deb025-achieved-sustained-viral-response-in-76-of-patients-with-chronic-hepatitis-c-new-phase-ii-study-shows/</loc>
		<lastmod>2011-04-05T09:04:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6363/news/featured-news/top-10-global-pharmaceutical-company-selects-payne-securitys-tear-tape-solution-to-protect-against-counterfeit-drugs/</loc>
		<lastmod>2011-04-01T13:41:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6353/news/industry-news/why-stem-cells-dont-just-want-to-make-neurons/</loc>
		<lastmod>2011-04-01T13:11:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6316/news/industry-news/clinical-trial-success-for-crohns-disease-cell-therapy/</loc>
		<lastmod>2011-03-31T09:11:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6345/news/industry-news/innovation-the-way-forward-for-pharma-industry/</loc>
		<lastmod>2011-03-31T09:04:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6328/news/featured-news/exco-intouch-continues-expansion-with-appointment-of-commercial-heavyweight-jack-edler-and-establishes-larger-us-operational-premises/</loc>
		<lastmod>2011-03-29T14:21:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6294/news/featured-news/thermo-fisher-scientific-simplifies-water-environmental-and-pharmaceutical-regulatory-compliance-and-transforms-process-efficiencies-at-nova-biologicals/</loc>
		<lastmod>2011-03-29T08:54:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6255/news/industry-news/pharmachemical-ireland-welcomes-amgen-purchase-of-pfizers-dublin-facility/</loc>
		<lastmod>2011-03-29T08:45:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6280/news/industry-news/roche-announces-positive-pivotal-phase-ii-results-for-hedgehog-pathway-inhibitor-in-advanced-basal-cell-carcinoma/</loc>
		<lastmod>2011-03-29T08:40:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6265/news/industry-news/sanofi-aventis-strengthens-commitment-to-ophthalmology-through-partnership-with-the-vision-institute/</loc>
		<lastmod>2011-03-29T08:37:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6272/news/industry-news/gsk-statement-on-avodart%e2%84%a2-dutasteride-for-prostate-cancer-risk-reduction/</loc>
		<lastmod>2011-03-29T08:34:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6262/news/industry-news/az-pfizer-and-gsk-leaders-endorse-university%e2%80%99s-quality-by-design-course/</loc>
		<lastmod>2011-03-29T08:32:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6276/news/industry-news/gsk-publishes-2010-corporate-responsibility-report/</loc>
		<lastmod>2011-03-29T08:23:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6229/news/featured-news/hudson-robotics-announces-new-easy-to-use-interfaces-for-complex-instruments/</loc>
		<lastmod>2011-03-28T15:48:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6290/news/industry-news/boehringer-ingelheim-finalizes-acquisition-of-amgen%e2%80%99s-fremont-facility-in-the-usa/</loc>
		<lastmod>2011-03-28T15:32:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6285/news/industry-news/sanofi-aventis-strengthens-support-for-patient-groups-with-launch-of-patient-group-bursary/</loc>
		<lastmod>2011-03-28T15:25:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6269/news/industry-news/novartis-completes-acquisition-of-majority-stake-in-zhejiang-tianyuan-expanding-vaccines-presence-in-china/</loc>
		<lastmod>2011-03-28T14:32:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6258/news/featured-news/itt-analytics-launches-the-new-si-analytics-titroline-titrator-series/</loc>
		<lastmod>2011-03-28T11:21:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6236/news/industry-news/fda-approves-yervoy%e2%84%a2-ipilimumab-for-the-treatment-of-patients-with-newly-diagnosed-or-previously-treated-unresectable-or-metastatic-melanoma-the-deadliest-form-of-skin-cancer/</loc>
		<lastmod>2011-03-28T10:16:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6241/company-directory/bruker-daltonik-gmbh/</loc>
		<lastmod>2011-03-28T10:14:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/wrong-membership-level/</loc>
		<lastmod>2011-03-24T17:16:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6215/news/featured-news/thermo-fisher-scientific-adds-new-atlas-cds-software-control-for-shimadzu-prominence-hplc/</loc>
		<lastmod>2011-03-23T16:14:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6210/news/featured-news/precos-and-argenta-extend-collaboration-to-offer-world-class-integrated-oncology-drug-discovery-services/</loc>
		<lastmod>2011-03-23T08:53:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6178/news/industry-news/isogenica-ltd-announces-collaboration-with-johnson-johnson-pharmaceutical-research-development-l-l-c/</loc>
		<lastmod>2011-03-22T13:53:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/182/company-directory/cisbio-bioassays/</loc>
		<lastmod>2011-03-22T12:18:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6170/news/featured-news/novozymes-biopharma-to-present-latest-research-on-recombinant-human-albumin-at-aaps/</loc>
		<lastmod>2011-03-21T14:35:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6158/news/featured-news/almac-and-exco-intouch-form-alliance-to-deliver-patient-compliance-and-epro-services-using-multiple-technologies/</loc>
		<lastmod>2011-03-21T14:34:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6164/news/industry-news/novartis-receives-european-commission-approval-for-gilenya%c2%ae-the-first-oral-multiple-sclerosis-treatment-for-use-in-the-eu/</loc>
		<lastmod>2011-03-21T10:27:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6148/news/industry-news/sigma%c2%ae-life-science-launches-suite-of-knockout-rats-to-model-parkinson%e2%80%99s-disease/</loc>
		<lastmod>2011-03-17T16:41:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6145/news/industry-news/can-personalised-medicine-save-the-pharma-sector/</loc>
		<lastmod>2011-03-17T16:02:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6131/news/featured-news/thermo-fisher-scientific-introduces-new-software-for-exactive-benchtop-lc-ms/</loc>
		<lastmod>2011-03-16T16:34:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6120/news/industry-news/astrazeneca-initiates-phase-iii-clinical-programme-evaluating-nktr-118-for-treatment-of-opioid-induced-constipation/</loc>
		<lastmod>2011-03-16T13:36:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6125/news/featured-news/toray-introduce-a-new-dimension-in-microarray-sensitivity/</loc>
		<lastmod>2011-03-16T10:05:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6109/news/featured-news/sigma%c2%ae-life-science-and-switchgear-genomics%e2%84%a2-launch-a-human-genome-wide-mission%c2%ae-3-utr-lenti-goclone%e2%84%a2-library-to-identify-and-validate-targets-for-microrna-regulation/</loc>
		<lastmod>2011-03-16T08:46:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6102/news/featured-news/thermo-fisher-scientific-launches-global-enterprise-services/</loc>
		<lastmod>2011-03-15T13:33:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/nir-2011-free-trial-subscription/</loc>
		<lastmod>2011-03-15T11:51:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6094/news/featured-news/tecan-breathes-new-life-into-cell-based-studies/</loc>
		<lastmod>2011-03-15T10:59:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6047/news/industry-news/sanofi-aventis-appoints-dr-richard-klausner-as-chairman-of-the-strategic-development-and-scientific-advisory-council/</loc>
		<lastmod>2011-03-14T15:23:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6052/news/industry-news/janssen-pharmaceutica-nv-receives-offer-to-acquire-its-animal-health-business/</loc>
		<lastmod>2011-03-14T15:19:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6058/news/industry-news/bristol-myers-squibb-awards-grant-to-the-american-college-of-physicians-foundation-to-address-u-s-hiv-medical-workforce-shortage/</loc>
		<lastmod>2011-03-14T15:17:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6063/news/industry-news/bayer-materialscience-to-invest-euro-100-million-in-germany/</loc>
		<lastmod>2011-03-14T15:14:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6069/news/industry-news/takeda-donation-to-aid-earthquake-relief-efforts-in-japan/</loc>
		<lastmod>2011-03-14T15:09:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6020/company-directory/camo-software-as/</loc>
		<lastmod>2011-03-14T15:06:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6039/news/industry-news/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-presentation-at-healthcare-conference/</loc>
		<lastmod>2011-03-14T14:03:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6014/news/featured-news/thermo-fisher-scientific-eliminates-time-consuming-laborious-hand-labeling-of-tubes/</loc>
		<lastmod>2011-03-14T11:46:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5984/news/featured-news/sigma-life-science-adds-1400-cell-lines-to-its-u-s-portfolio-of-ecacc-products/</loc>
		<lastmod>2011-03-10T16:57:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/6004/news/featured-news/prism-ideas-opens-north-american-office-in-global-growth-strategy/</loc>
		<lastmod>2011-03-10T16:55:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5941/news/industry-news/advanced-kidney-cancer-patients-now-able-to-access-votrient%c2%ae%e2%96%bc-pazopanib-on-nhs-scotland/</loc>
		<lastmod>2011-03-10T09:40:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5937/news/industry-news/fda-accepts-new-drug-application-for-investigational-compound-dapagliflozin-for-the-treatment-of-type-2-diabetes/</loc>
		<lastmod>2011-03-10T09:37:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5949/news/industry-news/lilly-ceo-calls-for-biopharmaceutical-industry-changes-and-policies-that-encourage-medical-innovation/</loc>
		<lastmod>2011-03-10T09:28:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5958/news/industry-news/european-commission-approves-xeplion%c2%ae-for-treatment-of-schizophrenia/</loc>
		<lastmod>2011-03-10T08:56:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5963/news/industry-news/fda-advisory-committee-recommends-us-approval-of-novartis-once-daily-bronchodilator-qab149-for-copd/</loc>
		<lastmod>2011-03-09T09:53:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5930/news/featured-news/optibrium-to-unveil-stardrop-5-and-revolutionary-nova-module-at-acs-spring-2011/</loc>
		<lastmod>2011-03-08T12:19:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5918/news/featured-news/redefine-your-absorbance-assays-with-a-free-spectrostar-nano-microplate-reader-from-bmg-labtech/</loc>
		<lastmod>2011-03-07T14:47:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5907/news/featured-news/quotient-clinical-announces-major-expansion-of-its-gmp-manufacturing-and-formulation-development-capacity-to-accommodate-demand-for-its-rapidfact-service/</loc>
		<lastmod>2011-03-07T10:10:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5903/news/featured-news/webinar-will-highlight-how-the-human-tumour-micro-environment-impacts-tumour-cell-biology-and-drug-pharmacology/</loc>
		<lastmod>2011-03-07T10:05:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5889/news/featured-news/the-met-one-3445-particle-counter-will-save-you-time/</loc>
		<lastmod>2011-03-02T13:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5880/news/industry-news/gsk-outlines-new-plan-to-drive-recruitment-and-attract-graduate-talent-in-the-uk/</loc>
		<lastmod>2011-03-02T10:48:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5871/news/industry-news/european-commission-continues-to-support-avastin-in-combination-with-paclitaxel-as-an-effective-treatment-option-for-women-with-metastatic-breast-cancer/</loc>
		<lastmod>2011-03-02T10:19:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5866/news/industry-news/pfizer-completes-acquisition-of-king-pharmaceuticals-inc/</loc>
		<lastmod>2011-03-02T09:25:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5860/news/industry-news/genzyme-completes-sale-of-pharmaceuticals-business-to-international-chemical-investors-group/</loc>
		<lastmod>2011-03-02T09:23:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5849/news/featured-news/point-of-care-cardiac-assays-shorten-turnaround-times-in-emergency-departments/</loc>
		<lastmod>2011-02-28T17:12:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5832/news/industry-news/ucb-establishes-innovative-collaboration-with-harvard-university/</loc>
		<lastmod>2011-02-28T15:52:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5771/news/industry-news/ge-healthcare-appoints-kieran-murphy-as-life-sciences-ceo-successor-to-peter-ehrenheim/</loc>
		<lastmod>2011-02-28T15:48:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5814/news/industry-news/court-of-appeals-overturns-1-8-billion-patent-verdict-for-centocor-ortho-biotech-inc/</loc>
		<lastmod>2011-02-28T15:23:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5828/news/industry-news/gilead-sciences-to-acquire-calistoga-pharmaceuticals-for-375-million/</loc>
		<lastmod>2011-02-28T15:12:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5821/news/industry-news/david-redfern-appointed-as-new-chairman-of-viiv-healthcare/</loc>
		<lastmod>2011-02-28T15:05:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5763/company-directory/watson-marlow-pumps-group/</loc>
		<lastmod>2011-02-25T15:52:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5789/news/featured-news/sigma%c2%ae-life-science-launches-pre-designed-compozr%c2%ae-knockout-zinc-finger-nucleases-for-entire-human-genome/</loc>
		<lastmod>2011-02-25T14:18:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5782/news/industry-news/nampak-healthcare-proposes-major-investment-in-portsmouth/</loc>
		<lastmod>2011-02-24T10:41:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5778/news/industry-news/brecon-appoints-director-of-qa-and-regulatory-affairs/</loc>
		<lastmod>2011-02-24T09:51:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5734/news/featured-news/sigma%c2%ae-life-science-launches-oncology-disease-model-cell-lines/</loc>
		<lastmod>2011-02-23T17:28:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5750/news/industry-news/onglyza%e2%84%a2-us-label-update-provides-further-evidence-regarding-use-in-renally-impaired-adults-with-type-2-diabetes/</loc>
		<lastmod>2011-02-23T17:26:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5741/news/industry-news/new-treatment-choice-for-advanced-kidney-cancer-patients-as-votrient%c2%ae%e2%96%bc-pazopanib-made-available-on-the-nhs/</loc>
		<lastmod>2011-02-23T17:22:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5729/news/featured-news/ert-announces-the-appointment-of-eric-schwartz-as-chief-legal-officer/</loc>
		<lastmod>2011-02-22T16:23:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5717/news/industry-news/anirvan-ghosh-named-head-of-discovery-for-roches-cns-discovery-translational-area/</loc>
		<lastmod>2011-02-21T15:39:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5711/news/industry-news/astrazeneca-to-invest-150m-in-russian-plant/</loc>
		<lastmod>2011-02-21T11:10:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/230/news/featured-news/new-foss-nir-article-monitoring-viable-cell-density-in-bioreactors-using-near-infrared-spectroscopy/</loc>
		<lastmod>2011-02-21T10:44:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5700/news/industry-news/ge-healthcare-appoints-kieran-murphy-as-life-sciences-ceo/</loc>
		<lastmod>2011-02-21T09:03:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/claim-your-complimentary-copy-of-european-pharmaceutical-review/thank-you/</loc>
		<lastmod>2011-02-18T09:50:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/email-newsletter/thank-you/</loc>
		<lastmod>2011-02-18T09:48:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5662/news/featured-news/sigma-life-science-adds-oligoarchitect-for-qpcr-to-online-portfolio-of-scientific-tools/</loc>
		<lastmod>2011-02-17T17:15:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5658/news/industry-news/novartis-appoints-naomi-kelman-as-new-head-of-the-novartis-otc-division/</loc>
		<lastmod>2011-02-17T17:06:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/non-members/</loc>
		<lastmod>2011-02-16T15:58:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5572/company-directory/hudson-robotics-inc/</loc>
		<lastmod>2011-02-16T14:44:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5552/news/featured-news/hudson-robotics-announce-a-major-expansion-in-europe/</loc>
		<lastmod>2011-02-16T14:14:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4803/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/biomarkers-and-targeted-therapies-in-lung-cancer-where-do-we-stand-and-where-will-we-go/</loc>
		<lastmod>2011-02-16T13:51:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4809/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/development-of-stabilised-vaccines-with-needle-free-devices-for-targeted-skin-immunisation/</loc>
		<lastmod>2011-02-16T13:51:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4816/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/developing-and-applying-recombinant-antibody-microarrays-for-high-throughput-disease-proteomics/</loc>
		<lastmod>2011-02-16T13:51:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4818/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/application-of-flowcytometry-in-drug-discovery/</loc>
		<lastmod>2011-02-16T13:51:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4827/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/pharmachemical-ireland-launch-innovation-and-excellence-strategy-in-new-york/</loc>
		<lastmod>2011-02-16T13:51:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4841/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2011-02-16T13:51:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4844/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/rnai-screens-for-the-identification-and-validation-of-novel-targets-current-status-and-challenges/</loc>
		<lastmod>2011-02-16T13:50:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4855/european-pharmaceutical-review-magazine/past-issues/issue-6-2010/pcr-and-personalised-cancer-medicine/</loc>
		<lastmod>2011-02-16T13:50:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5581/news/featured-news/wyatt-technology-corporation-wins-sbas-tibbetts-award-for-advanced-technological-innovations/</loc>
		<lastmod>2011-02-16T10:08:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5391/news/industry-news/lilly-announces-senior-leadership-changes/</loc>
		<lastmod>2011-02-16T09:34:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5564/news/industry-news/nsf-international-acquires-leader-in-pharmaceuticals-and-biotechnology/</loc>
		<lastmod>2011-02-16T09:25:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5558/news/industry-news/roche-initiates-phase-iii-study-investigating-infusion-free-administration-of-mabthera-for-patients-with-non-hodgkin%e2%80%99s-lymphoma/</loc>
		<lastmod>2011-02-16T09:14:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5546/news/featured-news/tecan-and-scirobotics-offer-integrated-colony-picking-for-molecular-biology/</loc>
		<lastmod>2011-02-15T16:26:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5505/news/featured-news/rodent-models-meeting-need-for-reduced-drug-attrition-rates/</loc>
		<lastmod>2011-02-14T17:33:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5512/news/featured-news/precos-doubles-capacity-and-appoints-new-senior-scientific-staff-to-accommodate-significant-growth/</loc>
		<lastmod>2011-02-14T17:31:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/news/industry-news/</loc>
		<lastmod>2011-02-14T16:55:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/news/featured-news/</loc>
		<lastmod>2011-02-14T16:55:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5344/news/industry-news/novartis-drug-afinitor%c2%ae-extends-progression-free-survival-in-patients-with-advanced-pancreatic-net-study-published-in-nejm-shows/</loc>
		<lastmod>2011-02-14T16:44:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5328/news/industry-news/novartis-studies-show-onbrez%c2%ae-breezhaler%c2%ae-plus-tiotropium-provided-greater-increase-in-lung-function-than-tiotropium-alone/</loc>
		<lastmod>2011-02-14T16:41:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5434/news/industry-news/apixaban-statistically-superior-to-aspirin-in-reducing-the-composite-of-stroke-or-systemic-embolism/</loc>
		<lastmod>2011-02-14T16:38:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5438/news/industry-news/abbott-streamlines-uk-supply-chain-routes/</loc>
		<lastmod>2011-02-14T16:29:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5386/news/industry-news/biocity-nottingham-experience-offers-pfizer-hope/</loc>
		<lastmod>2011-02-14T16:27:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5451/news/industry-news/clondalkin-group-appoints-peach-to-support-pharma-growth/</loc>
		<lastmod>2011-02-14T16:24:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5065/news/featured-news/molecular-profiles-expands-service-offering-with-new-manufacturing-capabilities/</loc>
		<lastmod>2011-02-14T16:01:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5119/news/featured-news/tecan-launches-innovative-hydrospeed%e2%84%a2-plate-washer/</loc>
		<lastmod>2011-02-14T16:01:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5142/news/featured-news/perkinelmer-launches-the-enspire%c2%ae-multimode-plate-reader-with-label-free-detection-technology-for-drug-discovery-research/</loc>
		<lastmod>2011-02-14T16:00:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5151/news/featured-news/new-trough-from-tecan-to-reduce-reagent-costs/</loc>
		<lastmod>2011-02-14T15:55:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5162/news/featured-news/thermo-fisher-scientific-to-launch-major-new-innovative-informatics-offerings-at-pittcon-2011/</loc>
		<lastmod>2011-02-14T15:54:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5181/news/featured-news/tecan-and-sword-diagnostics-announce-availability-of-high-performance-immunoassay-detection-technology/</loc>
		<lastmod>2011-02-14T15:53:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5206/news/featured-news/optibrium-to-preview-new-in-silico-drug-discovery-platform-at-molecular-med-tri-conference-2011/</loc>
		<lastmod>2011-02-14T15:51:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5237/news/featured-news/exco-intouch-drives-down-client-costs-with-the-introduction-of-unique-free-sms-and-free-data-download-features-for-retention-compliance-and-epro/</loc>
		<lastmod>2011-02-14T15:49:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5359/news/featured-news/pharmanet-announces-observational-research-survey-results/</loc>
		<lastmod>2011-02-14T15:47:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5247/news/featured-news/sigma-life-science-collaborates-with-cofactor-genomics-to-develop-publically-available-rat-genome-database/</loc>
		<lastmod>2011-02-14T15:28:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5308/news/featured-news/molecular-profiles-installs-xcelodose-system-speeding-drug-development-for-customers/</loc>
		<lastmod>2011-02-14T15:21:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5363/news/featured-news/novozymes-biopharma-supplies-neomend-with-albucult-for-use-in-unique-sealant-technology/</loc>
		<lastmod>2011-02-14T14:39:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5446/news/industry-news/elan-and-boehringer-ingelheim-announce-development-and-manufacturing-agreement-for-elan%e2%80%99s-antibody-based-therapeutics-pipeline/</loc>
		<lastmod>2011-02-14T14:33:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5431/news/industry-news/crucell-shareholders-adopt-offer-governance-resolutions-and-johnson-johnson-makes-announcement-on-u-s-regulatory-matters/</loc>
		<lastmod>2011-02-14T13:56:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/634/events/past-events/cellular-imaging-analysis-2009/</loc>
		<lastmod>2011-02-14T12:37:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5342/news/industry-news/lilly-ceo-says-industry-public-policy-must-pave-way-for-innovation/</loc>
		<lastmod>2011-02-10T14:51:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5315/news/featured-news/hamilton-extends-monitoring-technology-to-96-channel-pipetting-head/</loc>
		<lastmod>2011-02-10T14:45:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5305/news/industry-news/premier-research-adds-patient-recruitment-expert-to-team/</loc>
		<lastmod>2011-02-09T14:40:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5323/news/industry-news/astrazeneca-innovator-joins-idea-pharma/</loc>
		<lastmod>2011-02-09T14:39:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5300/news/featured-news/easing-the-transition-into-profitable-manufacture/</loc>
		<lastmod>2011-02-08T12:00:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5297/news/industry-news/astrazeneca-halts-phase-iii-trial-of-zibotentan-in-non-metastatic-castrate-resistant-prostate-cancer/</loc>
		<lastmod>2011-02-07T17:05:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5293/news/industry-news/astrazeneca-and-targacept-initiate-phase-iib-clinical-trial-of-tc-5214-as-a-switch-monotherapy-treatment-for-major-depressive-disorder/</loc>
		<lastmod>2011-02-07T17:03:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5290/news/industry-news/us-fda-assigns-new-pdufa-date-for-brilinta-ticagrelor-tablets/</loc>
		<lastmod>2011-02-04T15:21:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5285/news/industry-news/nextpharma-technologies-announces-the-appointment-of-new-quality-director-at-its-braine-l%e2%80%99alleud-site-in-belgium/</loc>
		<lastmod>2011-02-03T16:11:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5275/news/industry-news/andrew-packman-to-lead-pwc%e2%80%99s-uk-pharmaceutical-and-life-sciences-business/</loc>
		<lastmod>2011-02-03T15:59:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5278/news/industry-news/aesica-announces-european-appointments/</loc>
		<lastmod>2011-02-03T15:58:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5224/news/industry-news/owen-mumford-limited-appoints-new-general-manager/</loc>
		<lastmod>2011-02-01T15:26:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5234/news/industry-news/valeant-pharmaceuticals-to-acquire-pharmaswiss-s-a/</loc>
		<lastmod>2011-02-01T13:51:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5155/news/industry-news/emd-millipore-announces-change-in-supply-chain-of-insulin-for-cell-culture-media/</loc>
		<lastmod>2011-02-01T11:02:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5219/news/industry-news/european-commission-approves-nasal-spray-vaccine-fluenz-for-the-prevention-of-seasonal-influenza-in-children/</loc>
		<lastmod>2011-02-01T10:43:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5192/news/industry-news/bayer-and-zydus-cadila-sign-joint-venture-agreement-to-strengthen-pharmaceutical-business-in-india/</loc>
		<lastmod>2011-01-31T16:59:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5172/news/industry-news/fda-approves-rituxanmabthera-for-first-line-maintenance-use-in-follicular-lymphoma/</loc>
		<lastmod>2011-01-31T16:54:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5176/news/industry-news/fda-approves-the-novartis-quadrivalent-meningococcal-conjugate-vaccine-menveo%c2%ae-for-use-in-children-from-2-years-of-age/</loc>
		<lastmod>2011-01-31T16:44:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5186/news/industry-news/lundbeck-research-usa-inc-and-biofocus-sign-compound-management-agreement/</loc>
		<lastmod>2011-01-31T15:49:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2241/news/featured-news/new-purity-levels-and-options-for-tecan%e2%80%99s-mca96-disposable-tips/</loc>
		<lastmod>2011-01-28T12:11:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1783/news/featured-news/tecan-collaborates-with-arizona-state-university-to-rapidly-assess-radiation-exposure/</loc>
		<lastmod>2011-01-28T12:10:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2148/news/featured-news/tecan%e2%80%99s-remote-monitoring-for-automation-goes-up-a-notch/</loc>
		<lastmod>2011-01-28T12:09:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2711/news/featured-news/accessing-yeast-genomics/</loc>
		<lastmod>2011-01-28T12:08:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5147/news/industry-news/erbitux-long-term-survival-benefit-for-mcrc-patients-confirmed-with-folfox/</loc>
		<lastmod>2011-01-26T13:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/210/company-directory/discoverx-corporation/</loc>
		<lastmod>2011-01-25T15:11:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5129/news/industry-news/amgen-to-acquire-biovex-a-privately-held-biotechnology-company-headquartered-in-woburn-mass/</loc>
		<lastmod>2011-01-25T12:16:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5123/news/industry-news/glaxosmithkline-announces-start-of-two-phase-iii-studies-in-advancedmetastatic-melanoma/</loc>
		<lastmod>2011-01-25T11:45:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5116/news/industry-news/novartis-announces-agreement-to-acquire-genoptix-inc-in-all-cash-offer/</loc>
		<lastmod>2011-01-24T11:59:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5113/news/industry-news/novartis-gains-approval-for-gilenya%c2%ae-as-a-first-line-disease-modifying-oral-therapy-for-multiple-sclerosis-in-switzerland-and-australia/</loc>
		<lastmod>2011-01-24T11:56:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5108/news/industry-news/statement-from-lilly-and-avid-on-fda-advisory-committee-recommendation-for-amyvidtm-florbetapir-nda/</loc>
		<lastmod>2011-01-21T09:14:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5103/news/industry-news/astrazeneca-replies-to-the-us-fda-complete-response-letter-for-brilinta-ticagrelor-tablets/</loc>
		<lastmod>2011-01-21T09:10:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5098/news/industry-news/cognizant-selected-by-lilly-to-deliver-commercial-operations-solutions-to-enhance-sales-and-marketing-effectiveness-business-performance/</loc>
		<lastmod>2011-01-21T09:02:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5093/news/industry-news/merck-kgaa-and-lead-discovery-center-enter-collaboration-for-the-discovery-of-anti-cancer-compounds/</loc>
		<lastmod>2011-01-20T10:20:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5088/news/industry-news/publicprivate-partnership-improves-uk%e2%80%99s-clinical-research-competitiveness/</loc>
		<lastmod>2011-01-20T10:16:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5057/news/industry-news/glaxosmithkline-announces-q4-2010-legal-charge/</loc>
		<lastmod>2011-01-18T11:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4919/news/industry-news/mike-romanos-appointed-as-ceo-of-crescendo-biologics/</loc>
		<lastmod>2011-01-18T11:22:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4932/news/industry-news/bicycle-therapeutics-appoints-andy-sandham-as-non-executive-chairman/</loc>
		<lastmod>2011-01-18T11:17:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4938/news/industry-news/lab21-acquires-microgen-bioproducts/</loc>
		<lastmod>2011-01-18T11:01:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4909/news/featured-news/ec-ssrs-solution-from-ert-facilitates-compliance-with-new-fda-guidance-on-suicidality-assessment-in-clinical-trials/</loc>
		<lastmod>2011-01-18T10:59:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4913/news/featured-news/wyatt-technology-mals-detectors-used-in-breakthrough-virus-research/</loc>
		<lastmod>2011-01-18T10:53:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4943/news/featured-news/novozymes-biopharma-presents-research-on-recombinant-human-albumin-at-2011-peptalk-conference/</loc>
		<lastmod>2011-01-18T10:46:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4956/news/industry-news/lallemand-pharma-and-glaxosmithkline-partner-to-launch-ismigen-in-poland/</loc>
		<lastmod>2011-01-18T10:42:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4950/news/featured-news/thermo-fisher-scientific-to-showcase-unique-ability-to-assess-sepsis-risk-with-clinical-biomarker-b-r-a-h-m-s-procalcitonin-at-sccm-2011/</loc>
		<lastmod>2011-01-18T10:38:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4960/news/industry-news/lilly-and-boehringer-ingelheim-announce-strategic-alliance-to-bring-new-diabetes-treatments-to-patients-worldwide/</loc>
		<lastmod>2011-01-18T10:31:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4964/news/featured-news/prism-ideas-appoints-carol-hills-as-chief-operations-officer/</loc>
		<lastmod>2011-01-18T10:26:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4972/news/industry-news/statement-from-lilly-on-fda-advisory-committee-recommendation-regarding-liprotamase-new-drug-application-for-treatment-of-exocrine-pancreatic-insufficiency/</loc>
		<lastmod>2011-01-18T10:24:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4978/news/featured-news/seeing-is-believing-%e2%80%93-3d-scanning-with-tecan%e2%80%99s-infinite%c2%ae-m1000/</loc>
		<lastmod>2011-01-18T10:17:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5006/news/featured-news/dr-eric-gluck-swedish-covenant-hospital-professor-of-medicine-to-highlight-benefits-of-thermo-scientific-b-r-a-h-m-s-procalcitonin-assay-in-identifying-sepsis-in-critically-ill-patients-via-scientif/</loc>
		<lastmod>2011-01-18T10:11:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5015/news/industry-news/domain-therapeutics-and-merck-serono-announce-an-agreement-to-develop-drugs-for-parkinson%e2%80%99s-disease/</loc>
		<lastmod>2011-01-18T10:02:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5019/news/industry-news/changes-to-the-roche-corporate-executive-committee/</loc>
		<lastmod>2011-01-18T09:54:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/5010/company-directory/randox-pharma-services/</loc>
		<lastmod>2011-01-17T13:52:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4926/company-directory/smithers-viscient/</loc>
		<lastmod>2011-01-07T08:37:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/bronze-membership/bronze-welcome/</loc>
		<lastmod>2011-01-06T09:29:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4921/news/featured-news/avoid-costly-issues-within-clinical-trials-by-investing-in-proven-retention-and-compliance-solutions-advises-exco-intouch/</loc>
		<lastmod>2011-01-05T16:42:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4916/news/industry-news/quantum-pharmaceutical-appoints-new-national-account-manager/</loc>
		<lastmod>2011-01-05T16:21:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4904/news/industry-news/argen-x-signs-discovery-and-development-alliance-with-lilly/</loc>
		<lastmod>2011-01-05T10:13:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4900/news/featured-news/pharmanet-offers-guidance-on-regulatory-pathway-for-biosimilars-development-following-recent-fda-hearing/</loc>
		<lastmod>2011-01-04T16:39:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4893/news/industry-news/proximagen-acquires-two-cns-drug-development-programmes-from-glaxosmithkline/</loc>
		<lastmod>2011-01-04T16:34:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4889/news/featured-news/ert-announces-the-appointment-of-joel-morganroth-md-as-interim-ceo/</loc>
		<lastmod>2011-01-04T16:10:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4882/news/featured-news/gsk-head-of-patient-recruitment-joins-exco-intouch/</loc>
		<lastmod>2011-01-04T16:03:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4876/news/industry-news/astrazeneca-and-abbott-end-license-agreement-for-the-development-of-certriad/</loc>
		<lastmod>2011-01-04T10:28:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4871/news/industry-news/nice-recommends-votrient%c2%ae%e2%96%bc-pazopanib-for-the-first-line-treatment-of-advanced-renal-cell-carcinoma-rcc/</loc>
		<lastmod>2011-01-04T10:22:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4863/news/featured-news/the-scott-partnership-to-present-short-course-on-marketing-in-asia-pacific-at-major-laboratory-science-show-pittcon-2011/</loc>
		<lastmod>2010-12-16T15:59:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4860/news/featured-news/ert-unveils-full-range-of-epro-solutions-providing-the-power-of-choice-for-clinical-trial-sponsors/</loc>
		<lastmod>2010-12-16T15:26:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/105/homepage-promo/european-pharmaceutical-review-magazine/</loc>
		<lastmod>2010-12-16T14:11:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4307/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/ms-based-clinical-proteomics-biomarker-discovery-in-men%e2%80%99s-cancer/</loc>
		<lastmod>2010-12-16T09:41:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4312/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/the-sequencing-revolution-enabling-personal-genomics-and-personalised-medicine/</loc>
		<lastmod>2010-12-16T09:40:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4320/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/bio-mimetic-chromatography-to-predict-drug-distribution-in-vivo/</loc>
		<lastmod>2010-12-16T09:40:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4335/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/the-evolution-of-rnai-technologies-in-the-drug-discovery-business/</loc>
		<lastmod>2010-12-16T09:40:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4339/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/functional-genomics-as-a-tool-for-guiding-personalised-cancer-treatment/</loc>
		<lastmod>2010-12-16T09:40:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4346/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/advances-in-two-dimensional-cell-migration-assay-technologies/</loc>
		<lastmod>2010-12-16T09:39:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4357/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/biomarkers-in-drug-discovery-and-development/</loc>
		<lastmod>2010-12-16T09:39:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4363/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/applying-pat-in-pharmaceutical-processes/</loc>
		<lastmod>2010-12-16T09:38:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4369/european-pharmaceutical-review-magazine/past-issues/issue-5-2010/article-5-the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-12-16T09:38:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4781/news/featured-news/sigma%c2%ae-life-science-creates-world%e2%80%99s-first-knock-in-rats-using-zinc-finger-nuclease-technology/</loc>
		<lastmod>2010-12-13T11:43:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4767/news/featured-news/infinite%c2%ae-200-pro-offers-environmental-control-for-cell-based-applications/</loc>
		<lastmod>2010-12-09T11:38:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4763/news/industry-news/zealand-pharma-receives-milestone-payment-from-helsinn-healthcare/</loc>
		<lastmod>2010-12-09T11:33:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4754/news/featured-news/ert-facilitates-global-growth-with-appointment-of-klaus-besier-to-board-of-directors/</loc>
		<lastmod>2010-12-08T17:02:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4749/news/featured-news/biomerieux%e2%80%99s-bioball%c2%ae-mixed-kits-provide-flexibility-for-the-pharmaceutical-industry/</loc>
		<lastmod>2010-12-07T16:50:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4729/news/featured-news/the-scott-partnership-expands-life-sciences-client-base-with-new-client-prism-ideas/</loc>
		<lastmod>2010-12-06T15:53:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4722/news/featured-news/tecan%e2%80%99s-hydroflex%e2%84%a2-improves-plate-washing-for-elispot-assays/</loc>
		<lastmod>2010-12-06T15:45:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4716/news/industry-news/william-vickery-joins-hybrigenics-as-head-of-corporate-and-business-development/</loc>
		<lastmod>2010-12-06T15:24:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4713/news/industry-news/european-commission-approves-brilique%e2%84%a2-ticagrelor-tablets/</loc>
		<lastmod>2010-12-06T15:20:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4710/news/industry-news/phase-ii-study-with-first-in-class-investigational-drug-demonstrates-improvement-in-negative-symptoms-in-patients-with-schizophrenia/</loc>
		<lastmod>2010-12-06T15:18:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4705/news/industry-news/us-fda-advisory-committee-makes-recommendation-on-new-drug-application-for-vandetanib-in-advanced-medullary-thyroid-cancer/</loc>
		<lastmod>2010-12-06T15:13:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4703/news/industry-news/e-therapeutics-plc-board-appoints-stephen-self-to-direct-development/</loc>
		<lastmod>2010-12-06T15:08:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4698/news/industry-news/longer-term-phase-iii-data-show-novartis-drug-tasigna%c2%ae-continues-to-surpass-glivec%c2%ae-in-slowing-disease-progression-in-patients-with-newly-diagnosed-cml/</loc>
		<lastmod>2010-12-06T15:04:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/113/homepage-promo/european-pharmaceutical-review-digital-news/</loc>
		<lastmod>2010-12-06T14:21:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4676/news/industry-news/janssen-pharmaceutica-n-v-announces-collaboration-to-develop-diagnostic-biosignatures-for-pre-symptomatic-identification-of-alzheimer%e2%80%99s-disease/</loc>
		<lastmod>2010-12-02T10:28:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4674/news/industry-news/glaxosmithkline-to-increase-its-shareholding-in-theravance/</loc>
		<lastmod>2010-12-01T12:14:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4670/news/featured-news/chris-beaver-joins-pharmanet-as-director-immunochemistry-services/</loc>
		<lastmod>2010-11-29T16:12:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4664/homepage-promo/columbus%c2%ae-access-store-and-explore-whatever-the-source/</loc>
		<lastmod>2010-11-24T12:34:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4659/news/industry-news/zhong-chongyu-appointed-general-manager-of-ethypharm-china/</loc>
		<lastmod>2010-11-24T09:13:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4654/news/industry-news/frederic-fougerat-appointed-vice-president-communications-of-ethypharm/</loc>
		<lastmod>2010-11-24T09:07:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4649/news/industry-news/molmed-strengthens-top-management-team-with-the-appointment-of-germano-carganico-as-general-manager/</loc>
		<lastmod>2010-11-24T08:55:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4641/news/industry-news/roche-obtains-license-for-egfr-lung-cancer-assays-and-will-develop-tarceva-companion-diagnostic-test/</loc>
		<lastmod>2010-11-23T09:23:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4634/news/featured-news/precos-secures-multi-year-global-service-agreement-with-leading-pharmaceutical-company/</loc>
		<lastmod>2010-11-22T16:58:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4631/news/industry-news/abbott-announces-positive-results-from-phase-2-study-of-low-dose-atrasentan-for-treatment-of-diabetic-kidney-disease/</loc>
		<lastmod>2010-11-22T16:49:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4620/news/industry-news/convergence-pharmaceuticals-and-selcia-announce-drug-discovery-collaboration-around-chronic-pain/</loc>
		<lastmod>2010-11-22T12:26:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4613/news/featured-news/new-paper-from-optibrium-and-tessella-illustrates-scientists%e2%80%99-instincts-are-often-impaired-by-human-cognitive-biases-when-making-drug-discovery-decisions/</loc>
		<lastmod>2010-11-22T12:05:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4610/news/featured-news/optibrium-unveils-stardrop-4-3/</loc>
		<lastmod>2010-11-22T11:59:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4605/news/featured-news/sigma%c2%ae-life-science-collection-of-prestige-antibodies%c2%ae-exceeds-10000/</loc>
		<lastmod>2010-11-22T11:51:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4588/news/industry-news/bristol-myers-squibb-announces-the-pricing-terms-of-its-cash-tender-offer/</loc>
		<lastmod>2010-11-19T09:31:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4581/news/industry-news/appraise-2-study-with-investigational-compound-apixaban-in-acute-coronary-syndrome-discontinued/</loc>
		<lastmod>2010-11-19T09:21:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4572/news/featured-news/thermo-fisher-scientific-launches-calibration-validation-carousels-cvcs-to-streamline-performance-verification/</loc>
		<lastmod>2010-11-18T16:12:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4577/news/featured-news/tecan-and-covaris-co-market-freedom-evo%c2%ae-with-adaptive-focused-acoustics%e2%84%a2/</loc>
		<lastmod>2010-11-18T16:11:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4565/news/featured-news/the-scott-partnership-appointed-by-precos-leading-pre-clinical-research-and-development-organisation-to-run-global-pr-campaign/</loc>
		<lastmod>2010-11-17T15:55:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4561/news/industry-news/novartis-unveils-long-term-strategy-to-grow-in-a-dynamically-changing-healthcare-environment/</loc>
		<lastmod>2010-11-17T11:42:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4558/news/industry-news/leukocare-signs-cooperation-agreement-with-sterigenics/</loc>
		<lastmod>2010-11-17T09:58:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4551/news/featured-news/cerno-bioscience-announces-spectral-accuracy-is-a-proven-companion-concept-to-mass-accuracy-for-mass-spectrometry/</loc>
		<lastmod>2010-11-16T17:00:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4548/news/featured-news/itt-completes-acquisition-of-o-i-corporation-to-enhance-its-global-analytical-instrumentation-business/</loc>
		<lastmod>2010-11-16T16:50:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4530/company-directory/rapid-micro-biosystems/</loc>
		<lastmod>2010-11-16T12:13:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4541/news/featured-news/tecan-hosts-an-exclusive-applied-genomics-symposium-for-world-renowned-scientists/</loc>
		<lastmod>2010-11-16T12:01:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4535/news/industry-news/u-s-district-court-rules-from-bench-in-lillys-favor-confirms-validity-of-alimta-patent/</loc>
		<lastmod>2010-11-16T11:55:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4525/news/industry-news/caligor-rx-strengthens-its-european-team/</loc>
		<lastmod>2010-11-15T16:56:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4522/news/featured-news/the-scott-partnership-appointed-by-itt-analytics/</loc>
		<lastmod>2010-11-15T16:09:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4517/news/featured-news/leading-b2b-communications-agency-the-scott-partnership-enters-into-china-market-as-part-of-continued-expansion/</loc>
		<lastmod>2010-11-15T16:06:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4514/news/featured-news/the-scott-partnership-opens-us-office-in-global-growth-strategy/</loc>
		<lastmod>2010-11-15T16:01:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4511/news/featured-news/pharmanet-launches-new-brand-identity-at-upcoming-industry-conferences/</loc>
		<lastmod>2010-11-15T15:54:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4509/news/industry-news/argen-x-appoints-dr-debbie-allen-as-senior-director-business-development/</loc>
		<lastmod>2010-11-15T10:21:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1792/homepage-promo/industry-report/</loc>
		<lastmod>2010-11-12T11:31:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4499/news/featured-news/sage-n-research-optimizes-data-generation-for-the-sanford-burnham-medical-research-institute/</loc>
		<lastmod>2010-11-12T11:20:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4494/news/industry-news/roche-diagnostics-signs-memorandum-of-understanding-for-a-strategic-partnership-with-capitalbio/</loc>
		<lastmod>2010-11-11T16:47:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4490/news/industry-news/rts-life-science-acquired-by-entologi/</loc>
		<lastmod>2010-11-11T16:13:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4487/news/industry-news/clavis-pharma-and-clovis-oncology-extend-partnership-and-sign-new-205-million-deal/</loc>
		<lastmod>2010-11-11T08:52:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4481/news/featured-news/quotient-clinical-and-bend-research-announce-collaboration-to-accelerate-advancement-of-new-medicines/</loc>
		<lastmod>2010-11-10T17:03:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4478/news/featured-news/thermo-fisher-scientific-launches-mass-frontier-7-0/</loc>
		<lastmod>2010-11-10T14:46:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4474/news/industry-news/algeta-appoints-lars-abrahmsen-as-senior-vice-president-protein-therapeutics/</loc>
		<lastmod>2010-11-10T09:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4469/news/industry-news/next-generation-drug-development-summit-imaging-biomarkers/</loc>
		<lastmod>2010-11-09T16:31:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4464/news/industry-news/unilabs-york-bioanalytical-solutions-ybs-appoints-david-j-browne-to-business-development-manager/</loc>
		<lastmod>2010-11-09T08:56:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4459/news/industry-news/genentech%e2%80%99s-ecp-1-bacterial-manufacturing-facility-named-2010-facility-of-the-year-awards-overall-winner/</loc>
		<lastmod>2010-11-08T17:28:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4444/news/industry-news/wragge-co-enhances-ip-practice-with-new-partner-hire/</loc>
		<lastmod>2010-11-08T09:32:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4436/news/industry-news/kombiglyze%e2%84%a2-xr-tablets-approved-in-the-us-for-the-treatment-of-type-2-diabetes-mellitus-in-adults/</loc>
		<lastmod>2010-11-08T09:26:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4430/news/featured-news/wyatt-technology-mals-detectors-enable-pharmaceutical-manufacturers-to-perform-easy-and-reliable-transmembrane-protein-characterization/</loc>
		<lastmod>2010-11-04T16:11:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4424/news/featured-news/sigma%c2%ae-life-science-collaborates-with-the-jackson-laboratory-for-distribution-of-genetically-engineered-mice/</loc>
		<lastmod>2010-11-04T12:12:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4408/news/featured-news/quotient-bioresearch-celebrates-official-opening-of-new-state-of-the-art-radiochemistry-facility/</loc>
		<lastmod>2010-11-03T14:55:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4406/news/featured-news/specialist-business-unit-of-the-university-of-nottingham-spins-out-to-form-new-rd-oncology-company/</loc>
		<lastmod>2010-11-03T14:50:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4403/news/featured-news/prism-ideas-announces-collaboration-with-university-of-liverpool-to-prepare-students-for-careers-in-medical-communications/</loc>
		<lastmod>2010-11-03T14:47:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4400/news/featured-news/molecular-profiles-unveils-new-capabilities-at-aaps-2010/</loc>
		<lastmod>2010-11-02T16:43:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/789/european-pharmaceutical-review-magazine/past-issues/qbd-and-pat-from-science-to-compliance/</loc>
		<lastmod>2010-11-01T12:03:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/782/european-pharmaceutical-review-magazine/past-issues/drug-drug-interactions-tools-for-drug-transporter-protein-studies/</loc>
		<lastmod>2010-11-01T12:02:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/775/european-pharmaceutical-review-magazine/past-issues/real-time-environmental-monitoring-pat-solutions-using-rapid-microbiological-methods/</loc>
		<lastmod>2010-11-01T12:02:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/772/european-pharmaceutical-review-magazine/past-issues/drug-discovery-2009/</loc>
		<lastmod>2010-11-01T12:02:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/770/european-pharmaceutical-review-magazine/past-issues/cellular-imaging-analysis-business-unit/</loc>
		<lastmod>2010-11-01T12:02:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/766/european-pharmaceutical-review-magazine/past-issues/high-throughput-and-high-content-screening-microscopy-a-microscopy-based-guideline/</loc>
		<lastmod>2010-11-01T12:02:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/763/european-pharmaceutical-review-magazine/past-issues/new-dna-sequencing-technologies-applications-promises-and-challenges-for-pharmacogenomics/</loc>
		<lastmod>2010-11-01T12:02:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/756/european-pharmaceutical-review-magazine/past-issues/article-4-optimisation-of-the-pcr-step-of-a-qpcr-assay/</loc>
		<lastmod>2010-11-01T12:01:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/754/european-pharmaceutical-review-magazine/past-issues/rnai-applications-in-biology-and-medicine/</loc>
		<lastmod>2010-11-01T12:01:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/748/european-pharmaceutical-review-magazine/past-issues/the-leading-european-event-for-drug-discovery/</loc>
		<lastmod>2010-11-01T12:00:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/700/european-pharmaceutical-review-magazine/past-issues/next-generation-antibody-therapeutics-antibody-fragments-dual-targeting-strategies-and-beyond/</loc>
		<lastmod>2010-11-01T11:59:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/732/european-pharmaceutical-review-magazine/past-issues/real-time-nir-monitoring-of-pharmaceutical-blending-processes-with-multivariate-quantitative-models/</loc>
		<lastmod>2010-11-01T11:59:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/725/european-pharmaceutical-review-magazine/past-issues/article-5-qpcr-data-analysis-amplification-plots-cq-and-normalisation/</loc>
		<lastmod>2010-11-01T11:59:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/723/european-pharmaceutical-review-magazine/past-issues/innovation-welcome/</loc>
		<lastmod>2010-11-01T11:59:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/720/european-pharmaceutical-review-magazine/past-issues/sleep-changes-as-translational-pharmacodynamic-biomarkers/</loc>
		<lastmod>2010-11-01T11:59:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/711/european-pharmaceutical-review-magazine/past-issues/raman-spectroscopy-in-pharmaceutical-analysis/</loc>
		<lastmod>2010-11-01T11:59:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/706/european-pharmaceutical-review-magazine/past-issues/europes-leading-gathering-for-the-biotech-industry/</loc>
		<lastmod>2010-11-01T11:58:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/689/european-pharmaceutical-review-magazine/past-issues/novel-and-emerging-sterilisation-technologies/</loc>
		<lastmod>2010-11-01T11:58:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4347/news/industry-news/medivir-appoints-vice-president-research-development-projects/</loc>
		<lastmod>2010-11-01T10:34:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4342/news/industry-news/dr-ludo-reynders-appointed-chief-executive-officer-of-premier-research-group/</loc>
		<lastmod>2010-11-01T09:45:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3634/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/applying-systems-biology-and-computer-simulations-to-predicting-idiosyncratic-dili/</loc>
		<lastmod>2010-10-29T13:04:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3638/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/toxicology-and-pharmaceutical-industry-advanced-training-piat/</loc>
		<lastmod>2010-10-29T13:04:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3643/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/process-analytical-technology-an-industry-perspective/</loc>
		<lastmod>2010-10-29T13:04:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3646/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/indirect-modulation-of-cardiac-ion-channels-and-implications-for-preclinical-safety-assessment/</loc>
		<lastmod>2010-10-29T13:04:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3651/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/towards-a-comprehensive-open-source-platform-for-management-and-analysis-of-high-content-screening-data/</loc>
		<lastmod>2010-10-29T13:04:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3659/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/polymorph-screening-in-pharmaceutical-development/</loc>
		<lastmod>2010-10-29T13:04:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3670/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/raman-spectroscopy-and-cancer-cells/</loc>
		<lastmod>2010-10-29T13:04:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3677/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/article-4-the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-10-29T13:04:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3680/european-pharmaceutical-review-magazine/past-issues/issue-4-2010/primary-packaging-materials-for-pharmaceutical-freeze-drying-moulded-vs-serum-tubing-vials/</loc>
		<lastmod>2010-10-29T13:03:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4294/news/industry-news/astrazeneca-announces-co-promotion-agreement-with-daiichi-sankyo-for-nexium-in-japan/</loc>
		<lastmod>2010-10-29T11:12:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4287/news/featured-news/exco-intouch-receives-prestigious-epro-accolade-at-the-2010-european-outsourcing-awards/</loc>
		<lastmod>2010-10-27T15:24:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4284/news/featured-news/sigma%c2%ae-life-science-partners-with-autism-speaks-to-develop-improved-animal-models-of-autism/</loc>
		<lastmod>2010-10-27T12:42:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4280/news/industry-news/lab21-appoints-susan-lowther-as-chief-financial-officer/</loc>
		<lastmod>2010-10-27T08:43:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4274/news/featured-news/thermo-fisher-scientific-demonstrates-software-for-simplified-bioanalytical-workflows/</loc>
		<lastmod>2010-10-26T13:47:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4269/news/featured-news/thermo-fisher-scientific-and-proteome-sciences-form-protein-biomarker-collaboration/</loc>
		<lastmod>2010-10-26T13:43:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4264/news/featured-news/thermo-fisher-scientific-and-scienceaaas-host-webinar-on-the-future-of-quantitative-pcr-and-the-importance-of-standardization/</loc>
		<lastmod>2010-10-26T13:34:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4261/news/featured-news/thermo-fisher-scientific-simplifies-uv-vis-spectroscopy-streamlining-qaqc-processes-with-launch-of-its-evolution-200-series/</loc>
		<lastmod>2010-10-26T13:30:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4257/news/featured-news/thermo-fisher-scientific-introduces-new-incurred-sample-reanalysis-information-kit-for-reliable-quality-assessment-of-bioanalytical-methods/</loc>
		<lastmod>2010-10-26T13:26:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4253/news/featured-news/thermo-fisher-scientific-demonstrates-superiority-of-data-dependent-decision-tree-logic/</loc>
		<lastmod>2010-10-26T13:23:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4247/news/featured-news/thermo-fisher-scientific-and-intrinsic-bioprobes-announce-alliance-in-mass-spectrometric-immunoassay-msia-workflow-development/</loc>
		<lastmod>2010-10-26T13:18:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4242/news/featured-news/thermo-fisher-scientific-introduces-new-application-note-demonstrating-capabilities-of-nanodrop-3300-for-cancer-research/</loc>
		<lastmod>2010-10-26T13:08:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4237/news/industry-news/unilabs-york-bioanalytical-solutions-ybs-appoints-dr-viv-willson-to-strengthen-the-immunoassay-team-in-copenhagen/</loc>
		<lastmod>2010-10-26T12:44:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4220/news/featured-news/gxpis-x-docs-capa-module-selected-by-renovo-as-a-hosted-system-to-manage-vital-documents-during-the-drug-development-process/</loc>
		<lastmod>2010-10-22T14:49:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4213/news/featured-news/her2-theranostic-training-comes-to-you/</loc>
		<lastmod>2010-10-21T11:12:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4204/company-directory/almac/</loc>
		<lastmod>2010-10-20T08:59:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4186/company-directory/sapient-discovery/</loc>
		<lastmod>2010-10-19T09:02:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4177/news/industry-news/pharmaceutical-heads-meet-as-manufacturing-safety-raises-concern/</loc>
		<lastmod>2010-10-18T16:25:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4172/news/featured-news/thermo-fisher-scientific-nominated-for-three-european-outsourcing-awards/</loc>
		<lastmod>2010-10-15T13:40:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4165/news/featured-news/bio-rad%e2%80%99s-new-ssofast-probes-supermix-accelerates-gene-expression-analysis/</loc>
		<lastmod>2010-10-12T16:07:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4158/news/featured-news/quotient-bioresearch-to-highlight-integrated-early-stage-drug-development-platforms-at-fip-pharmaceutical-sciences-world-congress-2010/</loc>
		<lastmod>2010-10-12T15:46:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4114/news/industry-news/3-6-million-cash-placing-at-9-premium-and-maiden-dividend/</loc>
		<lastmod>2010-10-06T12:38:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4109/news/featured-news/itt-analytics-showcases-measurement-and-analysis-solutions-at-weftec-2010/</loc>
		<lastmod>2010-10-04T15:50:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4105/news/featured-news/precos-appoints-dr-neil-rotherham-as-chairman/</loc>
		<lastmod>2010-10-04T14:37:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4101/news/featured-news/thermo-fisher-scientific-announces-new-sales-and-support-office-for-microanalysis-business-in-the-uk/</loc>
		<lastmod>2010-10-04T11:22:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4095/news/featured-news/thermo-fisher-scientific-publishes-new-poster-illustrating-the-benefits-of-integrating-comprehensive-solutions-for-biobanks/</loc>
		<lastmod>2010-10-04T11:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4090/news/industry-news/new-outcomes-study-for-ticagrelor-brilinta%e2%84%a2-to-examine-longer-term-treatment-for-post-acs-patients/</loc>
		<lastmod>2010-10-01T13:50:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4065/news/featured-news/from-macro-to-micro-with-the-tecan-cavro%c2%ae-mini-sample-processor/</loc>
		<lastmod>2010-09-29T14:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4059/news/industry-news/astrazeneca-initiates-phase-iii-clinical-development-of-fostamatinib-for-the-treatment-of-rheumatoid-arthritis/</loc>
		<lastmod>2010-09-29T09:34:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4056/news/industry-news/creabilis-appoints-dr-eliot-forster-as-its-new-chief-executive-officer/</loc>
		<lastmod>2010-09-29T09:28:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4043/news/industry-news/results-of-zibotentan-phase-iii-trial-in-castration-resistant-prostate-cancer/</loc>
		<lastmod>2010-09-27T10:39:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4037/news/featured-news/new-version-of-copley-scientific%e2%80%99s-inhaler-testing-software-adds-automatic-data-import-from-waters-empower/</loc>
		<lastmod>2010-09-27T10:17:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/4032/news/industry-news/brilique-ticagrelor-receives-positive-opinion-from-european-chmp-for-the-treatment-of-acute-coronary-syndromes/</loc>
		<lastmod>2010-09-24T14:18:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3992/news/industry-news/synexus-puts-medical-affairs-at-the-top-of-its-agenda-with-new-chief-medical-officer/</loc>
		<lastmod>2010-09-23T16:00:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3989/news/featured-news/tecan%e2%80%99s-freedom-evo%c2%ae-automates-tropical-disease-research/</loc>
		<lastmod>2010-09-23T14:21:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3985/news/industry-news/shire-plc-becomes-obn%e2%80%99s-first-corporate-patron/</loc>
		<lastmod>2010-09-23T08:27:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3971/news/featured-news/biomerieux-awarded-nhsbt-contract-for-bacterial-screening-of-platelets/</loc>
		<lastmod>2010-09-20T08:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3941/news/industry-news/creabilis-appoints-george-f-horner-iii-as-its-chairman/</loc>
		<lastmod>2010-09-15T08:23:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3931/news/featured-news/sigma%c2%ae-life-science-to-supply-oligonucleotides-to-research-councils-uk/</loc>
		<lastmod>2010-09-14T09:53:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3918/news/industry-news/rexahn-pharmaceuticals-announces-the-appointment-of-peter-brandt-and-richard-kivel-to-board-of-directors/</loc>
		<lastmod>2010-09-13T14:14:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/bronze-membership/</loc>
		<lastmod>2010-09-13T13:16:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3862/news/industry-news/astrazeneca-glaxosmithkline-pfizer-roche-meet-to-discuss-the-future-of-the-pharma-industry/</loc>
		<lastmod>2010-09-10T07:54:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3853/news/industry-news/brecon-celebrates-30th-anniversary-with-strong-performance/</loc>
		<lastmod>2010-09-07T13:58:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3849/company-directory/comark-instruments/</loc>
		<lastmod>2010-09-07T09:29:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3839/news/industry-news/prism-ideas-appoints-nigel-brooksby-as-non-executive-chairman/</loc>
		<lastmod>2010-09-07T08:38:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3829/news/industry-news/european-commission-issues-positive-decision-for-approval-of-seroquel-xr-as-an-add-on-treatment-of-major-depressive-disorder/</loc>
		<lastmod>2010-09-07T08:30:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3826/news/industry-news/pharmaventures-appoints-paul-phull-as-senior-director/</loc>
		<lastmod>2010-09-07T07:54:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3820/news/featured-news/new-market-leader-for-clinical-cytogenetics-laboratory-services/</loc>
		<lastmod>2010-09-06T15:04:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3810/news/featured-news/sigma-life-science-enters-genetically-modified-cell-market/</loc>
		<lastmod>2010-09-06T08:47:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3805/news/featured-news/tecan-is-first-choice-for-quality-and-reliability/</loc>
		<lastmod>2010-09-06T08:30:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3773/news/featured-news/tecan-introduces-new-te-care%e2%84%a2-service-contracts-for-detection-instruments/</loc>
		<lastmod>2010-08-26T12:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3734/news/featured-news/tecan-automation-streamlines-veterinary-diagnostic-processes/</loc>
		<lastmod>2010-08-24T09:16:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3150/european-pharmaceutical-review-magazine/past-issues/biomarkers-in-the-development-of-novel-medicines-for-the-treatment-of-cancer/</loc>
		<lastmod>2010-08-20T08:54:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3122/european-pharmaceutical-review-magazine/past-issues/rnai-based-therapies-for-the-treatment-of-hiv/</loc>
		<lastmod>2010-08-20T08:53:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3074/european-pharmaceutical-review-magazine/past-issues/examining-receptor-activation-new-technologies-reveal-how-g-protein-coupled-receptors-recognise-ligands-and-talk-to-intracellular-partners/</loc>
		<lastmod>2010-08-20T08:52:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3088/european-pharmaceutical-review-magazine/past-issues/cellular-senescence-as-an-anti-tumour-mechanism/</loc>
		<lastmod>2010-08-20T08:52:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3108/european-pharmaceutical-review-magazine/past-issues/trends-in-laboratory-automation-from-speed-and-simplicity-to-flexibility-and-information-content/</loc>
		<lastmod>2010-08-20T08:52:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3168/european-pharmaceutical-review-magazine/past-issues/high-throughput-pcr-based-diagnostics-linking-sample-handling-to-molecular-oncology-risk-groups/</loc>
		<lastmod>2010-08-20T08:51:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3195/european-pharmaceutical-review-magazine/past-issues/article-3-the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-08-20T08:50:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3215/european-pharmaceutical-review-magazine/past-issues/high-content-cell-based-primary-screening-for-oncology-targets-%e2%80%93-a-perspective/</loc>
		<lastmod>2010-08-20T08:50:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3617/news/featured-news/automated-cell-biology-workflows-with-tecan-and-miltenyi-biotec/</loc>
		<lastmod>2010-08-17T13:09:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3614/news/industry-news/new-facility-to-fuel-further-growth-for-aesica/</loc>
		<lastmod>2010-08-17T11:14:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3611/news/industry-news/amarin-appoints-colin-w-stewart-as-president-and-ceo/</loc>
		<lastmod>2010-08-17T07:52:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3608/news/industry-news/corning-to-acquire-plaslab-s-a-s/</loc>
		<lastmod>2010-08-16T09:11:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3599/news/industry-news/rjw-partners-consolidates-senior-level-expertise-with-latest-appointment/</loc>
		<lastmod>2010-08-12T10:33:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3593/news/featured-news/new-malvern-presentation-tackles-the-%e2%80%9coverlooked-second-virial-coefficient%e2%80%9d/</loc>
		<lastmod>2010-08-11T08:15:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3585/news/industry-news/astrazeneca-announces-agreements-in-principle-in-seroquel-product-liability-litigation/</loc>
		<lastmod>2010-08-09T11:00:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3578/news/featured-news/sigma-life-science-and-switchgear-genomics-to-co-develop-simplified-novel-microrna-target-validation-system/</loc>
		<lastmod>2010-08-09T10:44:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3573/news/industry-news/generex-oncology-names-dr-craig-eagle-to-its-scientific-advisory-board-to-assist-with-its-proprietary-cancer-vaccines-program/</loc>
		<lastmod>2010-08-06T09:15:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3551/news/featured-news/sigma-aldrich-receives-national-institutes-of-health-funding-for-cardiovascular-disease-research/</loc>
		<lastmod>2010-08-05T12:10:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3541/news/industry-news/owen-mumford-appoints-head-of-operations/</loc>
		<lastmod>2010-08-02T11:28:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3538/news/industry-news/pharminox-appoints-dr-marc-hummersone-to-its-board-of-directors/</loc>
		<lastmod>2010-07-30T09:00:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3535/news/industry-news/astrazeneca-plc-appoints-new-non-executive-director/</loc>
		<lastmod>2010-07-29T15:18:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3530/news/industry-news/cmp-therapeutics-appoints-dr-neill-moray-mackenzie-as-ceo/</loc>
		<lastmod>2010-07-29T08:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3525/news/featured-news/tecan-and-phynexus-collaborate-to-automate-protein-purification/</loc>
		<lastmod>2010-07-28T09:20:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3522/news/industry-news/advisory-committee-briefing-materials-for-brilinta-ticagrelor-nda-available-on-us-fda-web-site/</loc>
		<lastmod>2010-07-27T10:22:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/events/industry-events/</loc>
		<lastmod>2010-07-22T11:10:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/events/industry-events/event-submission/</loc>
		<lastmod>2010-07-22T11:07:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3510/news/industry-news/pharma-%e2%80%98hts%e2%80%99-the-mark-with-screening/</loc>
		<lastmod>2010-07-21T13:27:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3504/news/industry-news/acr-image-metrix-names-clinical-project-manager/</loc>
		<lastmod>2010-07-20T14:39:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3500/news/industry-news/bill-gates-visited-intercell-to-discuss-vaccine-approaches-for-developing-countries/</loc>
		<lastmod>2010-07-20T13:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3479/news/industry-news/icon-clinical-research-announces-the-appointment-of-a-vice-president-and-global-head-for-the-infectious-diseases-therapeutic-area-group/</loc>
		<lastmod>2010-07-19T13:16:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3496/news/industry-news/trac-team-grows-again/</loc>
		<lastmod>2010-07-19T11:23:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3488/news/featured-news/tecan-automated-solutions-accelerate-crop-improvement/</loc>
		<lastmod>2010-07-14T15:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3485/news/industry-news/award-winning-mayo-clinic-scientist-joins-cardio3-biosciences/</loc>
		<lastmod>2010-07-14T12:45:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3451/news/industry-news/ingen-biosciences-appoints-research-development-director/</loc>
		<lastmod>2010-07-09T08:23:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3447/news/industry-news/phagenesis-appoints-chairman-and-ceo/</loc>
		<lastmod>2010-07-08T08:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/website-updates-by-email/</loc>
		<lastmod>2010-07-06T10:59:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3386/news/featured-news/tecan-provides-automated-solutions-for-molecular-pharmacology/</loc>
		<lastmod>2010-07-05T13:56:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3372/news/industry-news/astrazeneca-and-mrc-technology-form-strategic-alliance-in-discovery-research-utilising-shared-compound-libraries/</loc>
		<lastmod>2010-07-05T10:38:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2010/news/industry-news/new-analyses-demonstrate-novartis-onbrez%c2%ae-breezhaler%c2%ae-indacaterol-significantly-reduces-copd-patient-need-for-%e2%80%98relief%e2%80%99-medication/</loc>
		<lastmod>2010-07-05T08:05:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3336/news/featured-news/tecan-freedom-evo%c2%ae-offers-on-demand-protein-expression/</loc>
		<lastmod>2010-07-02T13:11:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3345/news/industry-news/outsource-to-europe/</loc>
		<lastmod>2010-07-02T10:41:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3340/news/industry-news/bgma-welcomes-eu-general-court-ruling-that-astrazeneca-abused-its-dominant-position-by-preventing-the-marketing-of-generic-omeprazole/</loc>
		<lastmod>2010-07-01T10:34:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3320/news/featured-news/registration-still-open-for-unique-personalized-cancer-medicine-event/</loc>
		<lastmod>2010-06-30T16:20:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3317/news/industry-news/crestor-patent-upheld-by-us-court/</loc>
		<lastmod>2010-06-30T15:45:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3314/news/industry-news/leading-pharmaceutical-company-announces-acquisition/</loc>
		<lastmod>2010-06-29T13:47:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3311/news/industry-news/astrazeneca-and-mmv-join-efforts-in-the-fight-against-malaria/</loc>
		<lastmod>2010-06-29T09:00:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3304/news/industry-news/ortho-mcneil-janssen-pharmaceuticals-inc-announces-oncology-research-collaboration-agreement-with-the-koch-institute-for-integrative-cancer-research-at-mit/</loc>
		<lastmod>2010-06-29T08:54:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3300/news/industry-news/molecular-partners-appoints-goran-ando-as-independent-non-executive-board-member/</loc>
		<lastmod>2010-06-29T08:38:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3258/european-pharmaceutical-review-magazine/past-issues/who-nose/</loc>
		<lastmod>2010-06-25T10:11:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3256/european-pharmaceutical-review-magazine/past-issues/management-strategies-for-risk-assessment/</loc>
		<lastmod>2010-06-25T10:02:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3254/european-pharmaceutical-review-magazine/past-issues/excellence-by-design/</loc>
		<lastmod>2010-06-25T09:57:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3251/european-pharmaceutical-review-magazine/past-issues/pat-for-api/</loc>
		<lastmod>2010-06-25T09:50:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3241/european-pharmaceutical-review-magazine/past-issues/versatile-miniaturised-hts/</loc>
		<lastmod>2010-06-25T09:45:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3228/european-pharmaceutical-review-magazine/past-issues/dosing-and-weighing-in-the-pharmaceutical-laboratory/</loc>
		<lastmod>2010-06-25T09:39:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3223/european-pharmaceutical-review-magazine/past-issues/changing-the-paradigm-expanding-high-content-imaging-for-early-cytotoxicity-assessments/</loc>
		<lastmod>2010-06-25T09:17:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3221/european-pharmaceutical-review-magazine/past-issues/a-process-analytical-tool/</loc>
		<lastmod>2010-06-25T09:13:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3214/european-pharmaceutical-review-magazine/past-issues/new-phases-for-rapid-ion-analysis/</loc>
		<lastmod>2010-06-25T09:08:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3207/european-pharmaceutical-review-magazine/past-issues/evaluating-drug-safety/</loc>
		<lastmod>2010-06-24T16:00:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3203/european-pharmaceutical-review-magazine/past-issues/a-network-of-innovation-from-canada/</loc>
		<lastmod>2010-06-24T15:53:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3196/european-pharmaceutical-review-magazine/past-issues/applications-in-drug-development/</loc>
		<lastmod>2010-06-24T15:48:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3184/european-pharmaceutical-review-magazine/past-issues/forging-therapeutics-from-small-interfering-rnas/</loc>
		<lastmod>2010-06-24T15:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3174/european-pharmaceutical-review-magazine/past-issues/ten-steps-to-success/</loc>
		<lastmod>2010-06-24T15:29:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3159/european-pharmaceutical-review-magazine/past-issues/die-wall-stress-measurement/</loc>
		<lastmod>2010-06-24T15:18:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3147/european-pharmaceutical-review-magazine/past-issues/the-future-of-process-design/</loc>
		<lastmod>2010-06-24T15:08:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3137/european-pharmaceutical-review-magazine/past-issues/implementation-validation-and-registration/</loc>
		<lastmod>2010-06-24T14:59:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3133/european-pharmaceutical-review-magazine/past-issues/harbinger-of-change/</loc>
		<lastmod>2010-06-24T14:52:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3121/european-pharmaceutical-review-magazine/past-issues/exploring-new-sources-of-raw-material/</loc>
		<lastmod>2010-06-24T14:48:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3117/european-pharmaceutical-review-magazine/past-issues/patch-clamp-electrophysiology-steps-up-a-gear/</loc>
		<lastmod>2010-06-24T14:35:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3109/european-pharmaceutical-review-magazine/past-issues/getting-a-handle-on-neuronal-behaviour-in-culture/</loc>
		<lastmod>2010-06-24T14:31:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3093/european-pharmaceutical-review-magazine/past-issues/integration-of-miniaturisation-technologies/</loc>
		<lastmod>2010-06-24T14:12:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3090/european-pharmaceutical-review-magazine/past-issues/a-powerful-tool-for-drug-discovery/</loc>
		<lastmod>2010-06-24T14:01:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3086/european-pharmaceutical-review-magazine/past-issues/easy-access-for-the-scientific-community/</loc>
		<lastmod>2010-06-24T13:55:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3078/european-pharmaceutical-review-magazine/past-issues/the-promise-of-pancreatic-beta-cells/</loc>
		<lastmod>2010-06-24T13:51:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3075/european-pharmaceutical-review-magazine/past-issues/target-validation/</loc>
		<lastmod>2010-06-24T13:47:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1919/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/turn-back-the-clock-and-be-healed-induced-pluripotent-stem-cells-and-their-future-impact-on-drug-discovery-and-regenerative-medicine/</loc>
		<lastmod>2010-06-24T13:11:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1917/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/isscr-8th-annual-meeting-international-society-for-stem-cell-research/</loc>
		<lastmod>2010-06-24T13:11:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1915/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/%e2%80%98pharmaceutical-industryuniversity%e2%80%99-rd-collaboration-on-process-analytical-technologies/</loc>
		<lastmod>2010-06-24T13:10:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1913/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/the-58th-asms-conference-on-mass-spectrometry-and-allied-topics/</loc>
		<lastmod>2010-06-24T13:09:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1911/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/implementation-of-appropriate-assays-and-hts-technologies-in-drug-discovery/</loc>
		<lastmod>2010-06-24T13:09:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1909/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/sbs-biopharmaceuticals-symposium-exploring-synergies-across-drug-formats/</loc>
		<lastmod>2010-06-24T13:08:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1907/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/finding-novel-targets-for-anticancer-therapy/</loc>
		<lastmod>2010-06-24T13:08:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1905/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/article-2-the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-06-24T13:07:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1898/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/qpcr-current-technologies-and-future-applications/</loc>
		<lastmod>2010-06-24T13:07:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1896/european-pharmaceutical-review-magazine/past-issues/issue-2-2010/raman-spectroscopy-for-the-analysis-of-drug-products-and-drug-manufacturing-processes/</loc>
		<lastmod>2010-06-24T13:06:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3050/european-pharmaceutical-review-magazine/past-issues/efficient-hts-in-the-nanoliter-range/</loc>
		<lastmod>2010-06-24T13:03:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3040/european-pharmaceutical-review-magazine/past-issues/the-current-challenge/</loc>
		<lastmod>2010-06-24T12:56:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3037/european-pharmaceutical-review-magazine/past-issues/more-than-just-cost-cutting/</loc>
		<lastmod>2010-06-24T12:49:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3030/european-pharmaceutical-review-magazine/past-issues/international-standards-a-tool-for-compliance/</loc>
		<lastmod>2010-06-24T12:45:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3023/european-pharmaceutical-review-magazine/past-issues/a-pfizer-perspective/</loc>
		<lastmod>2010-06-24T11:28:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3018/european-pharmaceutical-review-magazine/past-issues/the-rise-of-raman/</loc>
		<lastmod>2010-06-24T11:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3014/european-pharmaceutical-review-magazine/past-issues/the-road-ahead-and-how-to-get-there/</loc>
		<lastmod>2010-06-24T11:15:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3012/european-pharmaceutical-review-magazine/past-issues/support-for-lead-optimisation-and-target-validation/</loc>
		<lastmod>2010-06-24T11:10:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3004/european-pharmaceutical-review-magazine/past-issues/taking-care-of-innovation/</loc>
		<lastmod>2010-06-24T11:02:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/3000/european-pharmaceutical-review-magazine/past-issues/the-astrazeneca-acmf/</loc>
		<lastmod>2010-06-24T10:54:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2998/european-pharmaceutical-review-magazine/past-issues/analysing-the-monographs/</loc>
		<lastmod>2010-06-24T10:46:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2993/european-pharmaceutical-review-magazine/past-issues/initiatives-from-spain/</loc>
		<lastmod>2010-06-24T10:42:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2987/european-pharmaceutical-review-magazine/past-issues/plasma-protein-biomarker-discovery/</loc>
		<lastmod>2010-06-24T10:36:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2978/european-pharmaceutical-review-magazine/past-issues/biomarkers-of-efficacy-and-safety/</loc>
		<lastmod>2010-06-24T10:22:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2973/european-pharmaceutical-review-magazine/past-issues/the-promise-and-pitfalls/</loc>
		<lastmod>2010-06-24T10:14:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2966/news/industry-news/clavis-pharma-announces-the-appointment-of-athos-gianella-borradori-md-as-chief-medical-officer/</loc>
		<lastmod>2010-06-24T07:57:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2961/european-pharmaceutical-review-magazine/past-issues/microbial-detection-in-mammalian-cell-culture-systems/</loc>
		<lastmod>2010-06-23T11:48:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2950/european-pharmaceutical-review-magazine/past-issues/the-current-state-of-pat-in-freeze-drying/</loc>
		<lastmod>2010-06-23T11:43:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2943/european-pharmaceutical-review-magazine/past-issues/why-is-thermal-analysis-important-to-the-industry/</loc>
		<lastmod>2010-06-23T11:35:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2935/european-pharmaceutical-review-magazine/past-issues/applications-in-bioprocesses-and-biotechnology/</loc>
		<lastmod>2010-06-23T11:28:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2918/european-pharmaceutical-review-magazine/past-issues/mass-spectrometry-another-tool-from-the-pat-toolbox/</loc>
		<lastmod>2010-06-23T11:11:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2915/european-pharmaceutical-review-magazine/past-issues/a-bright-future-for-drug-discovery-and-development/</loc>
		<lastmod>2010-06-23T10:58:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2912/european-pharmaceutical-review-magazine/past-issues/a-new-approach-to-ion-channel-hit-identification/</loc>
		<lastmod>2010-06-23T10:52:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2908/european-pharmaceutical-review-magazine/past-issues/options-for-quantitative-analysis-by-real-time-pcr/</loc>
		<lastmod>2010-06-23T10:47:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2905/european-pharmaceutical-review-magazine/past-issues/meeting-the-challenge-with-a-new-facility/</loc>
		<lastmod>2010-06-23T10:40:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2898/european-pharmaceutical-review-magazine/past-issues/applications-in-target-id-and-validation/</loc>
		<lastmod>2010-06-23T10:31:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2893/european-pharmaceutical-review-magazine/past-issues/tool-for-candidate-drug-selection/</loc>
		<lastmod>2010-06-23T10:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2887/european-pharmaceutical-review-magazine/past-issues/making-the-lab-workhorse-run-faster/</loc>
		<lastmod>2010-06-23T10:10:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2880/european-pharmaceutical-review-magazine/past-issues/opportunities-for-rapid-microbial-methods/</loc>
		<lastmod>2010-06-23T10:03:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2873/european-pharmaceutical-review-magazine/past-issues/in-vitro-safety-pharmacology-profiling/</loc>
		<lastmod>2010-06-23T09:55:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2865/european-pharmaceutical-review-magazine/past-issues/setting-new-standards-in-ultra-hts/</loc>
		<lastmod>2010-06-23T09:47:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2862/european-pharmaceutical-review-magazine/past-issues/cost-knowledge-and-convenience-facing-the-facts/</loc>
		<lastmod>2010-06-23T09:39:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2858/european-pharmaceutical-review-magazine/past-issues/the-hupo-brain-proteome-project/</loc>
		<lastmod>2010-06-23T09:35:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2856/european-pharmaceutical-review-magazine/past-issues/in-vitro-and-in-vivo-techniques-in-cns-drug-discovery/</loc>
		<lastmod>2010-06-23T09:27:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2852/european-pharmaceutical-review-magazine/past-issues/connecting-hcs-to-cns-drug-targets/</loc>
		<lastmod>2010-06-23T09:20:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2849/european-pharmaceutical-review-magazine/past-issues/hts-using-sirna-libraries/</loc>
		<lastmod>2010-06-23T09:06:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2846/european-pharmaceutical-review-magazine/past-issues/co-operation-through-certification/</loc>
		<lastmod>2010-06-23T08:51:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2844/european-pharmaceutical-review-magazine/past-issues/integration-is-key/</loc>
		<lastmod>2010-06-23T08:48:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2835/european-pharmaceutical-review-magazine/past-issues/advances-in-fast-ion-chromatography/</loc>
		<lastmod>2010-06-23T08:41:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2829/european-pharmaceutical-review-magazine/past-issues/synchrotron-radiation-current-status-and-future-landscape/</loc>
		<lastmod>2010-06-23T08:31:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2823/european-pharmaceutical-review-magazine/past-issues/a-vision-for-the-future/</loc>
		<lastmod>2010-06-23T08:23:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2816/european-pharmaceutical-review-magazine/past-issues/rs-coupled-to-separations/</loc>
		<lastmod>2010-06-23T08:01:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2813/european-pharmaceutical-review-magazine/past-issues/quality-through-collaboration/</loc>
		<lastmod>2010-06-23T07:50:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2810/european-pharmaceutical-review-magazine/past-issues/carving-a-niche-in-the-realm-of-drug-discovery/</loc>
		<lastmod>2010-06-22T16:17:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2806/european-pharmaceutical-review-magazine/past-issues/critical-success/</loc>
		<lastmod>2010-06-22T16:14:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2801/european-pharmaceutical-review-magazine/past-issues/real-time-pcr-clinical-applications/</loc>
		<lastmod>2010-06-22T16:04:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2793/european-pharmaceutical-review-magazine/past-issues/identification-and-prevalidation-of-safety-biomarkers/</loc>
		<lastmod>2010-06-22T15:52:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2790/european-pharmaceutical-review-magazine/past-issues/is-pharma-getting-what-it-needs-from-rnai/</loc>
		<lastmod>2010-06-22T15:44:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2785/news/industry-news/deputy-first-minister-praises-new-pharma-facility/</loc>
		<lastmod>2010-06-22T14:07:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2782/european-pharmaceutical-review-magazine/past-issues/partnering-for-better-science/</loc>
		<lastmod>2010-06-22T10:54:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2780/european-pharmaceutical-review-magazine/past-issues/an-ever-evolving-technology/</loc>
		<lastmod>2010-06-22T10:50:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2770/european-pharmaceutical-review-magazine/past-issues/new-opportunities-for-understanding/</loc>
		<lastmod>2010-06-22T10:37:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2764/european-pharmaceutical-review-magazine/past-issues/the-role-of-pat-in-biotechnology/</loc>
		<lastmod>2010-06-22T10:23:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2761/european-pharmaceutical-review-magazine/past-issues/science-through-cooperation/</loc>
		<lastmod>2010-06-22T10:14:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2751/european-pharmaceutical-review-magazine/past-issues/merck-co-%e2%80%99s-automated-compound-distribution-centre/</loc>
		<lastmod>2010-06-22T10:10:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2748/european-pharmaceutical-review-magazine/past-issues/collaborating-to-find-new-approaches-to-tropical-disease/</loc>
		<lastmod>2010-06-22T09:59:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2735/european-pharmaceutical-review-magazine/past-issues/a-perspective-from-eli-lilly-and-co/</loc>
		<lastmod>2010-06-22T09:46:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2728/european-pharmaceutical-review-magazine/past-issues/the-human-plasma-proteome-a-biomarker-pool-too-deep-to-explore/</loc>
		<lastmod>2010-06-22T09:29:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2723/european-pharmaceutical-review-magazine/past-issues/a-new-approach-to-specify-rnai-experiments/</loc>
		<lastmod>2010-06-22T09:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2720/european-pharmaceutical-review-magazine/past-issues/structure-function-interaction/</loc>
		<lastmod>2010-06-22T08:30:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2715/news/industry-news/novartis-data-at-ecfs/</loc>
		<lastmod>2010-06-21T16:29:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2706/news/industry-news/saladax-biomedical-signs-deal-with-bristol-myers-squibb-to-develop-clinical-diagnostics/</loc>
		<lastmod>2010-06-21T13:14:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2699/european-pharmaceutical-review-magazine/past-issues/scta-for-pharma/</loc>
		<lastmod>2010-06-18T09:32:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2694/european-pharmaceutical-review-magazine/past-issues/maintaining-vaccine-security/</loc>
		<lastmod>2010-06-18T09:27:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2692/european-pharmaceutical-review-magazine/past-issues/solutions-for-the-next-stage/</loc>
		<lastmod>2010-06-18T09:19:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2689/european-pharmaceutical-review-magazine/past-issues/interfacing-lims-with-eln/</loc>
		<lastmod>2010-06-18T08:25:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2685/european-pharmaceutical-review-magazine/past-issues/structural-genomics-the-practical-way/</loc>
		<lastmod>2010-06-18T08:21:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2679/european-pharmaceutical-review-magazine/past-issues/the-business-benefits/</loc>
		<lastmod>2010-06-18T08:03:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2674/european-pharmaceutical-review-magazine/past-issues/four-years-and-counting-for-automation/</loc>
		<lastmod>2010-06-18T07:55:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2665/european-pharmaceutical-review-magazine/past-issues/identifying-human-toxicity-potential/</loc>
		<lastmod>2010-06-17T15:58:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2657/european-pharmaceutical-review-magazine/past-issues/affinity-based-screening/</loc>
		<lastmod>2010-06-17T15:44:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2652/european-pharmaceutical-review-magazine/past-issues/a-showcase-project-for-eu-research/</loc>
		<lastmod>2010-06-17T15:24:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2647/european-pharmaceutical-review-magazine/past-issues/novel-antisense-drugs-for-micro-rna-therapeutics/</loc>
		<lastmod>2010-06-17T15:00:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2643/european-pharmaceutical-review-magazine/past-issues/mitocheck-checking-mitosis/</loc>
		<lastmod>2010-06-17T14:54:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2637/european-pharmaceutical-review-magazine/past-issues/quantitative-pcr-assays-in-clinical-drug-development/</loc>
		<lastmod>2010-06-16T15:44:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2628/european-pharmaceutical-review-magazine/past-issues/essential-techniques-for-development/</loc>
		<lastmod>2010-06-16T15:36:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2625/european-pharmaceutical-review-magazine/past-issues/the-current-market-and-future-trends-for-rmm/</loc>
		<lastmod>2010-06-16T15:24:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2623/european-pharmaceutical-review-magazine/past-issues/the-right-technology-at-the-right-time/</loc>
		<lastmod>2010-06-16T15:20:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2618/european-pharmaceutical-review-magazine/past-issues/cell-based-imaging/</loc>
		<lastmod>2010-06-16T15:16:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2612/european-pharmaceutical-review-magazine/past-issues/streamlining-with-automation-and-robotics/</loc>
		<lastmod>2010-06-16T15:04:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2599/european-pharmaceutical-review-magazine/past-issues/wyeth-forges-ahead/</loc>
		<lastmod>2010-06-16T14:54:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2596/european-pharmaceutical-review-magazine/past-issues/bottlenecks-and-potential-improvements/</loc>
		<lastmod>2010-06-16T14:40:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2588/european-pharmaceutical-review-magazine/past-issues/the-role-of-hts-in-eadmet-profiling/</loc>
		<lastmod>2010-06-16T14:33:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2585/european-pharmaceutical-review-magazine/past-issues/an-essential-role-for-the-michael-barber-centre/</loc>
		<lastmod>2010-06-16T14:24:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2582/european-pharmaceutical-review-magazine/past-issues/the-right-approach-to-human-therapy/</loc>
		<lastmod>2010-06-16T14:19:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2579/european-pharmaceutical-review-magazine/past-issues/committee-e55-%e2%80%93-an-update/</loc>
		<lastmod>2010-06-15T15:46:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2573/european-pharmaceutical-review-magazine/past-issues/polyphasic-approach-to-microbial-identification/</loc>
		<lastmod>2010-06-15T15:31:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2569/european-pharmaceutical-review-magazine/past-issues/is-the-dream-becoming-reality/</loc>
		<lastmod>2010-06-15T15:22:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2566/european-pharmaceutical-review-magazine/past-issues/a-roadmap-for-development/</loc>
		<lastmod>2010-06-15T15:16:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2558/european-pharmaceutical-review-magazine/past-issues/pursuing-hot-targets-in-drug-discovery/</loc>
		<lastmod>2010-06-15T15:06:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2552/european-pharmaceutical-review-magazine/past-issues/designing-a-program-for-early-cns-development/</loc>
		<lastmod>2010-06-15T14:53:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2547/european-pharmaceutical-review-magazine/past-issues/industry-insight-the-measure-of-success/</loc>
		<lastmod>2010-06-15T14:45:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2543/european-pharmaceutical-review-magazine/past-issues/hupo-drives-the-creation-of-protein-test-standards/</loc>
		<lastmod>2010-06-15T14:36:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2538/european-pharmaceutical-review-magazine/past-issues/challenges-in-high-content-sirna-screening/</loc>
		<lastmod>2010-06-15T14:27:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2527/news/featured-news/safer-pumping-with-sealless-mag-drive-pumps/</loc>
		<lastmod>2010-06-15T13:17:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2531/news/featured-news/ogt-announces-details-of-acgh-satellite-meeting-at-eshg-2010-in-sweden/</loc>
		<lastmod>2010-06-15T10:56:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2525/european-pharmaceutical-review-magazine/past-issues/are-the-needs-of-the-pharmaceutical-industry-being-met/</loc>
		<lastmod>2010-06-14T15:57:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2513/european-pharmaceutical-review-magazine/past-issues/pat-for-the-product-lifecycle-of-a-biopharmaceutical-product/</loc>
		<lastmod>2010-06-14T15:53:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2505/european-pharmaceutical-review-magazine/past-issues/pat-for-freeze-drying-cycle-optimisation-in-the-laboratory/</loc>
		<lastmod>2010-06-14T15:33:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2496/european-pharmaceutical-review-magazine/past-issues/real-time-pcr-gene-expression-profiling/</loc>
		<lastmod>2010-06-14T15:25:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2486/european-pharmaceutical-review-magazine/past-issues/new-opportunities-for-protein-crystallisation/</loc>
		<lastmod>2010-06-11T11:16:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2480/news/featured-news/malvern-publishes-online-chemical-imaging-bibliography/</loc>
		<lastmod>2010-06-10T15:54:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2473/european-pharmaceutical-review-magazine/past-issues/high-throughput-electrophysiology-platforms-as-enablers/</loc>
		<lastmod>2010-06-10T15:47:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2469/european-pharmaceutical-review-magazine/past-issues/hcs-roundtable-achieving-the-potential-of-hcs/</loc>
		<lastmod>2010-06-10T15:24:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2465/european-pharmaceutical-review-magazine/past-issues/the-role-of-phospho-proteomics-in-drug-discovery-and-development/</loc>
		<lastmod>2010-06-10T15:07:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2458/european-pharmaceutical-review-magazine/past-issues/a-new-field-in-biomarker-discovery-and-target-identification/</loc>
		<lastmod>2010-06-10T14:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2453/european-pharmaceutical-review-magazine/past-issues/cancer-immunotherapy-using-rnai/</loc>
		<lastmod>2010-06-10T14:42:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2438/european-pharmaceutical-review-magazine/past-issues/a-new-challenge-in-the-pharmaceutical-supply-chain/</loc>
		<lastmod>2010-06-09T11:26:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2436/european-pharmaceutical-review-magazine/past-issues/taking-clinical-trials-into-the-future/</loc>
		<lastmod>2010-06-09T11:13:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2430/european-pharmaceutical-review-magazine/past-issues/cleanroom-standards/</loc>
		<lastmod>2010-06-09T11:01:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2427/european-pharmaceutical-review-magazine/past-issues/advancing-the-science-of-drug-discovery/</loc>
		<lastmod>2010-06-09T10:54:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2420/news/industry-news/brecon-signals-european-intent-with-creation-of-senior-business-development-role/</loc>
		<lastmod>2010-06-09T10:44:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2410/news/industry-news/vantia-therapeutics-appoints-andrew-crockett-as-chief-executive-officer/</loc>
		<lastmod>2010-06-09T08:51:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2389/european-pharmaceutical-review-magazine/past-issues/pat-and-scalable-automation-for-bioprocess-control-and-monitoring/</loc>
		<lastmod>2010-06-08T16:01:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2383/european-pharmaceutical-review-magazine/past-issues/calorimetry-for-polymorph-detection/</loc>
		<lastmod>2010-06-08T15:50:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2381/european-pharmaceutical-review-magazine/past-issues/10th-anniversary-of-miptec-2007-%e2%80%93-the-leading-european-event-for-drug-discovery-technologies/</loc>
		<lastmod>2010-06-08T15:39:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2377/european-pharmaceutical-review-magazine/past-issues/industry-insight-united-they-stand/</loc>
		<lastmod>2010-06-08T13:51:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2366/european-pharmaceutical-review-magazine/past-issues/hts-technologies-to-facilitate-chemical-genomics/</loc>
		<lastmod>2010-06-08T13:43:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2361/european-pharmaceutical-review-magazine/past-issues/novel-strategies-for-antidepressant-drug-discovery/</loc>
		<lastmod>2010-06-08T13:05:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2358/european-pharmaceutical-review-magazine/past-issues/the-8th-congress-of-the-french-neuroscience-society/</loc>
		<lastmod>2010-06-08T12:48:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2352/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/the-significance-and-detection-of-vbnc-microorganisms/</loc>
		<lastmod>2010-06-08T11:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2346/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/eupat-an-initiative-to-promote-progress-in-the-science-underpinning-pat/</loc>
		<lastmod>2010-06-08T11:27:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2332/european-pharmaceutical-review-magazine/past-issues/neuronal-morphology-screening-as-a-tool-in-neuroscience-drug-discovery/</loc>
		<lastmod>2010-06-08T11:22:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2330/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/pat-and-design-science/</loc>
		<lastmod>2010-06-08T11:17:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2314/european-pharmaceutical-review-magazine/past-issues/stathmin-immobilisation-on-a-chip-using-an-oligo-cysteine-tag/</loc>
		<lastmod>2010-06-08T10:59:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2325/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/spray-freeze-drying-in-the-manufacture-of-pharmaceuticals/</loc>
		<lastmod>2010-06-08T10:57:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2313/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/automated-classification-of-crystallisation-images/</loc>
		<lastmod>2010-06-08T10:52:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2311/european-pharmaceutical-review-magazine/past-issues/55th-asms-conference-on-mass-spectrometry/</loc>
		<lastmod>2010-06-08T10:46:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2309/european-pharmaceutical-review-magazine/past-issues/biomarkers-in-neurodegenerative-diseases/</loc>
		<lastmod>2010-06-08T10:42:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2306/european-pharmaceutical-review-magazine/past-issues/inducible-systemic-rna-silencing-in-caenorhabditis-elegans/</loc>
		<lastmod>2010-06-08T10:39:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2298/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/ion-channel-electrophysiology-in-pharmaceutical-research/</loc>
		<lastmod>2010-06-08T10:18:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2284/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/launching-an-hts-campaign-to-discover-new-antivirals/</loc>
		<lastmod>2010-06-08T10:11:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2288/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/calorimetry-for-amorphous-content-quantification/</loc>
		<lastmod>2010-06-08T10:09:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2273/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/the-handling-and-analysis-of-large-scale-high-content-screening-data/</loc>
		<lastmod>2010-06-08T09:55:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2269/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/biomarker-discovery-and-validation-in-clinical-proteomics/</loc>
		<lastmod>2010-06-08T09:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2262/european-pharmaceutical-review-magazine/past-issues/issue-3-2007/rnai-an-attractive-choice-for-future-therapeutics/</loc>
		<lastmod>2010-06-08T09:24:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2255/news/industry-news/gea-diessel-signs-new-contract-with-julphar-in-ras-al-khaimah/</loc>
		<lastmod>2010-06-07T08:32:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2237/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/pat-in-the-pharmaceutical-industry/</loc>
		<lastmod>2010-06-02T15:50:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2235/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/a-%e2%80%9cpat%e2%80%9d-on-the-back-for-rapid-microbiological-methods/</loc>
		<lastmod>2010-06-02T15:35:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2231/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/implementing-near-infrared-spectroscopy-as-a-pat-tool-in-the-biopharmaceutical-industries/</loc>
		<lastmod>2010-06-02T15:27:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2226/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/implementation-of-an-enterprise-eln-a-case-study/</loc>
		<lastmod>2010-06-02T15:16:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2218/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/the-impact-of-automation-on-drug-discovery/</loc>
		<lastmod>2010-06-02T15:11:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2213/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/academic-contribution-to-high-content-screening-for-functional-and-chemical-genomics/</loc>
		<lastmod>2010-06-02T11:27:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2211/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/industry-insight-biology-and-data-capture-in-the-life-sciences-industry/</loc>
		<lastmod>2010-06-02T11:21:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2205/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/how-will-micrornas-affect-the-drug-discovery-landscape/</loc>
		<lastmod>2010-06-02T11:13:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2200/european-pharmaceutical-review-magazine/past-issues/issue-4-2007/in-vivo-drug-target-validation-using-rnai/</loc>
		<lastmod>2010-06-02T11:04:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2188/news/industry-news/expo-technologies-cobalt-light-systems-ltd-agrees-pat-partnership/</loc>
		<lastmod>2010-05-27T16:21:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2184/european-pharmaceutical-review-magazine/past-issues/roundtable-the-future-direction-for-clinical-trials/</loc>
		<lastmod>2010-05-27T12:39:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2174/european-pharmaceutical-review-magazine/past-issues/an-eight-step-six-sigma-toll-gate-approach-to-pat-implementation/</loc>
		<lastmod>2010-05-27T11:03:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2170/european-pharmaceutical-review-magazine/past-issues/a-new-era-for-microcalorimetry-in-drug-development/</loc>
		<lastmod>2010-05-27T10:52:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2162/european-pharmaceutical-review-magazine/past-issues/protein-crystallography-in-drug-design-current-bottlenecks/</loc>
		<lastmod>2010-05-27T10:47:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2159/news/industry-news/biomarker-detection-firm-appoints-new-chairman/</loc>
		<lastmod>2010-05-26T15:56:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2153/news/industry-news/funxional-therapeutics-raises-10-million-euros-in-a-private-series-b-financing-round-to-fund-the-initial-phase-ii-clinical-studies-of-fx125l-in-inflammation/</loc>
		<lastmod>2010-05-26T15:50:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2128/european-pharmaceutical-review-magazine/past-issues/issue-5-2007/maintaining-a-spore-free-environment-in-the-cleanroom/</loc>
		<lastmod>2010-05-26T07:36:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2122/european-pharmaceutical-review-magazine/past-issues/the-real-time-reverse-transcription-polymerase-chain-reaction-%e2%80%93-treat-with-caution/</loc>
		<lastmod>2010-05-25T14:22:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2105/european-pharmaceutical-review-magazine/past-issues/maximising-the-efficiency-and-application-of-automated-planar-patch-clamp-electrophysiology/</loc>
		<lastmod>2010-05-25T14:13:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2115/news/industry-news/michael-cann-picks-up-the-reins-at-the-bgma/</loc>
		<lastmod>2010-05-25T11:15:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2100/european-pharmaceutical-review-magazine/past-issues/statistical-techniques-for-handling-high-content-screening-data/</loc>
		<lastmod>2010-05-25T09:49:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2091/european-pharmaceutical-review-magazine/past-issues/proteomics-%e2%80%93-the-frontiers-and-beyond/</loc>
		<lastmod>2010-05-25T09:31:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2080/european-pharmaceutical-review-magazine/past-issues/the-expanding-world-of-small-rna-from-germ-cells-to-cancer/</loc>
		<lastmod>2010-05-25T09:24:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2061/news/industry-news/clavis-pharma-appoints-two-internationally-experienced-pharma-executives-anders-p-wiklund-and-annette-v-clancy-to-its-board-of-directors/</loc>
		<lastmod>2010-05-21T10:17:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2058/news/industry-news/first-self-replicating-synthetic-bacterial-cell/</loc>
		<lastmod>2010-05-21T10:08:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2050/news/featured-news/perkinelmer-first-to-introduce-gmp-compliant-lutetium-177-nuclide/</loc>
		<lastmod>2010-05-20T15:55:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2017/news/featured-news/antibody-discovery-just-got-easier%e2%80%a6/</loc>
		<lastmod>2010-05-20T12:47:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/2006/news/industry-news/tpp-global-development-secures-9-6m-for-future-drug-candidate-development/</loc>
		<lastmod>2010-05-19T08:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1992/news/industry-news/seward-secures-new-manufacturing-fund/</loc>
		<lastmod>2010-05-18T11:00:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/592/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/cancer-biology-where-do-we-go-next/</loc>
		<lastmod>2010-05-14T07:44:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1986/news/featured-news/chip-man-technologies-appoints-ionovation-gmbh-as-german-distributor/</loc>
		<lastmod>2010-05-13T15:41:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/587/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/cancer-secreted-micrornas-travelers-messengers-and-blood-borne-biomarkers/</loc>
		<lastmod>2010-05-11T07:49:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/561/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/segregation-of-molecular-mechanisms-of-genotoxicity-and-carcinogenicity-across-human-yeast-and-salmonella-species/</loc>
		<lastmod>2010-05-11T07:49:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/581/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/analytica-2010/</loc>
		<lastmod>2010-05-11T07:48:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/558/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/society-of-toxicology-2010/</loc>
		<lastmod>2010-05-11T07:48:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/545/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/article-1-the-implementation-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-05-11T07:47:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/543/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/pittcon-conference-and-expo-2010/</loc>
		<lastmod>2010-05-11T07:47:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/537/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/ex-vivo-lps-stimulation-model-coupled-with-quantitative-pcr-and-its-multispecies-application-in-immunonutrition/</loc>
		<lastmod>2010-05-11T07:47:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/521/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/qpcr-2010-symposium-and-exhibition/</loc>
		<lastmod>2010-05-11T07:46:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/494/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/protein-pegylation-an-overview-of-chemistry-and-process-considerations/</loc>
		<lastmod>2010-05-11T07:46:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/498/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/sbs-16th-annual-conference-and-exhibition/</loc>
		<lastmod>2010-05-11T07:46:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/115/european-pharmaceutical-review-magazine/past-issues/issue-1-2010/applying-statistical-inference-in-genomics-with-evidence-based-pathways-towards-elucidating-new-functional-correlations-of-biomarkers/</loc>
		<lastmod>2010-05-11T07:46:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/649/european-pharmaceutical-review-magazine/past-issues/issue-6-2009/rnai-screening-in-the-era-of-high-throughput-genetics/</loc>
		<lastmod>2010-05-10T13:40:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/254/company-directory/hach-lange-gmbh/</loc>
		<lastmod>2010-05-10T07:49:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1854/news/industry-news/win-symposium-announces-awards-for-young-researchers-in-personalized-cancer-care/</loc>
		<lastmod>2010-05-05T15:17:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1763/european-pharmaceutical-review-magazine/past-issues/micrornas-and-their-relatives-%e2%80%93-new-avenues-in-biomedical-research/</loc>
		<lastmod>2010-05-05T14:14:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1851/european-pharmaceutical-review-magazine/past-issues/industry-insight-applied-biosystems-%e2%80%93-the-next-generation-of-sequencing/</loc>
		<lastmod>2010-05-05T14:12:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1849/european-pharmaceutical-review-magazine/past-issues/hvac-energy-savings-in-the-pharmaceutical-industry/</loc>
		<lastmod>2010-05-05T14:09:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1842/european-pharmaceutical-review-magazine/past-issues/the-future-direction-of-astm-e55-committee-on-manufacture-of-pharmaceutical-products/</loc>
		<lastmod>2010-05-05T14:06:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1840/european-pharmaceutical-review-magazine/past-issues/issue-6-2007/cutting-edge-technologies-and-their-potential-role-in-pharmaceutical-microbiology/</loc>
		<lastmod>2010-05-05T13:56:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1835/european-pharmaceutical-review-magazine/past-issues/enthalpic-efficiency-and-the-role-of-thermodynamic-data-in-drug-development-possibility-or-a-pipeline-dream/</loc>
		<lastmod>2010-05-05T13:51:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1813/european-pharmaceutical-review-magazine/past-issues/automated-workflow-optimisation-and-assay-development-strategies-for-high-content-research-facility-trinity-college-dublin/</loc>
		<lastmod>2010-05-05T13:46:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1789/news/industry-news/pharmanet-development-group-expands-phase-iv-team/</loc>
		<lastmod>2010-05-05T13:31:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1808/european-pharmaceutical-review-magazine/past-issues/driving-lab-automation-forward/</loc>
		<lastmod>2010-05-05T13:14:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1806/news/industry-news/uk%e2%80%99s-golden-triangle-partnership-gtp-signs-memorandum-of-understanding-with-us-biocom-to-promote-life-science-industry/</loc>
		<lastmod>2010-05-05T13:09:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1805/european-pharmaceutical-review-magazine/past-issues/analysis-of-microrna-expression-by-qpcr/</loc>
		<lastmod>2010-05-05T13:03:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1776/news/featured-news/malvern-adds-new-applications-to-market-leading-gpcsec-system/</loc>
		<lastmod>2010-05-04T08:26:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1758/european-pharmaceutical-review-magazine/past-issues/contract-manufacturing-organisations-poised-for-great-opportunities/</loc>
		<lastmod>2010-04-29T15:19:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1754/european-pharmaceutical-review-magazine/past-issues/specialisation-impacts-the-european-contract-research-services-market/</loc>
		<lastmod>2010-04-29T15:09:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1752/european-pharmaceutical-review-magazine/past-issues/pharmaceutical-analysis-in-drug-development/</loc>
		<lastmod>2010-04-29T15:06:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1749/european-pharmaceutical-review-magazine/past-issues/pharmaceutical-manufacturing-%e2%80%93-for-now-and-the-future/</loc>
		<lastmod>2010-04-29T15:04:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1743/european-pharmaceutical-review-magazine/past-issues/the-state-of-industrial-laboratory-automation/</loc>
		<lastmod>2010-04-29T15:00:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1741/european-pharmaceutical-review-magazine/past-issues/industry-focus-2007/assessing-the-current-proteomics-field/</loc>
		<lastmod>2010-04-29T14:56:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1294/news/featured-news/tecan%e2%80%99s-infinite%c2%ae-offers-the-midas-touch/</loc>
		<lastmod>2010-04-28T10:35:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1297/news/featured-news/tecan-automation-greatly-increases-speed-of-protein-complex-production/</loc>
		<lastmod>2010-04-28T10:35:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1303/news/featured-news/tecan-helps-to-throw-new-light-on-kidney-function/</loc>
		<lastmod>2010-04-28T10:34:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1643/news/featured-news/tecan-%e2%80%93-a-reliable-service-partner-for-nycomed/</loc>
		<lastmod>2010-04-28T10:33:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1682/news/industry-news/algeta-elects-us-experienced-pharma-industry-executives-judith-hemberger-and-kapil-dhingra-to-its-board-of-directors/</loc>
		<lastmod>2010-04-28T09:52:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1239/european-pharmaceutical-review-magazine/past-issues/utilisation-of-secondary-screening/</loc>
		<lastmod>2010-04-28T09:02:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/884/european-pharmaceutical-review-magazine/past-issues/high-content-analysis-roundtable/</loc>
		<lastmod>2010-04-28T08:59:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/terms-conditions/</loc>
		<lastmod>2010-04-28T08:16:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/events/past-events/</loc>
		<lastmod>2010-04-27T16:28:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/events/upcoming-events/</loc>
		<lastmod>2010-04-27T16:27:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/privacy-policy/</loc>
		<lastmod>2010-04-27T16:03:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1440/european-pharmaceutical-review-magazine/past-issues/biomarkers-roundtable/</loc>
		<lastmod>2010-04-27T15:25:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1215/european-pharmaceutical-review-magazine/past-issues/ifpac%e2%80%a6the-first-name-in-pat%e2%80%a6the-essential-name-in-pat/</loc>
		<lastmod>2010-04-27T14:39:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1201/european-pharmaceutical-review-magazine/past-issues/from-data-to-knowledge-through-smart-process-analytical-technologies-pat-and-process-systems-engineering/</loc>
		<lastmod>2010-04-27T14:38:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1196/european-pharmaceutical-review-magazine/past-issues/a-practical-approach-to-microbial-testing-to-support-non-sterile-product-stability/</loc>
		<lastmod>2010-04-27T14:36:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1189/european-pharmaceutical-review-magazine/past-issues/disinfectant-validation/</loc>
		<lastmod>2010-04-27T14:35:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1182/european-pharmaceutical-review-magazine/past-issues/application-of-dsc-and-mdsc-in-the-development-of-freeze-dried-pharmaceuticals/</loc>
		<lastmod>2010-04-27T14:34:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1178/european-pharmaceutical-review-magazine/past-issues/neurotoxicity-in-preclinical-studies/</loc>
		<lastmod>2010-04-27T14:34:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1176/european-pharmaceutical-review-magazine/past-issues/where-science-technology-and-industry-come-together/</loc>
		<lastmod>2010-04-27T14:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1172/european-pharmaceutical-review-magazine/past-issues/the-role-of-liquid-handling-technologies-in-successfully-executing-screening-campaigns/</loc>
		<lastmod>2010-04-27T14:32:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1168/european-pharmaceutical-review-magazine/past-issues/the-original-hca-event-2/</loc>
		<lastmod>2010-04-27T14:31:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1161/european-pharmaceutical-review-magazine/past-issues/development-of-cardiac-cell-based-assays-for-study-of-cardiac-disease-%e2%80%93-in-with-the-new-by-automating-the-old/</loc>
		<lastmod>2010-04-27T14:30:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1158/european-pharmaceutical-review-magazine/past-issues/the-third-annual-stem-cells-world-congress/</loc>
		<lastmod>2010-04-27T14:29:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1151/european-pharmaceutical-review-magazine/past-issues/small-molecule-mediators-of-cell-differentiation-tools-to-generate-tissue-from-stem-cells-for-screening-applications/</loc>
		<lastmod>2010-04-27T14:28:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1148/european-pharmaceutical-review-magazine/past-issues/the-definitive-protein-focused-event/</loc>
		<lastmod>2010-04-27T14:27:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1144/european-pharmaceutical-review-magazine/past-issues/european-prospects-for-proteomics-and-systems-biology/</loc>
		<lastmod>2010-04-27T14:26:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1137/european-pharmaceutical-review-magazine/past-issues/real-time-polymerase-chain-reaction-%e2%80%93-towards-a-more-reliable-accurate-and-relevant-assay/</loc>
		<lastmod>2010-04-27T14:26:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1131/european-pharmaceutical-review-magazine/past-issues/detecting-microrna-targets-or-sirna-off-targets-using-expression-data/</loc>
		<lastmod>2010-04-27T14:25:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1033/european-pharmaceutical-review-magazine/past-issues/pat-roundtable-trends-and-issues/</loc>
		<lastmod>2010-04-27T14:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1015/european-pharmaceutical-review-magazine/past-issues/raman-spectroscopic-techniques-for-biotechnology-and-bioprocessing/</loc>
		<lastmod>2010-04-27T14:15:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1008/european-pharmaceutical-review-magazine/past-issues/itc-affinity-is-not-everything/</loc>
		<lastmod>2010-04-27T14:14:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1002/european-pharmaceutical-review-magazine/past-issues/application-and-optimisation-of-existing-and-emerging-biotechnologies/</loc>
		<lastmod>2010-04-27T14:13:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/997/european-pharmaceutical-review-magazine/past-issues/biomarkers-and-the-tumour-microenvironment/</loc>
		<lastmod>2010-04-27T14:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/995/european-pharmaceutical-review-magazine/past-issues/progress-by-the-proteomics-standards-initiative/</loc>
		<lastmod>2010-04-27T14:10:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/993/european-pharmaceutical-review-magazine/past-issues/cellular-imaging-and-analysis-2009/</loc>
		<lastmod>2010-04-27T14:10:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/986/european-pharmaceutical-review-magazine/past-issues/high-content-analysis-approach-for-targeted-gene-silencing-and-probing-nanoscale-cell-responses/</loc>
		<lastmod>2010-04-27T14:09:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/983/european-pharmaceutical-review-magazine/past-issues/article-1-the-importance-of-sample-quality-for-qpcr/</loc>
		<lastmod>2010-04-27T14:07:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/981/european-pharmaceutical-review-magazine/past-issues/mirna-and-viral-infections-in-vertebrates/</loc>
		<lastmod>2010-04-27T14:06:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/978/european-pharmaceutical-review-magazine/past-issues/the-57th-asms-conference-on-mass-spectrometry/</loc>
		<lastmod>2010-04-27T14:04:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/975/european-pharmaceutical-review-magazine/past-issues/an-international-exhibition-on-chemical-engineering-environmental-protection-and-biotechnology/</loc>
		<lastmod>2010-04-27T14:04:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/962/european-pharmaceutical-review-magazine/past-issues/quality-risk-management-and-the-economics-of-implementing-rapid-microbiological-methods/</loc>
		<lastmod>2010-04-27T14:02:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/959/european-pharmaceutical-review-magazine/past-issues/cia-2009-overview/</loc>
		<lastmod>2010-04-27T14:01:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/944/european-pharmaceutical-review-magazine/past-issues/the-determination-of-structural-changes-of-biopharmaceuticals-during-freeze-drying-using-fourier-transform-infrared-spectroscopy/</loc>
		<lastmod>2010-04-27T13:57:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/942/european-pharmaceutical-review-magazine/past-issues/sbs-15th-annual-conference-and-exhibition/</loc>
		<lastmod>2010-04-27T13:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/939/european-pharmaceutical-review-magazine/past-issues/development-and-implementation-of-an-automated-compound-screening-activities-facility/</loc>
		<lastmod>2010-04-27T13:54:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/930/european-pharmaceutical-review-magazine/past-issues/high-content-screening-and-analysis/</loc>
		<lastmod>2010-04-27T13:52:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/926/european-pharmaceutical-review-magazine/past-issues/stem-cells-roundtable/</loc>
		<lastmod>2010-04-27T13:50:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/919/european-pharmaceutical-review-magazine/past-issues/the-data-cave-a-collaborative-method-for-interpreting-genomic-data/</loc>
		<lastmod>2010-04-27T13:46:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/915/european-pharmaceutical-review-magazine/past-issues/article-2-reverse-transcription-a-necessary-evil/</loc>
		<lastmod>2010-04-27T13:43:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/911/european-pharmaceutical-review-magazine/past-issues/small-non-coding-rnas-as-therapeutics/</loc>
		<lastmod>2010-04-27T13:42:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/905/european-pharmaceutical-review-magazine/past-issues/applying-pat-in-chemical-process-development/</loc>
		<lastmod>2010-04-27T13:40:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/886/european-pharmaceutical-review-magazine/past-issues/concurrent-evaluation-of-both-compendial-and-rapid-methods-atp-bioluminescence-for-monitoring-water-quality-in-pharmaceutical-manufacturing/</loc>
		<lastmod>2010-04-27T13:39:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/880/european-pharmaceutical-review-magazine/past-issues/international-society-for-stem-cell-research/</loc>
		<lastmod>2010-04-27T13:36:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/878/european-pharmaceutical-review-magazine/past-issues/addressing-unmet-needs/</loc>
		<lastmod>2010-04-27T13:35:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/862/european-pharmaceutical-review-magazine/past-issues/cellular-reprogramming-and-its-implications-for-therapeutic-applications/</loc>
		<lastmod>2010-04-27T13:35:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/858/european-pharmaceutical-review-magazine/past-issues/frozen-cells-and-automated-cell-culture/</loc>
		<lastmod>2010-04-27T13:34:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/846/european-pharmaceutical-review-magazine/past-issues/article-3-qpcr-assay-design/</loc>
		<lastmod>2010-04-27T13:33:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/842/european-pharmaceutical-review-magazine/past-issues/6th-joint-bsprebi-proteomics-meeting/</loc>
		<lastmod>2010-04-27T13:32:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/834/european-pharmaceutical-review-magazine/past-issues/quantitative-proteomics-for-systems-biology/</loc>
		<lastmod>2010-04-27T13:31:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/825/european-pharmaceutical-review-magazine/past-issues/biomarkers-in-cns-drug-discovery-and-development-focus-on-molecular-blood-markers/</loc>
		<lastmod>2010-04-27T13:31:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/685/european-pharmaceutical-review-magazine/past-issues/a-successful-meeting-covering-innovative-technologies-for-cell-based-drug-discovery-in-hamburg/</loc>
		<lastmod>2010-04-27T13:08:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/681/european-pharmaceutical-review-magazine/past-issues/the-weakest-link-is-getting-stronger/</loc>
		<lastmod>2010-04-27T13:07:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/675/european-pharmaceutical-review-magazine/past-issues/labautomation2010/</loc>
		<lastmod>2010-04-27T13:06:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/672/european-pharmaceutical-review-magazine/past-issues/lab-automation-roundtable/</loc>
		<lastmod>2010-04-27T13:05:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/664/european-pharmaceutical-review-magazine/past-issues/a-sensitive-and-selective-vibrational-spectroscopy-technique-in-life-sciences/</loc>
		<lastmod>2010-04-27T12:45:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/661/european-pharmaceutical-review-magazine/past-issues/stem-cells-and-regenerative-medicine-world-congress-2010/</loc>
		<lastmod>2010-04-27T12:44:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/658/european-pharmaceutical-review-magazine/past-issues/combining-perspectives-multiscale-integration-of-stem-cell-research/</loc>
		<lastmod>2010-04-27T12:43:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/655/european-pharmaceutical-review-magazine/past-issues/drug-metabolism-and-pharmacokinetics-an-overview/</loc>
		<lastmod>2010-04-27T12:42:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/645/european-pharmaceutical-review-magazine/past-issues/the-original-hca-event/</loc>
		<lastmod>2010-04-27T12:41:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/640/european-pharmaceutical-review-magazine/past-issues/basics-of-image-analysis-in-high-content-screening/</loc>
		<lastmod>2010-04-27T12:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/636/european-pharmaceutical-review-magazine/past-issues/ifpac-2010/</loc>
		<lastmod>2010-04-27T12:40:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/621/european-pharmaceutical-review-magazine/past-issues/process-analytical-technology-pat-in-freeze-drying-tunable-diode-laser-absorption-spectroscopy-as-an-evolving-tool-for-cycle-monitoring/</loc>
		<lastmod>2010-04-27T12:39:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/613/european-pharmaceutical-review-magazine/past-issues/contributing-to-the-sustainability-of-the-uk-chemicals-and-pharmaceuticals-industries/</loc>
		<lastmod>2010-04-27T11:30:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/611/european-pharmaceutical-review-magazine/past-issues/microbiological-quality-for-non-sterile-drug-product-for-the-21st-century/</loc>
		<lastmod>2010-04-27T11:29:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/608/european-pharmaceutical-review-magazine/past-issues/2009-a-landmark-year-for-stem-cells/</loc>
		<lastmod>2010-04-27T11:28:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/606/european-pharmaceutical-review-magazine/past-issues/the-changing-landscape-of-automation-in-pre-clinical-drug-discovery/</loc>
		<lastmod>2010-04-27T11:28:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/600/european-pharmaceutical-review-magazine/past-issues/digital-polymerase-chain-reaction-new-diagnostic-opportunities/</loc>
		<lastmod>2010-04-27T11:28:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1075/european-pharmaceutical-review-magazine/past-issues/the-increasing-use-of-microbial-genotypic-techniques-for-the-identification-of-pharmaceutical-isolates/</loc>
		<lastmod>2010-04-27T11:27:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1071/european-pharmaceutical-review-magazine/past-issues/2008-pat-initiative-review/</loc>
		<lastmod>2010-04-27T11:26:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1066/european-pharmaceutical-review-magazine/past-issues/the-changing-role-of-automation-in-high-throughput-screening/</loc>
		<lastmod>2010-04-27T11:26:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1063/european-pharmaceutical-review-magazine/past-issues/future-trends-for-proteomics/</loc>
		<lastmod>2010-04-27T11:25:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1060/european-pharmaceutical-review-magazine/past-issues/stem-cell-research-and-therapeutic-innovation-not-always-a-long-term-perspective/</loc>
		<lastmod>2010-04-27T11:25:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1058/european-pharmaceutical-review-magazine/past-issues/what-the-future-holds-for-real-time-pcr/</loc>
		<lastmod>2010-04-27T11:24:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1494/european-pharmaceutical-review-magazine/past-issues/p-mec-europe-where-technology-meets-ambition/</loc>
		<lastmod>2010-04-27T10:51:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1492/european-pharmaceutical-review-magazine/past-issues/product-and-process-optimization/</loc>
		<lastmod>2010-04-27T10:48:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1485/european-pharmaceutical-review-magazine/past-issues/key-aspects-to-a-successful-implementation-in-pharmaceutical-manufacturing/</loc>
		<lastmod>2010-04-27T10:44:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1479/european-pharmaceutical-review-magazine/past-issues/a-significant-comparison-between-collapse-and-glass-transition-temperatures/</loc>
		<lastmod>2010-04-27T10:37:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1477/european-pharmaceutical-review-magazine/past-issues/pharmig-16th-annual-conference-latest-updates-and-hot-topics-in-microbiology/</loc>
		<lastmod>2010-04-27T10:29:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1475/european-pharmaceutical-review-magazine/past-issues/recent-development-in-rapid-microbiology-methods/</loc>
		<lastmod>2010-04-27T10:25:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1473/european-pharmaceutical-review-magazine/past-issues/europe%e2%80%99s-leading-biotech-industry-event/</loc>
		<lastmod>2010-04-27T10:21:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1466/european-pharmaceutical-review-magazine/past-issues/human-embryonic-stem-cells-progress-in-culture-and-maintenance/</loc>
		<lastmod>2010-04-27T10:18:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1458/european-pharmaceutical-review-magazine/past-issues/addressing-kinetic-applications-in-high-content-screening/</loc>
		<lastmod>2010-04-27T10:05:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1453/european-pharmaceutical-review-magazine/past-issues/europe%e2%80%99s-premier-event-for-drug-discovery/</loc>
		<lastmod>2010-04-27T09:57:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1446/european-pharmaceutical-review-magazine/past-issues/applying-automation-in-early-drug-discovery-lessons-learnt-and-future-perspectives/</loc>
		<lastmod>2010-04-27T09:51:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1433/european-pharmaceutical-review-magazine/past-issues/quest-for-a-new-generation-of-biomarkers-using-quantitative-proteomics/</loc>
		<lastmod>2010-04-27T09:41:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1426/european-pharmaceutical-review-magazine/past-issues/a-unique-theme-conference-and-exhibition-in-the-micrornomics/</loc>
		<lastmod>2010-04-27T09:36:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1416/european-pharmaceutical-review-magazine/past-issues/there-is-more-to-qpcr-than-the-pcr-reaction/</loc>
		<lastmod>2010-04-27T09:29:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1406/european-pharmaceutical-review-magazine/past-issues/computational-prediction-of-microrna-and-targets/</loc>
		<lastmod>2010-04-27T09:21:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1403/european-pharmaceutical-review-magazine/past-issues/industry-insight-exceeding-innovation-excellence/</loc>
		<lastmod>2010-04-27T09:12:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1378/european-pharmaceutical-review-magazine/past-issues/quality-by-design-validation-and-pat-operational-statistical-and-engineering-perspectives/</loc>
		<lastmod>2010-04-27T09:07:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1372/european-pharmaceutical-review-magazine/past-issues/advanced-aseptic-processing-rabs-and-isolator-operations/</loc>
		<lastmod>2010-04-26T16:15:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1358/european-pharmaceutical-review-magazine/past-issues/fast-scan-differential-scanning-calorimetry/</loc>
		<lastmod>2010-04-26T16:10:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1351/european-pharmaceutical-review-magazine/past-issues/chromatin-cracking-the-chemical-code/</loc>
		<lastmod>2010-04-26T15:57:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1349/european-pharmaceutical-review-magazine/past-issues/drug-discovery-2008/</loc>
		<lastmod>2010-04-26T15:49:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1345/european-pharmaceutical-review-magazine/past-issues/information-automation-in-r-past-and-future/</loc>
		<lastmod>2010-04-26T15:44:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1339/european-pharmaceutical-review-magazine/past-issues/live-cell-high-content-screening-in-drug-development/</loc>
		<lastmod>2010-04-26T15:34:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1337/european-pharmaceutical-review-magazine/past-issues/hupo-2008-%e2%80%93-proteome-biology/</loc>
		<lastmod>2010-04-26T15:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1331/european-pharmaceutical-review-magazine/past-issues/accessing-stem-cells-via-proteomics/</loc>
		<lastmod>2010-04-26T15:16:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1329/european-pharmaceutical-review-magazine/past-issues/7th-hupo-world-congress/</loc>
		<lastmod>2010-04-26T15:07:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1325/european-pharmaceutical-review-magazine/past-issues/industry-insight-an-interview-with-s%c3%b8ren-morgenthaler-echwald/</loc>
		<lastmod>2010-04-26T15:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1323/european-pharmaceutical-review-magazine/past-issues/rnai-europe-advances-in-qpcr/</loc>
		<lastmod>2010-04-26T14:55:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1319/european-pharmaceutical-review-magazine/past-issues/real-time-quantitative-pcr-%e2%80%93-opportunities-and-pitfalls/</loc>
		<lastmod>2010-04-26T14:45:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1313/european-pharmaceutical-review-magazine/past-issues/rnai-therapeutics-addressing-targets/</loc>
		<lastmod>2010-04-26T14:36:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/300/news/featured-news/ogt-introduces-new-array-cgh-interpretation-software/</loc>
		<lastmod>2010-04-26T12:42:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1300/news/featured-news/clients-win-with-crl-global-services-integrated-structure/</loc>
		<lastmod>2010-04-26T10:33:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1285/european-pharmaceutical-review-magazine/past-issues/pat-%e2%80%93-reducing-the-cost-of-quality-in-consumer-products-manufacturing/</loc>
		<lastmod>2010-04-26T09:00:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1283/european-pharmaceutical-review-magazine/past-issues/implementation-validation-and-registration-of-rapid-microbiological-methods/</loc>
		<lastmod>2010-04-26T08:55:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1276/european-pharmaceutical-review-magazine/past-issues/micrornas-for-high-throughput-functional-analysis/</loc>
		<lastmod>2010-04-26T08:51:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1274/european-pharmaceutical-review-magazine/past-issues/expo-sets-a-new-standard-in-pat-implementation/</loc>
		<lastmod>2010-04-26T08:34:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1272/european-pharmaceutical-review-magazine/past-issues/wyeth%e2%80%99s-pat-variations-submitted-through-the-emea-worksharing-procedure/</loc>
		<lastmod>2010-04-26T08:30:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1263/european-pharmaceutical-review-magazine/past-issues/lyophilization-cycle-robustness-and-process-tolerances-transfer-and-scale-up/</loc>
		<lastmod>2010-04-26T08:24:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1261/european-pharmaceutical-review-magazine/past-issues/siemens-innovation-industry-and-implementation/</loc>
		<lastmod>2010-04-26T08:08:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1251/european-pharmaceutical-review-magazine/past-issues/peracetic-acid-in-the-study-of-rhil-11-methionine-oxidation/</loc>
		<lastmod>2010-04-23T14:31:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1245/european-pharmaceutical-review-magazine/past-issues/platform-technology-for-routine-three-dimensional-cell-culture/</loc>
		<lastmod>2010-04-23T14:13:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1241/european-pharmaceutical-review-magazine/past-issues/in-vitro-toxicity-screening-as-pre-selection-tool/</loc>
		<lastmod>2010-04-23T13:57:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1234/european-pharmaceutical-review-magazine/past-issues/high-content-imaging-subpopulation-analysis-for-phenotypic-drug-discovery/</loc>
		<lastmod>2010-04-23T13:44:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1228/news/industry-news/ims-forecasts-global-pharmaceutical-market-growth-of-5-8-annually-through-2014-maintains-expectations-of-4-6-growth-in-2010/</loc>
		<lastmod>2010-04-22T14:00:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1218/news/industry-news/cresset-announces-appointment-of-rob-scoffin-as-new-ceo/</loc>
		<lastmod>2010-04-22T13:50:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1127/european-pharmaceutical-review-magazine/past-issues/maldi-ft-icr-ms-platform-for-proteomics-rationale-for-an-offline-approach-and-optimised-implementation/</loc>
		<lastmod>2010-04-21T15:34:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1062/european-pharmaceutical-review-magazine/past-issues/rnai-therapeutics-for-neurodegenerative-disease-challenges-and-prospects/</loc>
		<lastmod>2010-04-21T10:30:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1119/european-pharmaceutical-review-magazine/past-issues/pat-not-a-purpose-in-itself/</loc>
		<lastmod>2010-04-21T10:30:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1115/european-pharmaceutical-review-magazine/past-issues/thermal-analysis-and-calorimetry-latest-developments/</loc>
		<lastmod>2010-04-21T10:25:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1112/european-pharmaceutical-review-magazine/past-issues/test-method-validation-for-cleaning-validation-samples/</loc>
		<lastmod>2010-04-21T10:19:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1110/european-pharmaceutical-review-magazine/past-issues/industry-insight-%e2%80%93-idbs-integrated-framework/</loc>
		<lastmod>2010-04-21T10:14:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1108/european-pharmaceutical-review-magazine/past-issues/going-paperless-is-now-the-time/</loc>
		<lastmod>2010-04-21T10:11:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1102/european-pharmaceutical-review-magazine/past-issues/high-content-screening-as-improved-lead-finding-strategy/</loc>
		<lastmod>2010-04-21T10:07:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1093/european-pharmaceutical-review-magazine/past-issues/personalised-medicine-are-we-ready-for-the-revolution/</loc>
		<lastmod>2010-04-21T10:02:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1085/european-pharmaceutical-review-magazine/past-issues/antibody-based-proteomics-to-study-cellular-signalling-networks/</loc>
		<lastmod>2010-04-21T09:49:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1081/european-pharmaceutical-review-magazine/past-issues/the-role-of-chemokines-in-type-1-diabetes-as-assessed-by-rt-pcr/</loc>
		<lastmod>2010-04-21T09:29:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1073/european-pharmaceutical-review-magazine/past-issues/night-on-highway-128/</loc>
		<lastmod>2010-04-21T09:20:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1055/european-pharmaceutical-review-magazine/past-issues/pat-a-comprehensive-guide/</loc>
		<lastmod>2010-04-21T08:49:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1049/european-pharmaceutical-review-magazine/past-issues/pqli-%e2%80%93-providing-practical-solutions/</loc>
		<lastmod>2010-04-21T08:40:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1041/european-pharmaceutical-review-magazine/past-issues/trends-in-pharmaceutical-cleanroom-technology/</loc>
		<lastmod>2010-04-20T16:33:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1037/european-pharmaceutical-review-magazine/past-issues/microbiology-microbiologists-%e2%80%93-where-next/</loc>
		<lastmod>2010-04-20T16:23:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1020/european-pharmaceutical-review-magazine/past-issues/high-throughput-materials-discovery-reducing-product-time-to-market/</loc>
		<lastmod>2010-04-20T16:20:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1013/european-pharmaceutical-review-magazine/past-issues/genome-wide-high-content-analysis-of-cellular-pathways/</loc>
		<lastmod>2010-04-20T16:12:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1009/european-pharmaceutical-review-magazine/past-issues/proteomics-in-the-pharmaceutical-industry-is-the-analytical-challenge-just-too-large/</loc>
		<lastmod>2010-04-20T16:07:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/1000/european-pharmaceutical-review-magazine/past-issues/size-does-matter-macro-ncrnas-and-the-regulation-of-imprinted-gene-clusters/</loc>
		<lastmod>2010-04-20T16:04:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/871/european-pharmaceutical-review-magazine/past-issues/cros-as-a-strategic-fit-%e2%80%93-the-one-stop-shop-for-rd-services/</loc>
		<lastmod>2010-04-20T10:49:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/822/european-pharmaceutical-review-magazine/past-issues/genomics-for-the-new-biomedicine/</loc>
		<lastmod>2010-04-20T10:37:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/868/european-pharmaceutical-review-magazine/past-issues/pharmaceutical-analysis-in-quality-control/</loc>
		<lastmod>2010-04-20T10:34:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/850/european-pharmaceutical-review-magazine/past-issues/qbd-and-pat-%e2%80%93-2008-is-the-year-it-goes-mainstream/</loc>
		<lastmod>2010-04-20T10:32:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/845/european-pharmaceutical-review-magazine/past-issues/quo-vadis-laboratory-automation-education/</loc>
		<lastmod>2010-04-20T10:16:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/827/european-pharmaceutical-review-magazine/past-issues/mass-spectrometry-based-proteomics-trends-in-tools-and-strategies/</loc>
		<lastmod>2010-04-20T10:02:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/134/european-pharmaceutical-review-magazine/past-issues/article-6-qpcr-data-analysis-2-controls-and-troubleshooting/</loc>
		<lastmod>2010-04-15T13:09:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/124/news/industry-news/healthcare-cfo%e2%80%99s-v-tach-on-obama%e2%80%99s-healthcare-reform/</loc>
		<lastmod>2010-04-14T14:04:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/287/company-directory/natoli-engineering-company-inc/</loc>
		<lastmod>2010-04-14T13:09:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/174/company-directory/bmg-labtech-gmbh/</loc>
		<lastmod>2010-04-14T12:53:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/280/company-directory/horiba-scientific/</loc>
		<lastmod>2010-04-14T12:46:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/284/company-directory/idbs/</loc>
		<lastmod>2010-04-14T12:46:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/421/company-directory/waters-corporation/</loc>
		<lastmod>2010-04-14T12:44:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/414/news/featured-news/acumen%c2%ae-ex3-viable-alternative-for-fmat-analysis/</loc>
		<lastmod>2010-04-14T11:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/406/news/featured-news/ttp-labtech-launches-new-high-content-contract-screening-service/</loc>
		<lastmod>2010-04-14T11:25:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/295/news/featured-news/ogt-expands-cytosure%e2%84%a2-acgh-offering-with-high-resolution-duchenne-muscular-dystrophy-array/</loc>
		<lastmod>2010-04-13T16:19:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/216/news/featured-news/tyvek%c2%ae-and-tychem%c2%ae-protecting-against-cytostatic-contamination/</loc>
		<lastmod>2010-04-13T14:39:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/203/news/featured-news/copley-scientific-to-introduce-new-automation-device-for-inhaled-product-testing-at-rdd-2010/</loc>
		<lastmod>2010-04-13T14:08:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/120/news/industry-news/owen-mumford-appoints-paula-staples-as-global-head-of-quality/</loc>
		<lastmod>2010-04-08T14:46:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/subscribe/silver-membership/</loc>
		<lastmod>2010-04-07T14:00:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/wishlist-member/</loc>
		<lastmod>2000-01-01T00:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/a-van-schepdael/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aaron-garrett/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aaron-miller/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abb/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abbott/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abbott-glaxosmithkline-biologicals-s-a/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abina-m-crean/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abingworth-llp/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abrf/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/abs-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/accelrys/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/accord-healthcare-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ace-biosciences/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/achema/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/achim-kaufhold/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/achim-von-leoprechting/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/acolyte-biomedica-ltd/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/acr-image-metrix/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/actavis/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/acura-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/adam-h-schechter/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/adam-schechter/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/adam-sims/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/adrian-tersteegen/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aerial-%e2%80%93-crt/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aes-chemunex/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aesica/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aesica-pharmaceuticals/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/afatinib/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/afif-abdel-nour/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/afinitor/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/agilebio/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/agilent/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/agilent-technologies/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/agne-lieden/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aidas-kriauciunas/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aideen-long/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aisling-burnand/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ajit-jadhav/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/akihisa-harada/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/al-ivens/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alain-hedoux/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alan-garber/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alan-lamont/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alan-moses/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alan-raymond/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alastair-compston/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/albert-einstein-college-of-medicine/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/albert-kim/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alcon-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ales-vancura/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alex-brindle/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alex-zukiwski/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexander-eggermont/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexander-scheer/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexander-w-bell/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexandra-staerk/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexandre-manguele/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexandre-merieux/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexandre-williams/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alexis-borisy/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alfred-sandrock/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/algeta-asa/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ali-afnan/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ali-pervez/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alistair-j-florence/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alkermes/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/allen-melemed/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/allen-s-melemed/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/almac/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/almsco-international/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/altana-pharma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/altonyx-consulting/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/altus-pharma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/alzheimers/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amancio-carnero/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amanda-lund/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amarin-corporation-plc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ambit-biosciences/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ameet-mallik/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ametek-process-instruments/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amgen/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amicus-therapeutics/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amin-forootan/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amira-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amorphous-content-quantification/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amphora-discovery/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amy-buck/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amy-mcdaniel/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amy-schulman/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amylin-pharmaceuticals/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/amylin-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anadys-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/analytica/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/analytical-techniques/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/analytik/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anand-gumaste/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anastrozole/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anders-ekblom/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anders-gersel-pedersen/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anders-grahnen/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anders-p-wiklund/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrea-becarri/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andreas-barner/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andreas-busch/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andreas-huhmer/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andreas-penk/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andreas-vogt/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-a-parsons/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-chadwick/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-crockett/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-fire/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-kay/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-lansley/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-lloyd/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-middleton/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-mitchell/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-packman/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-r-blight/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-riches/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrew-witty/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andrin-oswald/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andromeda-biotech/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-chang/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-kemp/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-sandham/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-scaife/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-sutton/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-thomson/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/andy-vinter/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/angela-bauch/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/angloscientific/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anirvan-ghosh/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ann-f-hoffman/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ann-goodspeed/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ann-van-schepdael/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anna-chira-de-luca/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anna-gluskin/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anna-lok/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/annalisa-jenkins/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anne-c-moore/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anne-c-whitaker/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anne-katrin-werenskiold/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anne-kopf-sill/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anne-marie-zuurmond/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/annette-v-clancy/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-barnett/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-c-hooper/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-costello/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-davies/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-hooper/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-j-coyle/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-m-cundell/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-mcelligott/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-murphy/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anthony-ryan/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/antibody-microarrays/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/antivirals/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/anton-j-enright/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/antonia-carruthers/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/apixaban/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/applied-biosystems/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/applied-precision-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/appointments/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/argen-x-bv/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/argenta/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ariad-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aripiprazole/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arizona-state-university-asu/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arnd-kaldowski/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arnold-verbeek/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/artemis-pharmaceuticals/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arthur-kavanaugh/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arthur-r-smith/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/arya-m-sharma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aseptic-processing/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ash-khorzad/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/ashoka/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aslan-pharmaceuticals-pte-ltd/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/asms/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/association-for-laboratory-automation-ala/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/asta-zubriene/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astellas-pharma-europe-ltd-apel/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astellas-pharma-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astm-international/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astra-tech/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astrazeneca/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/astrazeneca-rd/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atherosclerosis/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/athos-gianella-borradori/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atilla-a-seyhan/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atorvastatin/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atrial-fibrillation/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atsushi-nagai/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/atta-behfar/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/attana-ab/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/attila-a-seyhan/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/audion-therapeutics-audion/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/australian-therapeutic-goods-administration-tga/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/autifony-therapeutics-limited/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/auto-q-biosciences/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/autophagy/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/avacta-analytical/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/avacta-group/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/avandia/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/aveo-pharmaceuticals-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/avid-radiopharmaceuticals/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bw-tek-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/babur-z-chowdhry/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bahija-jallal/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/barry-j-goldstein/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bart-hazes/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/baxter-healthcare/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bayer-schweiz-ag/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bayer-healthcare/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bayer-materialscience/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bayer-schering-pharma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bayer-zydus-pharma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bbsrc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bd-biosciences/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beat-riederer/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beatrice-cazala/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beatson-institute-for-cancer-research/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/becki-davis/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beckman-coulter-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beckman-research-institute-of-the-city-of-hope/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/belatacept/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bend-research-inc/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bengt-ljungqvist/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/benjamin-eshun/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bergamo/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/berit-reinmuller/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernard-faller/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernard-pecoul/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernd-c-kieseier/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernd-renger/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernd-rinn/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernhard-kirschbaum/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernhard-rupp/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernhard-schrader/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bernie-treidl/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bert-klebl/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bertil-samuelsson/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/beth-schodin/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bhupinder-bhullar/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bicycle-therapeutics/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bikash-chatterjee/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bill-dawson/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bill-gates/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bill-wedlake/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bill-weldon/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/billy-bullock/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bio-farma/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bio-rad/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/biocity-nottingham/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/biocom/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.europeanpharmaceuticalreview.com/tag/bioden-idec/</loc>
		<changefreq>weekly</changefreq>
	
